Molecular mechanisms regulating NMDA receptor trafficking by Tang, Tina Tze-Tsang
                          
This electronic thesis or dissertation has been





Molecular mechanisms regulating NMDA receptor trafficking
General rights
The copyright of this thesis rests with the author, unless otherwise identified in the body of the thesis, and no quotation from it or information
derived from it may be published without proper acknowledgement. It is permitted to use and duplicate this work only for personal and non-
commercial research, study or criticism/review. You must obtain prior written consent from the author for any other use. It is not permitted to
supply the whole or part of this thesis to any other person or to post the same on any website or other online location without the prior written
consent of the author.
Take down policy
Some pages of this thesis may have been removed for copyright restrictions prior to it having been deposited in Explore Bristol Research.
However, if you have discovered material within the thesis that you believe is unlawful e.g. breaches copyright, (either yours or that of a third
party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation,
libel, then please contact: open-access@bristol.ac.uk and include the following information in your message:
• Your contact details
• Bibliographic details for the item, including a URL
• An outline of the nature of the complaint
On receipt of your message the Open Access team will immediately investigate your claim, make an initial judgement of the validity of the
claim, and withdraw the item in question from public view.
Molecular Mechanisms Regulating NMDA Receptor Trafficking 
Tina Tze-Tsang Tang 
Thesis submitted in fulfillment of the degree of Doctor of Philosophy 
September 2009 
Department of Anatomy 
Faculty of Medical & Veterinary Sciences 
University of Bristol 
Abstract 
The modulation of the NMDA receptor (NMDAR) abundance at excitatory 
synapses is crucial in regulating synaptic plasticity. Functional NMDARs are 
tetramers composed of obligatory NRI and regulatory NR2 and/ or NR3 subunits. 
Endogenous NMDARs are composed of diheteromeric- (NRl/NR2A, NR1/NR2B) 
as well as triheteromeric assemblies. However, the relative contribution of each 
subunit to the trafficking of a triheteromeric complex is not understood. Here, I 
designed an approach based on the dimeric feature of the class II major 
histocompatibility complex (MHCII), in which MHCII a and ß chains must dimerise 
to exit the ER and traffic to the cell surface. I created chimeras of MHCII a or ß 
chains appended to the NR2A /NR2B C-termini to study the relative contributions of 
the C-termini of NR2 subunits and I found that the endocytic trafficking of NMDA 
receptors is dependent on the combination of NR2 subunits. It is surprising that 
trafficking of heteromeric NR2A/NR2B chimeras is same as homomeric NR2B, but 
not NR2A dimers. These findings suggest a dominant role for the NR2B C-terminus 
in regulating the trafficking of triheteromeric NMDARs in vivo. 
Abnormalities in NMDAR function have been implicated in schizophrenia. My 
experiments utilising dysbindin null mice (Dys-/-) show that dysbindin, a 
schizophrenia-susceptibility gene widely expressed in the forebrain, controls the 
surface expression of NMDAR in a subunit-specific manner. 'A combination of 
imaging, biochemical and electrophysiological analyses revealed a marked increase 
in cell surface NR2A, but not NR2B, in Dys-/- hippocampal neurones. Synaptic 
plasticity in Dys-/- hippocampal slices is also altered, with significant enhancement 
in LTP, whereas LTD is unaffected. These data reflect that dysbindin controls 
hippocampal LTP by selective regulation of surface-expressed NR2A. ;, 
My findings in this thesis define novel roles for the NR2B C-terminus in 
regulating the preferential trafficking of triheteromeric NMDARs. My findings also 
reveal an unexpected link between NMDARs and dysbindin, which may contribute 
to the molecular mechanisms underlying the aetiology and pathophysiology of 
schizophrenia and the related cognitive impairments. 
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"The task of neural science is to explain behaviour in terms of the activities of the brain. 
How does the brain marshal its millions of individual nerve cells to produce behaviour, 
and how are these cells influenced by the environment? " - Eric Kandel, Principles of 
Neural science, fourth edition. 
The study of the brain began centuries ago, but only in recent decades, due to the 
advancement in molecular biology, electrophysiology and computational technology, 
has it been possible to study the nervous system using a broad range of disciplines. 
These varied approaches include biochemical and genetic analyses based on the 
constituents of individual cells and the molecular mechanisms of cell-cell interactions, 
as well as functional imaging and electrophysiology used to analyse neural circuitry 
representing the perceptual and motor co-ordination of the brain. However, our 
understanding of the development function and plasticity of the nervous system still 
remains relatively naive compare to other systems. Important questions remain 
unanswered, including the fine-tuning and the co-ordination of distinct circuitries and 
regions in the brain, as well as the pathophysiology of neurological diseases and 
disorders, which affect so many but are only poorly understood. 
1.1.1. Neurones and synaptic transmission 
Astonishing discoveries were made in the early twentieth century, including the 
groundbreaking histological work by Ramon y Cajal using the silver staining method. 
He was the first to illustrate the fact that the nervous system was composed of a network 
of individual and autonomous cells, neurones, rather than a large continuous web, a 
belief which had predominated in the past (Ram6n y Cajal, 1906). His findings were 
later referred to as the neurone doctrine, the idea that neurones are the basic structural 
and functional units of the nervous system. The discoveries of chemical synapses and 
the related synaptic transmission, which involves the elementary form of signal 
transduction from a pre-synaptic neurone to a single postsynaptic cell, were other 
landmark discoveries made in the field of neuroscience. It was well established that 
signal conduction along neurones involves electrical activity; however, it was not easily 
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conceivable that information was propagated in between neurones rather than conducted, 
due to the fast speed of neuronal transmission. The early characterisation of how a 
chemical signal could generate electrical activities in synapses was shown by Loewi on 
cholinergic transmission from the vagus nerve to cardiac muscle in the heart (Loewi and 
Navratil, 1926). Since the discovery of acetylcholine (Ach) as a neurotransmitter being 
released by the axonal terminal into the synaptic cleft and subsequently bound by 
nicotinic receptors on the postsynaptic membrane, many other neurotransmitters have 
been identified including dopamine (Carlsson and Waldeck, 1958) and glutamate 
(Hayashi, 1954). While the general principle of synaptic transmission at the 
neuromuscular junction also applies in the central nervous system (CNS), neurones in 
the CNS receive input from a number of presynaptic neurones whereas a single muscle 
fibre is innervated by just one motor neurone. Moreover, synaptic transmission in the 
CNS can be either excitatory or inhibitory, and it is well established that glutamate is the 
major excitatory neurotransmitter in the CNS. 
1.1.2. Glutamate 
The excitatory action of the amino acid, L-glutamate (glutamic acid), was first 
demonstrated in the early 1950s with the observation that an injection of glutamate into 
motor cortex produced convulsions in animals (Hayashi, 1954). A few years later, Curtis 
et al. found that glutamate induced depolarisation and increased firing rate in spinal 
neurones (Curtis et al., 1959). Subsequent findings showed that the depolarization 
induced by glutamate is the result of sodium ion influx (Curtis et al., 1972; Hosli et al., 
1973). Glutamate is released into the synaptic cleft from the presynaptic nerve endings 
upon depolarization, and binds to glutamate receptors on the postsynaptic membrane 
(Hamberger et al., 1978; Hamberger et al., 1979; Nadler et al., 1976). 
1.1.3 Mammalian glutamate receptors 
Based on electrophysiological and pharmacological advances, the identification of 
multiple receptor subtypes for glutamate in the brain preceded definitive evidence for 
their distinct synaptic function. The evidence for different receptor subtypes for 
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glutamate came initially from the observation that different subsets of neurones showed 
differences in the relative potencies to a number of agonists (Duggan, 1974; McCulloch 
et al., 1974). Studies of Mg 2+ sensitivities first subdivided ionotropic glutamate receptors 
into NMDA receptors and non-NMDA receptors. Non-NMDA receptors were further 
subdivided into kainate and quisqualate subtypes according to their sensitivities to the 
analogues of glutamate: NMDA, quisqualate and kainate (Davies et al., 1981; Evans et 
al., 1979). Later it was discovered that quisqualate also activated another subset of 
glutamate receptors, the G-protein-coupled metabotropic receptors (Nicoletti et al., 
1986; Sladeczek et al., 1985), the ionotropic quisqualate receptors were renamed AMPA 
receptors because of the discovery of a more selective agonist a-amino-3-hydroxy-5- 
methyl-4-isoxazolepropionate (AMPA) (Krogsgaard-Larsen et al., 1980). Therefore, in 
mammalian brain, glutamate receptors are subdivided in to metabotropic (mGluR) and 
ionotropic (iGluR) receptors according to their functional properties. iGluRs have been 
shown to mediate fast excitatory neurotransmission, whereas mGluRs are coupled to G- 
proteins and mediate signaling events and have modulatory roles in synaptic 
transmission. 
Glutamate receptor subtypes are widely expressed in the CNS and are critically 
important for normal brain function. Glutamate receptors are involved in plastic changes 
at synapses: long-term potentiation (LTP) and long-term depression (LTD), which are 
thought to underlie learning and memory in brain. Non-NMDARs mediate the majority 
of fast excitatory neurotransmission, whereas NMDARs are critical in triggering 
synaptic plasticity at silent synapses (Watkins and Jane, 2006). Understanding the role 
of glutamate receptors in regulating synaptic plasticity has become one of the most 
active areas of research because understanding the role of these receptors may be useful 
in identifying therapeutic targets in diseases associated with deficits in learning and 
memory formation. 
Ionotropic glutamate receptors also play an important role in development of the CNS. 
Expression of glutamate receptors appear to be regulated over synaptogenesis, and 
experience during development has been shown to alter topographical maps in the visual 
system in a NMDAR-dependent manner (Constantine-Paton et al., 1990). In recent 
22 
decades, there have been remarkable advances in our understanding of the physiological 
function and molecular structure of glutamate receptor subtypes. 
1.2. Molecular characterisation of glutamate receptors 
1.2.1. Cloning of glutamate receptor subunits 
The conventional method for neurotransmitter receptor cloning consisted of the 
purification of the receptor protein to obtain partial protein sequences for making 
oligonucleotide probes for screening a cDNA library. However, this method did not 
work for functional glutamate receptors largely due to the lack of high affinity and 
specific ligands suitable for receptor purification. Ultimately, functional expression 
cloning was used to clone glutamate receptors. This approach employed the injection of 
mRNAs encoded by a cDNA library into oocytes and screening for functional receptors 
using a combination of molecular biological and electrophysiological techniques. This 
technique was used to identify the first glutamate receptor subunit, GluRl (Hollmann et 
al., 1989), NMDAR subunit, NR1 (Moriyoshi et al., 1991) and metabotropic receptor, 
mGluR1 (Houamed et al., 1991; Masu et al., 1991). Based on the information obtained 
from the first clone, standard homology, polymerase-chain reaction (PCR)-mediated 
screening identified further related receptor subunits to reveal a large family of 
glutamate receptors (Hollmann and Heinemann, 1994). 
1.2.1.1 Cloning of AMPAR subunits 
Four AMPAR subunits have been cloned, GluRI- G1uR4 (Bettler et al., 1990; Boulter et 
al., 1990; Hollmann et al., 1989) or GluR A- G1uR D (Keinanen et al., 1990), which are 
of similar size with approximately 900 amino acids and share 68- 73% amino acid 
sequence identity. 
1.2.1.2 Cloning of Kainate receptor subunits 
Using a high homology region between G1uR1-G1uR4, another three receptor subunits 
were cloned, termed G1uR5- G1uR7 (Bettler et al., 1990; Bettler et at., 1992; Egebjerg et 
at., 1991; Schiffer et at., 1997). Since they only share 40% of sequence identity with 
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G1uR1-G1uR4 and have low affinity for the ligand, they were set apart as a distinct 
group of receptors called low affinity kainate receptor (KAR). Another two KAR 
subunits were cloned, KAI and KA2 (Herb et al., 1992; Werner et al., 1991), which 
share 68% homology but only approximately 37% with G1uR1- G1uR4 and 43% with 
G1uR5- GluR7. KAI-2 show high affinity to kainate, and therefore were classified as a 
distinct subtype of KAR, termed high affinity KAR (Herb et al., 1992; Kamboj et al., 
1992; Sakimura et al., 1992; Werner et al., 1991). Each KAR subunit comprises 
approximately 900 amino acids and has a molecular weight of approximately 100 kDa 
(Hollmann and Heinemann, 1994). 
1.2.1.3. Cloning of NMDAR subunits 
The first NMDAR subunit, NR1 was identified using the expression cloning method 
(Moriyoshi et al., 1991). Thereafter, several groups also cloned NR1 and showed that 
NR1 only shares 22-29% sequence homology with other AMPAR and KAR subunits 
and is slightly larger consisting of 920 amino acids (Nakanishi, 1992; Yamazaki et al., 
1992). Another four NMDAR subunits, NR2A-NR2D, were subsequently cloned. They 
share considerable homology with each other (42-56% amino acid sequence homology) 
but low homology to AMPAR and KAR subunits (21-27% identity) and even the NR1 
subunit (26-27% identity), thus they established a new subfamily of iGluR (Ikeda et al., 
1992; Meguro et al., 1992; Monyer et al., 1992). Several years later, the final group of 
NMDAR was identified which was first named as chi-1 (Ciabarra et al., 1995) or 
NMDAR-like subunit (NMDAR-L) (Sucher et al., 1995). They share 47% sequence 
homology with each other but share less sequence homology with NR1 and NR2 (17- 
21%), and other non-NMDAR families (13-16% identity). Subsequently, it was renamed 
NR3, which comprises two subunits, NR3A and NR3B (Chatterton et al., 2002; Das et 
al., 1998). They are slightly larger than NR1 consisting 1002 amino acids. 
1.2.1.4 Cloning of metabotropic glutamate receptor subunits 
The first metabotropic glutamate receptor, mG1uR1, was also cloned using an expression 
cloning method (Houamed et al., 1991; Masu et al., 1991). Surprisingly, mGluRI has 7 
transmembrane domains (TMD), but shares very little sequence homology with other G- 
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protein-coupled receptors. mGluRs are considered large proteins which consist of 854- 
1179 a. a. The other 7 mGluR subunits were cloned subsequently, named mGluR2 - 
mGluR8 (Abe et al., 1992; Duvoisin et al., 1995; Joly et al., 1995; Minakami et al., 1994; 
Nakajima et al., 1993; Okamoto et al., 1994; Pin et al., 1992; Saugstad et al., 1994; 
Tanabe et al., 1992). mGluR subunits are divided into three subgroups according to their 
sequence similarities, signal transduction mechanisms, and pharmacological properties: 
1. Group I mGluRs comprise mGluRl and mGluR5. 
2. Group II mGluRs comprise mGluR2 and mGluR3. 
3. Group III mGluRs comprise mGluR4, mGluR6, mGluR7 and mGluR8 
mGluRs share approximately 70% sequence homology within the same group, but only 
approximately 45% between groups. 
Glutamate Receptors 
lonotropic Glutamate Receptors Metabotropic Glutamate Receptors 
AMPARs NMDARs KARs mGluRl mGIuR2 mGluR4 
mGluR5 mGIuR3 mGluR6 
GIuR1 
NRI 
NR2A NR3A GIuR5 KAI mGIuR7 GIuR2 NR2B NR3B GIuR6 KA2 mGIuR8 GIuR3 NR2C GIuR7 
GluR4 NR2D 
Fig. 1.1 Phylogenic tree showing all subtypes of lonotropic and metabotropic glutamate 
receptors. 
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1.2.2. lonotropic glutamate receptor topology 
Ionotropic glutamate receptors are subdivided into AMPARs, NMDARs and KARs 
based on pharmacological and structural similarities. All iGluR subunits share a 
common transmembrane topology. The initial prediction is that they had four 
hydrophobic regions within the central portion of the sequence which would be 
predicted to be located within the membrane. The presence of consensus sites for N- 
gycosylation within the N-terminal domain, and by analogy with the well characterised 
structure of the nicotinic acetylcholine receptor subunits, it was proposed that iGluR 
subunits had a large extracellular ligand-binding N-terminal domain (NTD) and four 
membrane spanning regions resulting in an extracellular C-terminus (Hollmann et al., 
1989). However, based on glycosylation (Roche et al., 1994; Tavema et al., 1994; Wo 
and Oswald, 1994), immunocytochemical (Wo and Oswald, 1995), protease protection 
(Seal et al., 1995), and phophorylation studies (Moss et al., 1993; Tingley et al., 1993), 
the proposed topology was revised. The C-terminal domain of iGluRs is located 
intracellularly (Fig. 1.2). iGluRs contain four TMDs, with TMD 1,3 and 4 being 
membrane spanning while TMD2 forms a re-entrant loop in the membrane which lines 
the pore of the channel (Bennett and Dingledine, 1995; Wo and Oswald, 1994). Both the 
long N-terminal domain and the loop between TM3 -TM4 are extracellular whereas the 
small loops between TMD 1-TMD2 and TMD2-TMD3, together with the long C- 
terminal domain are located intracellularly. In addition, part of the loop between TM3- 
TM4 forms the glutamate-binding site with the NTD and portion of the N-terminal 
domain extracellularly (Tygesen et al., 1995). Single subunits of iGluR assemble to form 
multimeric channels. Early studies suggested that AMPAR subunits formed pentamers 
(Ferrer-Montiel and Montal, 1996; Wenthold et al., 1992); however, it is now well , 
accepted that GluRs are formed as multimeric complexes of four subunits around the. 
central pore, which ions pass through (Laube et al., 1998; Mano and Teichberg, 1998; 




Fig. 1.2 General topology of an ionotropic Glutamate receptor subunit. 
All ionotropic glutamate receptor subunits share basic structure containing an extracellular N- 
terminal domain, four transmembrane domains and an intracellular C-terminal domain. The N- 
terminal domain and the extracellular loop between TM3 and TM4 form the ligand-binding 
domain. 
1.2.3. NMDA Receptors 
Since the discovery of N-methyl-D-aspartate receptors (NMDARs) in the 1970s (Evans 
et al., 1979), they have been extensively studied and the signal transduction events are 
shown to play an important role in neuronal development, synaptic plasticity 
and memory formation. NMDARs have many unique features: the ion channel is subject 
to a voltage-sensitive extracellular Mg2+ block, the relief of the Mgt' block is triggered 
when pre- and postsynaptic cells are fired in unison. The Mg 2+ block and NMDAR are 
highly permeable to Ca 2+ ions, and channel opening allows Ca 2+ influx and triggers LIP 
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or LTD. Dysfunction of these receptors has been implicated in a number of 
neurodegenerative diseases, neurological disorders and stroke (Waxman and Lynch, 
2005). As mentioned above, the NMDAR is an iGluR subtype, which forms tetrameric 
receptors composed of three subunits: NR I, NR2 and NR3. Each functional NMDAR 
comprises two obligatory NR1 subunits and two NR2 and/ or NR3 subunits (Mcllhinney 
et al., 1998). Besides the four NR2 (NR2A-NR2D) and two NR3 (NR3A-NR3B) 
subunits, the diversity of NMDARs is further increased by eight different NR1 subunits 
generated by alternative splicing from a single gene (Durand et al., 1992). Functional 
NMDARs are assembled from a large pool of homologous subunits in the endoplasmic 
reticulum (ER), and further processed in the Golgi apparatus prior to the distribution to 
the trans-Golgi network (TGN). Subsequently, the mature NMDARs are targeted to 
synapses as well as to extrasynaptic sites. 
1.2.3.1. Coincidence detection 
One feature of NMDARs that is distinct from other iGluRs is that they require co- 
agonist binding of glutamate and glycine to be activated (Kleckner and Dingledine, 
1988). Glycine and L-glutamate share structurally similar binding sites and seem to play 
equivalent roles in NMDAR activation. Physiologically, glycine and glutamate have 
distinct roles. While L-glutamate is released from specific presynaptic terminals, a low 
concentration of endogenous glycine is present at the synapse at all times and is thought 
to be sufficient to induce receptor activation (review in Biology of the NMDA Receptor, 
Chapter 13, Blanke & VanDongen). Besides glycine, D-serine has also been suggested 
as an endogenous NMDAR ligand acting on the co-agonist site (Mothet et al., 2000; 
Schell et al., 1995). Another unique feature includes the presence of voltage-dependent 
blockade of the ion pore by extracellular Mg 2+ at resting membrane potential, which 
prevents ions from passing through the channel even when activated (Ault et al., 1980; 
Mayer et al., 1984). The Mgt+block can only be removed from the pore of the channel 
when the postsynaptic cell is depolarised (Nowak et al., 1984), and depolarisation is 
usually caused by the sustained activation of AMPARs or KARs. The Mg 2+ block is 
therefore acting as a molecular coincidence switch and NMDARs are regarded as 
`coincidence detectors', which require both ligand-binding and postsynaptic 
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depolarisation to allow current to pass through. This coincidence detection of NMDARs 
is essential for the induction of synaptic plasticity and regulating synaptic strength 
through Cat+-activated signalling cascades. 
1.2.3.2. Ca 2+ permeability 
Besides acting as a coincidence detector, another unique property of NMDARs is their 
permeability to Ca 2+ as well as to Na+ and K+. Non-NMDARs, on the other hand, are 
only permeable to Na+ and K+ when open but are usually not permeable to Cat+. 
Following an action potential, glutamate is released presynaptically and binds to iGluRs 
on postsynaptic sites. The cells are depolarised by Na+ influx, which activates NMDARs 
by removing the Mgt+block, and dramatically enhances Ca2+ influx through NMDARs. 
The intracellular [Ca2+] must be tightly regulated due to the fact that [Ca21 activates 
intracellular signalling cascades including phosphorylation, gene expression and protein 
synthesis, which promotes persistent changes of synaptic strength in the postsynaptic 
cells, such as LTP and LTD. Ca2+ also regulates channel opening. Excess glutamate 
binding can also induce Cat+-dependent excitotoxicity as excessive amounts of [Ca2+]; 
are highly toxic (Lucas and Newhouse, 1957), which is a phenomenon thought to 
underlie cell death in cerebral ischemia (Gagliardi, 2000). The Ca 2+ permeability of 
NMDAR subunits is regulated by a critical asparagine residue located in the TM2 
domain within the re-entrant pore loop. This site is directly analogous to the Q/R 
(glutamine-arginine) site in non-NMDARs and controls their C2+ permeability. The 
same site also determines the selectivity of the NMDAR channel for Mgt+block and the 
antagonist MK-801(Sakurada et al., 1993). 
1.2.3.3. Alternative Splicing 
Functional diversity of the NMDAR is further increased by alternative splicing of NR1 
subunits. Splice variants of NR1 affect several key features of NMDAR, such as proton 
sensitivities, polyamine potentiation, as well as Zn2+ inhibition. A single gene of NR1 
has eight isoforms from combinations of three independent splice variations. One is 
generated by the insertion of exon 5 in the N-terminus and seven were generated by 
exon deletions in the C-terminus. The N-terminal exon insertion determines gating 
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kinetics, whereas the C-terminal splice variants determine subcellular sorting of NR1 
subunits and receptor assemblies of NMDARs and will be discussed in a later section 
(Cull-Candy and Leszkiewicz, 2004). 
1.2.3.4. Subunit composition 
As mentioned above, NMDARs form tetrameric complexes in which a dimer of NR1 
subunits must assemble with a dimer of NR2 and sometimes NR3 subunit to form 
functional channels. In the CNS, most NMDARs are made up of NR1 and NR2 subunits. 
Moreover, NR2A and NR2B are the most abundant NR2 subunits expressed in the 
forebrain. The NR2B subunit is expressed early in development, whereas NR2A 
expression is low at early postnatal stages but gradually increases with development. 
NR2C expression is largely restricted to the cerebellum and NR2D is most heavily 
expressed early in development. It is well established that the functional diversity of 
NMDAR is generated by differential incorporation of various types of NMDAR 
subunits. In the forebrain, most NMDAR subunits form NR1/NR2A or NR1/NR2B 
diheteromeric complexes; however functional diversity can also arise from the assembly 
of more than one type of NR2 subunits in the same receptor complex. Triheteromeric 
NMDARs containing NR1/NR2A /NR2B have been consistently observed, particularly 
in cortical and hippocampal neurones (Didier et al., 1995; Luo et al., 1997; Sheng et at., 
1994). Other triheteromeric NMDAR complexes containing NR2C or NR2D have also 
been shown in vivo, most particularly NR1/NR2A/NR2C complexes in the cerebellar 
granule cells and NR1/NR2B/NR2D in substantia nigra dopaminergic neurones (Cull- 
Candy et at., 2001). The distinct expression patterns and developmental profile of 
NMDAR subunits, together with the receptor composition at individual synapses could 
be the key mechanism to determine the synaptic response of neurones to various stimuli. 
1.2.3.5. Developmental expression of NMDAR subtypes 
The expression profile of all NMDAR subunits is both spatially and developmentally 
regulated, suggesting subunit-specific roles of NMDARs during development in 
different brain regions (reviewed in Cull-Candy & Leszkiewicz; 2004). 
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NRI: 
In situ hybridization studies show that, in general, expression of all NR1 splice variants 
begins as early as embryonic day 14 (E 14), peaks around the third post-natal week, and 
then declines slightly in adulthood. The NR1 isoforms without the N-terminal N1 exon 
(NR1-a) are expressed ubiquitously throughout the brain, whereas those containing the 
Ni cassette (NR1-b) are more restricted to specific areas such as the neonatal caudate, 
sensorimotor cortex, and thalamus. The four splice variants generated from alternative 
splicing of the C-terminus show the following approximate expression abundance 
pattern: NR1-2 > NR1-1 > NR1-4» NR1-3. The NR1-1 and NR1-4 isoforms form 
almost complementary patterns, with NR1-1 restricted to the cortex, hippocampus and 
caudate whereas NR1-4 to the thalamus and cerebellum The NR1-2 splice variant is 
widely and more or less homogeneously expressed throughout the brain, whereas the 
NR1-3 expression is barely detectable at birth and restricted postnatally to very low 
levels in cortex and hippocampus (adapted from Biology of the NMDA receptor, Chapter 
1, Ewald & Clines). 
NR2: 
NR2 subunits, in contrast to NR1 isoforms, show distinct expression patterns during 
development, and they play important roles in neurodevelopment, for example, NR2B 
knockout mice die early in development (reviewed in Cull-Candy & Leszkiewicz; 
2004). In situ hybridization of rat brain slices showed that NR2B and NR2D are the only 
two subunits expressed during embryonic development. NR2B and NR2D expression 
emerges as early as E14 and gradually increases as embryonic development continues. 
NR2B expression predominates prenatally in cortex, and is high in the thalamus and 
spinal cord. It was low in the hippocampus and hypothalamus at embryonic stages, but 
becomes stronger around birth and persists through postnatal day 0 (P0). This is when 
NR2B could also be detected in the cerebellum, it is predominantly expressed during 
early postnatal stages, but subsequently decreases. NR2B expression is overall the 
highest among the NR2 subunits during the early postnatal stage, and its expression 
peaks in the hippocampus and cortex during the third postnatal week and then declines 
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to moderate/low levels in adult. NR2D is highly expressed throughout the whole brain at 
embryonic and juvenile stages (around P7) and then it declines to a very low level in 
adulthood and is restricted mainly in the mid-brain. NR2A is expressed soon after birth 
at low levels in the hippocampus and cerebellum, and its expression continuously 
increases in the hippocampus and cortex postnatally. It becomes dramatically 
upregulated during the second postnatal week and is expressed throughout the brain. Its 
expression, like NR2B, peaks in the third postnatal week before they decline to adult 
levels. NR2C expresses at a very low level in the cerebellum and forebrain early in 
development (before P7) and its expression becomes markedly increased in the 
cerebellum and olfactory bulb following P 12. It is highly expressed in cerebellar granule 
cells and expression peaks during the third postnatal week and remains high in 
adulthood in cerebellum (adapted from Biology of the NMDA receptor, Chapter 1, 
Ewald & Clines). 
NR3: 
NR3 subunit expression is also developmentally and spatially regulated. In rats, NR3A 
is prenatally expressed in the spinal cord and brain stem. Its expression increases at 
postnatal stages to also include the hippocampus, amygdala, and parts of cortex. NR3A 
expression peaks around P8 and then rapidly decreases to adult levels by P20 (Ciabarra 
et al., 1995; Sucher et al., 1995; Wong et al., 2002). NR3B expression, in contrast, is 
restricted to motoneurones of the brain stem and spinal cord (Chatterton et al., 2002; 
Nishi et al., 2001). Its expression levels peak postnatally around P14 and stay elevated 
through adulthood (Matsuda et al., 2002). 
1.2.3.6. Pharmacology of NMDARs 
Due to the important roles that NMDARs play in regulating synaptic function in the 
nervous system and their involvement in a number of physiological and pathological 
processes, NMDARs have long been a target for therapeutic drug development. The 
NMDAR was identified of as a distinct subpopulation of glutamate receptors by 
discovery of NMDA as a specific agonist (Curtis et al., 1972) and the subsequent 
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synthesis of various antagonists that specifically block responses triggered by NMDA, 
but not kainate or quisqualate (Biscoe et al., 1977; Davies et al., 1982). 
1.2.3.7. Structural basis of NMDAR pharmacology 
Pharmacology of the NMDAR is primarily based on the domain structure of its subunits, 
particularly in the N-terminal extracellular region. The extracellular region of each 
subunit contains two domains that share structural homology to two families of bacterial 
amino acid-binding proteins. The first 350 amino acids contain the NTD that show 
homology to the bacterial amino acid-binding protein leucine/isoleucine/valine (LIVBP) 
(Dingledine et al., 1990; O'Hara et al., 1993). This domain contains an allosteric 
regulatory site which binds to polyamines and increases NMDAR responses to inhibitors 
(Fig. 1.1) (Paoletti and Neyton, 2007). The second domain shows homology to bacterial 
leucine-arginine-ornithine-binding protein (LAOBP) and comprises two segments, Si 
and S2 (- 120 amino acids each), which form the agonist binding domain (ABD) for 
glutamate in NR2 and glycine in NR1(Fig. 1.1) (Stern-Bach et al., 1994). 
1.2.3.8. NMDAR antagonists 
The first NMDAR antagonists were competitive inhibitors which compete for the 
glutamate binding site on the NR2 subunits include D-a-amino-adipate (DAA) (Biscoe 
et al., 1977) and 2-amino-5-phosphonovalerate (AP-5) (Davies and Watkins, 1982), of 
which AP-5 is still the most commonly used NMDAR antagonist for its potency and 
selectivity for NMDARs over other iGluRs. Glycine, as mentioned above, is the co- 
agonist of glutamate at NMDARs. A number of compounds were synthesised for the 
glycine-binding site on NMDARs. Kynurenic acid is the first competitive antagonist that 
acts on the glycine-binding site in the NR1 subunit (Kessler et al., 1989). A number of 
compounds occlude NMDAR activation by acting on the channel pore and are therefore 
non-competitive antagonists. The highest affinity NMDAR blocker available to date is 
MK-801, whereas Memantine and Ketamine both have lower affinity inhibiting 
NMDARs. None of the compounds above effectively distinguish between NMDAR 
subunits. It is clear that NMDARs are heteromeric complexes assembled from multiple 
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subunits, thus the pharmacology of NMDARs has been focused on identifying 
compounds which are able to distinguish different NMDAR subtypes. 
As mentioned above, NR1 is encoded from a single gene, includes the glycine binding 
sites. In contrast, NR2 is encoded by four distinct genes, includes glutamate-binding 
sites and different allosteric regulatory sites in the NTD (Kutsuwada et al., 1992; 
Monyer et al., 1994; Monyer et al., 1992). Since NR2 subunits play a major role in 
regulating distinct biological and physiological properties of NMDARs, selective 
antagonists to distinguish different NR2 subunits have been intensively studied as 
therapeutic targets. A large competitive antagonist which acts on the glutamate-binding 
site, NVP-AAM077, was first claimed to have a 100 fold higher affinity for blocking 
NR2A- over NR2B- containing receptors (Auberson et al., 2002; Massey et al., 2004). 
However, several groups have later cast doubt on its selectivity for NR2A over NR2B 
(Berberich et al., 2005; Neyton and Paoletti, 2006). Nevertheless, none of the glutamate- 
binding antagonists available display a high degree of NR2 subunit selectivity for native 
NMDARs. Zinc, which acts on the allosteric site in the NTD, displays a 100-fold higher 
selectivity for NR2A over NR2B, and it does not bind NR2C or NR2D (Chen and 
Lipton, 1997; Choi and Lipton, 1999; Paoletti et al., 1997; Rachline et al., 2005). Other 
available NMDAR antagonist that could distinguish NMDAR subunits are ifenprodil 
and derivatives, which bind to the allosteric site in the NTD and is voltage-dependent. 
These compounds display more than 100-fold greater affinity for NR1/NR2B-containing 
receptors over NRl/NR2A receptors (Williams et al., 1993). Ro 25-6981 is so far the 
most well characterised antagonist of this group which displays a 3000-fold selectivity 
for NR2B- containing NMDARs (Fisher and Tally, 1997). These compounds have been 
useful in defining the function of NR2B-containing NMDARs in the brain. However, the 
existence of triheteromeric assemblies of NMDARs in different brain regions further 
hinders the development of subunit-specific antagonists for NMDARs. It has been 
shown that both zinc and ifenprodil have low efficacy on NR2A- and NR2B- containing 
triheteromeric NMDARs, respectively (Hatton and Paoletti, 2005). Therefore, until a 
specific antagonist is discovered that can distinguish between di- and tri-heteromeric 
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Fig. 1.3 Diagram showing the structure of the ligand binding sites and antagonist binding sites 
of NMDAR complexes. 
The extracellular region of NMDARs composed of the N-terminal domains (NTDs) and agonist- 
binding domains (ABDs). The NR2 ABD binds glutamate, whereas the NRI ABD binds co-agonist 
glycine. White arrows represent the binding sites for competitive agonists and antagonist; orange 
arrows indicate sites known to bind allosteric modulators such as zinc or ifenprodil (NR2B NTD). 
The ion channel domain forms binding site for pore blockers such as MK-801 and endogenous Mg''. 
Adapted from Paoletti & Neyton, 2007, Current Opinion in Pharmacology 7: 39-47 
1.3. Trafficking of NMDARs 
1.3.1 Biosynthesis of NMDARs in the endoplasmic reticulum 
The endoplasmic reticulum (ER) serves as an essential organelle in the cell where 
membrane proteins are synthesised. It also serves as a quality control site and ensures 
misfolded or unfolded proteins retain in the ER until they are properly folded into a 
functional form. For the multimeric NMDAR complexes, monomers of NR 1, NR2 or 
NR3 subunits are retained in the ER until they are fully assembled in various 
combinations to form functional tetrameric channels (Fukaya et al., 2003; Mcllhinney et 
al., 1998; Okabe et al., 1999). To pass the quality control and to export a protein out of 
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the ER, the ER-retention signal(s) in the protein must be sterically hindered or 
overridden by the presence of ER export signal(s) when the protein is fully assembled. 
1.3.3. Sequence determinants regulate ER-retention of NR1 splice variants and 
NR2 subunits 
It has been known for some time that NR2 dimers are retained in the ER unless forming 
a tetrameric complex with NR1 dimers. An ER-retention motif, RXR, was identified in 
the Cl cassette, which is an alternatively spliced exon in the intracellular C-terminal 
domain of the NR1 subunit (Scott et al., 2001; Standley et al., 2000; Xia et al., 2001) 
(Fig. 1.4). Expression ofNR1.1, which contains the Cl cassette, revealed no cell surface 
expression in heterologous cells. However, expression of NR1.1 containing the disrupted 
RXR motif partially restored surface expression. In contrast, NR1.2 and NR1.4 splice 
variants lack the Cl cassette and are robustly expressed on the plasma membrane when 
exogenously expressed in heterologous cells. The NR1.3 splice variant contains the Cl 
cassette but is still efficiently expressed on the plasma membrane due to the presence of 
C2' cassette in the C-terminus, which carries a PDZ binding domain, STVV, and/ or a 
COPII binding domain (Fig. 1.4; Fig. 1.6a), which are sufficient to suppress the ER- 
retention by masking or overriding the RRR ER-retention signal in the Cl cassette when 
expressed in heterologous cells (Mu et al., 2003; Standley et al., 2000). A recent study 
has identified another ER-retention signal in NR1 variants, in addition to the Cl signal 
previously described. By expressing truncated and chimeric NMDAR in heterologous 
cells, the author identified another ER-retention motif, KKK, which also localised in the 
C1 cassette of NR1 C-terminus (Horak et al., 2008) (Fig. 1.4). In addition, it is reported 
that an extra ER-retention signal is present within the third transmembrane domains 
(TM3) in NR1 subunits. Interestingly, the analogous region in NR2B is also shown to 
comprise an ER-retention signal (Horak and Wenthold, 2009). In addition to the TM3 
domain, another ER-retention signal is suggested to be localised in the C-terminal 
domain of NR2B (Hawkins et al., 2004). Nevertheless, the precise ER-retention motif in 
NR2 subunits remaine elusive. 
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1.3.4. Regulation of NR1 forward trafficking by phosphorylation 
Phosphorylation has also been shown to regulate the release of NR1 from the ER. PKC 
phosphorylation of the serine near the RXR ER-retention motif in the Cl cassette was 
shown to relieve ER-retention and promotes robust surface expression of recombinant 
NR 1 (Scott et al., 2001). Subsequent findings showed that the masking of the RXR ER- 
retention signal is a co-ordinated effort between this protein kinase C (PKC) and the 
adjacent serine phosphorylation by cAMP dependent protein kinase (PKA) in the Cl 
cassette (Scott et al., 2003). Apart from the Cl cassette being the major cassette in 
regulating NRI forward trafficking, CO and C2' were also shown to enhance surface 
targeting of the NR 1, and C2, on the other hand was shown to inhibit the forward 
trafficking of NR1 subunits (Horak and Wenthold, 2009) (Fig. 1.4). 
NR1.1 TMD I ER retained 







Fig. 1.4 The C-terminal domain of various NRI splice variants and the amino acid sequences of 
each C-terminal cassettes 
The Cl cassette contains a RRR ER-retention motif such that NRI. I is ER-retained whereas the 
STVV ER-export motif in the C2' cassette of NR 1.3 overrides the RRR ER-retention motif in Cl 
cassette thus NRI. 3 expresses on the cell surface. The CO cassette contains two endocytic motifs 
(YKRH and VWRK) which regulate endocytosis of NRI splice variants. 
"-"--: ' .- '-. -- -. 
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1.3.5 Subunit assemblies promote forward trafficking of NMDARs 
In neurones, the ER-exit mechanisms of NMDARs are likely to involve assemblies of 
NR1 with NR2 and/ or NR3 subunits. NR2 subunits must oligomerise with NR1 
subunits to exit the ER and traffic towards the plasma membrane. In CAI pyramidal 
neurones derived from mice with NR1 deletion restricted to the CAI region, NR2 
subunits were shown to aggregate in the intracistemal granule of the ER (Fukaya et al., 
2003). Previous studies have shown that the HLFYmotif immediately after the TM4 
domain in NR2B subunit mediated the exit of NR1/NR2B complexes out of the ER 
(Hawkins et al., 2004) (Fig. 1.6b). However, it was later showed that HLFY is not 
required for ER-exit as long as the rest of the C-terminal proximal region is absent 
(Yang et al., 2007). A recent study has shown that the TM3 regions of NR1 and NR2B 
subunits, together with the TM4 domain of NR1 are necessary for negating the ER- 
retention signal in the assembled NR1/NR2B receptor expressed in heterologous cells 
(Horak et al., 2008a). 
1.3.6 General mechanisms of integral -membrane protein trafficking 
In neurones, the maintenance of appropriate number of receptors express on the post- 
synaptic membrane is crucial in regulating synaptic transmission and is thought to play a 
vital role in synaptic plasticity. In this system, the secretory pathway delivers newly 
synthesised or recycled receptors to the plasma membrane, where the endocytic pathway 
internalises receptors from the plasma membrane into the cytoplasm as vesicles or 
endosomes. 
Sorting signals of integral proteins and adaptor protein complexes (AP) 
Sorting of integral membrane proteins first involves internalisation from the plasma 
membrane into early endosomes (EEs), which were then delivered to late endosomes 
(LEs) and lysosomes, or targeted to recycling endosomes. It is well established that 
lysosomal targeting of most integral membrane proteins are mediated by signals encoded 
within the intracellular domain of the proteins. Two types of motifs have been well 
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characterised: tyrosine-based motifs and di-leucine-based motifs. Tyrosine-based motifs 
conform to the motif YXXý, for Y represents tyrosine, X is any amino acids, and ý 
represents a bulky hydrophobic amino acid such as leucine, isoleucine, phenylalanine, 
methionine or valine. For dileucine motifs, contain critical leucine-leucine (LL) or 
leucine-isoleucine (LI) pairs and often an acidic residue four or five positions upstream 
of the pair (Bonifacino and Traub, 2003). These signals interact with different 
heterotetrameric adaptor protein complexes (AP-1 to AP- 4) at different affinities. 
Tyrosine-based motifs bind to the µ subunits of he four AP complexes, whereas 
dileucine motifs bind to the AP-1 y-al and AP-3 8-a3 subunits. AP-2 is associated to 
clathrin and the cytosolic face of plasma membrane to mediate endocytosis; whereas 
AP-1, AP-3 and AP-4 are localised in the endosomes and trans-Golgi-network (TGN) 
and mediate intracellular sorting events. Such that AP-1 binds to clathrin and regulates 
protein sorting between TGN and endosomes; AP-3 is known to regulate biogenesis of 
melanosomes and platelet dense bodies, and AP-4 mediates sorting from the TGN to 
endosomes (Bonifacino and Lippincott-Schwartz, 2003). 
General mechanism for endocytosis 
Endocytosis usually occurs by two general mechanisms: clathrin-dependent and clathrin- 
independent internalisation. The well-accepted endocytosis model is that receptors are 
transported to the endocytic zones, where they are internalised by cargo protein- 
clathrin, which regulates the most widely studied form of endocytosis, they are then 
sorted to different compartments in the endosomal-lysosomal system. 
Clathrin-dependent endocytosis involves binding of AP-2 adapter proteins to the 
transmembrane protein to be internalised, which then recruit the binding of clathrin 
triskelia to form a hexagonal structure around invaginated membrane, and the activity of 
the GTPase dynamin results in pinching of the vesicle. The newly formed vesicles are 
fused with the EEs, and the internalised proteins are either sorted into the recycling 
endosomes and sent back to the plasma membrane, or targeted to the LEs prior to sorting 
into lysosomes for degradation. 
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Protein sorting in endosomal-lysosomal system and protein degradation 
A vast majority of membrane proteins are sorted to lysosomes for degradation following 
ubiquitination. Ubiquitination is the post-translational modification of protein by 
covalent attachment of one or multiple ubiquitins (Ub) catalysed by enzymes called 
ubiquitin ligases. A key feature of Ub is the presence of 7 lysine residues in its C- 
terminus, which bind to multiple Ubs to form a polyubquitin-chain once a single 
ubiquitin is attached to the protein. Membrane proteins are often tagged with single 
ubiquitin (monoubquitination), which alters the subcellular localisation of the protein, 
often targeting the protein for degradation in lysosomes. Ub also attaches to membrane 
proteins on the plasma membrane, the TGN and at endosomes, serving as a sorting 
signal for endocytosis, trafficking from TGN to endosomes, and sorting of proteins into 
the endosomal lumenal vesicles that accumulate to form multivesicular bodies (MVB) 
(Piper and Luzio, 2007; Raiborg et al., 2003). EEs are the main recipients of incoming 
endocytosed proteins from the plasma membrane. They receive cargo that cycles back to 
the plasma membrane, as well as material that is transported further along the 
endosomal-lysosomal system. In such case, EEs fused with internalised membrane 
proteins and bind to ubiquitinated cargo including the Hrs/STAM complex and subunits 
of the ESCRT-1 and ESCRT-II complexes, which subsequently transport to the interior 
lumen of LEs and form MVBs (Piper and Luzio, 2001,2007; Raiborg et al., 2003). In 
most cell types, MVBs ultimately -fuse with the lumen of lysosomes. Lysosomes are 
ubiquitous organelles that constitute the primary degradative compartments of the cell. 
The catabolic function of lysosomes is complemented by lysosome-related organelles 
(LROS). LROs share many properties with lysosomes, but they also contain cell-type- 
specific proteins and might require additional cellular machinery for their biogenesis 
(Bonifacino, 2004). The fusion of MVBs with the lysosome results in the delivery of the 
internal vesicles, along with their associated cargoes, to the lumen of the lysosomes 
where they are degraded by a host of hydrolytic enzymes. 
Cellular proteins can also be degraded by proteasomes in an ubiquitin- 
independent pathway. For example, Orithin decaroxyläse (ODC), the first enzyme in the 
polyamine biosynthesis pathway, is also the first protein for which ubiquitin- 
independent degradation by the proteasome has been described. The proteasome is a 
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major non-lysosomal proteolytic apparatus that destroys damaged or misfolded proteins 
as well as to maintain fundamental cell signalling events. The catalytic core of this large 
multisubunit complex has two forms, 20S proteasome and 26S proteasome. The 20S 
proteasome consists of 14 a- and 14 ß- subunits. The a- and ß- subunits form rings then 
assemble into a cylindrical barrel that the ß-rings harbour all the proteolytic sites for 
substrate cleavage inside the barrel, whereas the a- rings provide the gated entry sites for 
protein substrates (Zhou, 2006). Apart from degradation of ODC by 20S proteasomes, 
ODC can also be degraded by the 26S proteasomes in an antizme (Az) - dependent 
manner. Az interacts with ODC and stimulates its degradation by enhancing the 
interaction of ODC with the 26S proteasome (Jariel-Encontre et al., 2008; Kahana, 
2007). Although there are several more cellular proteins that were shown to be degraded 
in an ubiquitin-independent manner, majority of cellular proteins especially integral 
membrane proteins are degraded in an unbiquitin-dependent pathway. 
1.3.7 Postsynaptic trafficking of NMDARs 
13.7.1 Targeting of NMDARs to synapses 
After NMDAR subunits are assembled into tetrameric complexes in the ER, they are 
further modified in the Golgi apparatus and then sorted into the trans-golgi-network 
(TGN) to package into different types of vesicular or tubulovesicular carriers. In young 
rat cortical neurones, NMDARs and AMPARs were shown to traffic through distinct 
mobile transport packets before and during synaptogenesis, with NMDARs travel in the 
dendrites along the microtubules more rapidly than AMPARs (Washbourne et al., 2002). 
These NMDARs are contained in the tubulovesicular packets and are associated to the 
early endosomal antigen 1 (EEA 1). Prior to synaptic formation, a portion of nascent 
NMDAR packets was shown to cycle sequentially to and from the plasma membrane 
while some internal NMDAR packets are moving along the microtubule (Washbourne et 
al., 2004). Nascent NMDAR packets also associate with modular scaffolding proteins to 
promote the targeting to the postsynaptic membrane. SAP102, a member of the 
membrane-associated guanylate kinase (MAGUK) protein family, is known for its direct 
association with NMDARs early in development, when nascent NMDAR packets travel 
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in the dendrite within the tubulovesicular organelles, most likely to early endosomes 
(Washboume et al., 2004). SAP 102 also binds directly to the exocyst component sec 8 
through the PDZ domain, the same region that it binds NR2B subunit. The exocyst 
complex localises at the proximal region of the outgrowth neurites, which may allow sec 
8 to recognise and direct newly synthesised intracellular NMDAR complexes in vesicles 
to their site of insertion on the plasma membrane. Expression of dominant negative form 
of sec 8 in neurones prevent sec 8 and SAP 102 interaction, thus it disrupts synaptic 
insertion of NR2B subunits (Sans et al., 2000). Moreover, SAP 102 also binds through its 
Src-homology-3 (SH3)-guanylate kinase (GK) domains to mPins, which is the 
mammalian form of Drosophila Pins that plays a role in cell polarity and cell division. 
mPins forms a complex with SAP 102 and NR2B and regulates SAP 102 and NR2B 
trafficking (Fig. 1.5), expression of the dominant negative form of mPins in neurones 
reduces both SAP 102 expression level in dendrite and NR2B surface expression. Direct 
binding of mPins to the inhibitory subunit of G-protein, Ga;, which mediates G-protein 
signalling, may help to stabilise the mPin-SAP102-NR2B complexes for proper folding 
early in the secretory pathway and thus for targeting to the dendritic spines (Sans et al., 
2005). 
The NR2B subunit also binds to a complex containing two other intermediate adaptor 
proteins, LIN2 and LINT, and an adaptor protein, LIN 10. Which are then bind to KIF 17 
and transport the NMDAR-containing vesicles along the microtubule in dendrite to 
nascent synapses (Guillaud et al., 2003; Setou et al., 2000) (Fig. 1.5). The knockdown or 
functional blockade of KIF 17 disrupts the expression and synaptic localisation of NR2B, 
and induces a subsequent increase in NR2A expression in synapses (Guillaud et al., 
2003; Setou et al., 2000). 
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Fig. 1.5 Schematic diagram of NMDAR assembly in the ER and transport to the surface of 
dentritic spine through the trans-golgi network and microtubules 
Adapted from Lau & Zukin, 2007, with permission from Nature Review Neuroscience. 
1.3.7.2 Exocytosis and receptor insertion 
Exocytosis of NMDARs takes place at the or near the synapse; however, the exact sites 
are unknown. The insertion of NMDARs at the plasma membrane is tightly regulated 
during development and in response to synaptic activity and sensory experience. PKC 
has been shown to potentiate and increase NMDAR insertion to the cell surface in both 
recombinant systems and neurones. Furthermore, this rapid channel insertion occurs 
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through SNARE-dependent exocytosis (Lan et al., 2001). This form of PKC activation 
does not involve direct phosphorylation of NMDAR subunits but the phosphorylation of 
the scaffolding or anchoring proteins (Zheng et al., 1999). Binding of NMDARs with 
PSD-95 also enhances synaptic insertion but at the same time occludes the PKC 
potentiation and the corresponding effect on channel activities (Lin et al., 2006) (Fig. 
1.5). Besides PKC, insertion of NMDARs is also enhanced by activation of other 
receptors, such as the insulin receptor (Skeberdis et al., 2001) and dopamine D1/D5 
receptors (Dunah and Standaert, 2001; Hallett et al., 2006; Schilstrom et al., 2006). 
Furthermore, a recent study showed a non-conventional secretory pathway of 
NMDARs in hippocampal neurons, which utilise a specialised endoplasmic reticulum 
subcompartment containing NR1 and NR2B, together with the microtubule-dependent 
motor protein KIF 17, and the MAGUK family proteins CASK and SAP-97, to directly 
traffic to the plasma membrane via the dendritic Golgi outposts. This study suggests that 
NMDARs can be more rapidly delivered to the synapses through an alternative secretory 
pathway, providing a local control platform for a more efficient insertion of NMDARs 
near synapses (Jeyifous et al., 2009). However, the occurrence and biological function of 
this non-conventional secretory pathway as well as the partition of small Golgi outposts 
in dendrites remain debatable (Horton and Ehlers, 2003; Horton et al., 2005; Ye et al., 
2007; Ye et al., 2006). 
1.3.7.3 Clathrin-dependent endocytosis of NMDARs 
On the plasma membrane, NMDARs can either be stabilised or can undergo 
endocytosis. Endocytosis is a ubiquitous mechanism that allows cells to regulate the 
level of plasma membrane proteins. In neurones, endocytosis is a key mechanism 
regulating synapse maturation, synaptic activity and synaptic strength. The most widely 
studied form of endocytosis is mediated by clathrin, a triskelion composed of three 
heavy chains and three light chains, which forms lattice-like structures on the interior 
face of the plasma membrane. Endocytosis via clathrin-coated vesicles requires the 
interaction of plasma membrane endocytic cargo proteins with the clathrin adaptor 
complex, AP-2 (Bonifacino and Dell'Angelica, 1999; Bonifacino and Traub, 2003). The, 
plasma membrane adaptor complex AP-2 directly binds to internalised cargo proteins 
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via their medium chain, µ2 (Ohno et al., 1995), thus linking the target internalised 
proteins and initiates membrane invagination and budding of clathrin-coated vesicles. 
These newly internalised vesicles then shed their clathrin coats and fuse with sorting 
endosomes (Kennedy and Ehlers, 2006). 
1.3.7.4 The role of the PDZ-binding domain in NR2 subunits endocytosis 
Different NMDAR subunits internalise and are sorted into distinct pathways, as it is known that 
NR2A and NR2B subunits contain distinct endocytic motifs and sorting information within their 
distal C-termini. Both NR2A and NR2B contain the PDZ-binding domain (-ESDV) in their 
distal C-termini which mediates binding to PSD-95 (Fig. 1.6b). Activation of the NMDAR- 
CAMKII pathway regulates phosphorylation by Casein Kinase 2 (CK2) at the serine residue in 
the PDZ-binding domain (Chung et al., 2004), which reduces NR2B surface expression in 
neurones due to the disruption of the NR2B-PSD95/ SAP102 interaction, subsequently 
enhancing the endocytosis of NMDARs from the plasma membrane (unpublished data by San- 
Clemente et al. in Dr. Katherine Roche's lab). Another PDZ binding protein, GIPC, also 
contains a PDZ domain and binds to the -ESDV motif in the C-terminus of NR2B subunit. It 
preferentially plays a role in regulating surface expression of extrasynaptic NMDARs, but 
precise trafficking mechanisms remain unclear (Yi et al., 2007). 
1.3.7.5 Tyrosine-based phosphorylation regulates internalisation of NR2B but not 
NR2A 
Besides the PDZ-binding domains in the distal C-termini of NR2 subunits, consensus 
tyrosine-based internalisation motif, (1472YEKL1475), was identified in the distal C- 
terminus of the NR2B subunit (Roche et al., 2001) (Fig. 1.6b). On the other hand, NR2A 
contains several potential internalisation motifs, including a putative tyrosine-based 
endocytic motif and several dileucine motifs. Both tyrosine-based motifs and dileucine 
motifs are consensus endocytic motifs that can regulate clathrin-mediated endocytosis. 
However, it has been shown that the analogous YEKL motif in NR2A, 1454YKKM1457, 
was not essential for NR2A endocytosis in a recombinant system (Lavezzari et al., 2003). 
Instead, the internalisation of NR2A in heterologous cells was shown to be regulated by a 
di-leucine motif, 1319LL1320, in the distal C-terminus of NR2A (Lavezzari et al., 2004) 
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(Fig. 1.6b). At immature glutamatergic synapses early in development, NR2B-containing 
NMDARs are highly mobile in the membrane and undergo rapid internalisation (Roche et 
al., 2001). In mature neurones, NR2B is also internalised more robustly than NR2A 
(Lavezzari et al., 2004). This rapid endocytosis is likely to be mediated by the robust 
interaction of the YEKL motif in NR2B and the µ2 chain of the AP-2 complex, which is 
the adaptor medium chain of clathrin to mediate endocytosis. This adaptor protein, AP-2, 
does not interact with NR2A. This is consistent with the YKKM motif in NR2A not 
playing a critical role in internalising NR2A from the plasma membrane of heterologous 
cells (Lavezzari et al., 2004). NMDARs can be internalised under a regulated mechanism. 
In neurones, the phosphorylation mediated by Fyn kinase at the tyrosine residue in the 
YEKL NR2B endocytic motif suppresses the AP-2 binding to NR2B and thus prevents the 
clathrin-dependent endocytosis of NMDARs (Prybylowski et al., 2005) (Fig. 1.6c). Fyn- 
mediated phosphorylation on Y1472 is also required to maintain proper localisation of 
NR2B- containing receptors on the synapses of hippocampus (Prybylowski et al., 2005) 
and amygdala (Nakazawa et al., 2006). 
13.7.6 Activity-induced endocytosis of NMDARs 
Regulated NMDAR endocytosis also involves several other factors and largely on 
synaptic activity (Lau and Zukin, 2007). Synaptic activity could be induced by direct 
activation of agonist binding (Nong et al., 2003; Vissel et al., 2001). Surface stabilisation 
of the NR2A subunit is regulated by dephosphorylation of Tyr842 in the C-terminus of 
NR2A subunit which is promoted by repeated application of NMDAR agonist, glutamate, 
over several minutes. It induces internalisation of NMDARs and is independent of ion 
flux (Nong et al., 2003; Vissel et al., 2001). Glutamate also triggers Cat+- dependent loss 
of NMDARs primarily in the extrasynaptic sites (Li et at, 2002). Similarly, repetitive 
application of NMDAR co-agonist, glycine, primes clathrin-dependent internalisation of 
NMDARs even in the absence of ion flux (Nong et al., 2003; Vissel et al., 2001). Glycine 
primes both synaptic and extra-synaptic NMDARs. Although the underlying mechanism 
of priming remains elusive, it is possible that it acts as a protection mechanism against 
high neuronal firing conditions such as during seizure, or insult by reducing NMDAR 
number, such as during ischemia (reviewed in Lau & Zukin., 2007). 
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1.3.7.7 Additional endocytic motifs in NRI and NR2 subunits 
More endocytic motifs were found in the membrane proximal region near the last- 
transmembrane domain in the C-termini of NR1 and NR2 subunits. Including two 
independent signals in the NR1 subunit, YKRH and VWRK; and one each, YWKL and 
YWQF, in the NR2A and NR2B subunits, respectively. These endocytic motifs, apart 
from being mandatory and sufficient to drive endocytosis of NMDARs, they also seem 
to contribute to post-endocytic trafficking of NMDARs by targeting internalised 
NMDARs into late endosomes for degradation whereas the endocytic motif localised in 
the distal C-terminus of NR2B primarily regulates the recycling of internalised NR2B 
back on to the plasma membrane (Scott et al., 2004) (Fig. 1.6a, b). 
1.3.7.8 Differential post-endocytic sorting pathways of NR2 subunits 
The post-endocytic sorting of NR2 subunits also displays distinct subunit-specific 
patterns, with NR2B preferentially sorts into recycling endosomes. In contrast, NR2A is 
delivered to late endosomes with a progressive loss of NR2A immunofluorescene 
observed on the neuronal surface, which was interpreted as NR2A-containing NMDARs 
degradation. Although, the sequence determinants regulating these differential post- 
endocytic sorting pathways are localised in the distal C-termini of NR2A and NR2B 
subunits, the precise motifs or sequences are yet to be defined (Lavezzari et al., 2004) 
(Fig 1.6c). 










= Endocytic - Export PDZ-binding 
= 









Endocytk L. "c/ Eaocytk 
_t ýa hnn erul>wrri : one? 
_ý. ý . _____J' 
`ý 
1.3.7.9 Clathrin-independent endocytosis of NMDARs 
NMDARs may be internalised through other mechanisms independent to clathrin- 
mediated -endocytosis. Some proteins can be endocytosed through clathrin-dependent or 
clathrin-independent mechanisms. For epidermal growth factor receptor (EGFR), 
clathrin-dependent endocytosis is triggered when stimulated by low level of EGF. In 
contrast, high levels of EGF trigger ubiquitination of EGFR and are endocytosed 
through a clathrin-independent, lipid raft-associated mechanism (Sigismund et al., 2005). 
Calpain has been implicated in clathrin-independent endocytosis and subsequent 
degradation of NR2A and NR2B. It is shown to regulate prolonged activation of 
NMDARs which leads to downregulation of NMDAR current (Wu et al., 2005). 
Moreover, calpain is known to be neuroprotective against neuronal overactivity by 
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cleaving NR2 subunits on the cell surface, which subsequently triggers downstream 
clathrin-independent endocytosis and degradation of NMDARs. Susceptibility of 
NMDARs to calpain-mediated cleavage could be inhibited by PSD-95 clustering and 
direct binding to NR2A during excitotoxic conditions in synaptic transmission (Dong et 
al., 2004). Furthermore, lipid rafts and associated proteins such as flotillin and caveolin 
are suggested to interact with NMDARs and other glutamate receptors under certain 
conditions (Besshoh et al., 2007; Suzuki, 2002), thus they are possibly be involved in 
clathrin-independent endocytosis of NMDARs. 
1.3.7.10 Ubiquitination and degradation of NMDARs 
Several PSD proteins, such as PSD-95, Shank, GKAP and AKAP 79/ 109, are identified 
as substrates of ubiquitination (Colledge et al., 2003; Ehlers, 2003). Ubiquitination may 
be involved in regulating the activity-dependent changes of NMDARs. F-box protein 2 
(Fbx-2), a neuronal-specific protein that links NR1 to E3 ligase (an ubiquitin- 
transferring enzyme), plays a role in NR1 degradation. Fbx-2 recognises N-linked high- 
mannose oligosaccharides on the extracellular N-terminus of NRl and enhances NR1 
ubiquitination, it is shown that dominant negative mutant of Fbx-2 blocks NR1 
ubiquitination and increases the density of extrasynaptic NMDARs in hippocampal 
neurones in an activity-dependent manner (Kato et al., 2005). However, the mechanism 
of how Fbx-2 regulates NMDAR ubiquitination is still unclear. 
1.3.7.11 Extrasynaptic NMDARs 
Although various brain regions show a distinct synaptic component of NMDAR subunits, 
in general there is a gradual switch from NR2B- containing receptors to NR2A- 
containing receptors at synapses during postnatal development and synaptic activity 
(Barria and Malinow, 2002; Tovar and Westbrook, 1999). Typically, NR2B-containing 
receptors localised at extrasynaptic sites whereas NR2A-containing receptors mainly 
reside in synaptic compartments (Townsend et al., 2003). This is supported by the 
evidence that PSD-95 preferentially binds to NR2A, which may enhance synaptic 
localisation of NR2A-containing receptors and prevents them from being internalised 
(Lin et al., 2004). In addition, NR2B-containing receptors are shown to be more mobile 
49 
than NR2A-containing receptors on the surface of cultured hippocampal neurones (Groc 
et al., 2006). However, this view of NR2 subunits localisation has been challenged in 
recent years. Some NR2B was still found at synapses in mature hippocampal neurones 
(Thomas et al., 2006), as in NR1/NR2B diheteromers or NRI/NR2A/NR2B 
triheteromers, and NR2A-containing receptors are detected in extrasynaptic sites 
(Rumbaugh and Vicini, 1999). The function of this subunit-specific localisation of NR2 
subunits is still unclear, though it is developmentally regulated. Synaptic NMDARs 
receptors are presumably activated by direct release of glutamate at synapses, whereas it 
is generally believed that extrasynaptic NMDARs are activated by glutamate spillover 
during high frequency presynaptic stimulation. Therefore, it is possible that 
extrasynaptic NMDARs act as the sites for buffering during drastic synaptic changes or 
overeactivity. 
1.3.7.12 Lateral diffusion of NMDARs 
The identification of precise sites for glutamate receptor exo- /endocytosis has always 
been challenging. NMDARs could be removed from the synapse by direct endocytosis, 
alternatively they could move to a specific zone for internalisation (Fig 1.6c). Several 
studies suggest that the specialised endocytic zone is lateral to the synapse and the PSD 
in mature neurones, and proteins to be internalised are first diffused laterally away from 
the synapse (where proteins are tightly anchored) on the plasma membrane, to the 
perisynaptic region (where proteins are more mobile) for endocytosis (Blanpied et al., 
2002; Racz et al., 2004). Moreover, studies in rat hippocampal neurones by immunogold 
electron microscopy reveal that clathrin-coated-pits are localised both at the proximal 
region of the PSD and also at further postsynaptic distances in glutamatergic synapses, 
including the perisynaptic- and extrasynaptic sites. Clathrin-coated-pits were shown to 
be able to internalise both AMPARs and NMDARs at extrasynaptic sites (Petralia et al., 
2003). Recently, studies of mature hippocampal neurones using quantum dots and single 
molecule tracing reveal that NMDARs laterally move between synaptic and 
extrasynaptic sites within the plasma membrane, and diffuse at a rate comparable to 
AMPARs. These studies further show that NR2A-containing receptors diffuse at a 
slower rate than NR2B-containing receptors within the synapse (Groc et al., 2004). This 
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is an explanation for the decrease in NMDARs laterally mobility with neuronal 
development in parallel of gradual inclusion of NR2A-containing NMDARs into 
synapses. These results further suggest that endocytosis of NMDARs can also take place 
in endocytic zone localised laterally to the synapse, and lateral diffusion of NMDARs 
plays an important role in NMDAR endocytosis. 
1.4 NMDARs and synaptic plasticity 
Synaptic plasticity means that synaptic connections are adjustable, such that the strength 
and efficacy of synaptic information being transferred across the synapse are subject to 
increases or decreases. This is thought to be the underlying mechanism regulating 
learning and memory (Bliss and Collingridge, 1993; Hebb, 1949; Kandel, 1997). 
As mentioned previously, NMDARs are activated by both ligand-binding and strong 
depolarisation to remove the Mg2+ block. These properties, together with the slow 
activation and decay kinetics of NMDARs allow them to integrate and differentiate 
incoming synaptic activities. Since NMDARs are highly permeable to Cat+, it is well 
established that they are crucial in regulating functional and structural plasticity of 
individual synapses, dendrites, or neurones by triggering Ca2+ influx and activating the 
downstream signalling pathways, and subsequently transforming specific synaptic inputs 
into long-lasting synaptic strength. 
1.4.1 Long-Term Potentiation and Long-Term Depression 
It has been proposed by Donald Hebb in 1949 that co-activity at both presynaptic and 
postsynaptic sites would lead to the strengthening of the connections between neurones 
(Hebb, 1949). However, this theory of Hebbian synaptic plasticity was not proven 
experimentally until 1973, by Bliss and Lomo. They showed that brief high frequency 
synaptic inputs (50-100 stimuli at 100Hz) through the perforant path in the hippocampus 
resulted in strengthened synaptic activity in dentate gyros cells which lasted for an 
extended period of time (hours to days) (Bliss and Lomo, 1973). This phenomenon was 
later known as long-term potentiation (LTP). 
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Long-term depression (LTD), the counterpart of LTP, is a long-lasting decrease in 
synaptic transmission at glutamatergic synapses following synaptic stimulation. It can be 
induced by prolonged low frequency stimulation (900 stimuli at 1 Hz) at the excitatory 
synapses in the Schafer collateral path (Sch-CAI) (Dudek and Bear, 1992). 
Based on the Hebbian theory, synaptic plasticity can be adjusted either presynaptically 
or postsynaptically, or both. Presynaptic changes include the neurotransmitter release 
probability and the number of neurotransmitter release sites, whereas postsynaptic 
changes include alterations in the number of receptors on neuronal surface or their single 
channel conductance (Collingridge et al., 2004). These hypotheses of the Hebbian 
synapse and the finding of LTP and LTD have then initiated a broad range of pioneer 
researches to reveal the mechanisms regulating synaptic plasticity and the possible 
physiological functions and significance. 
1.4.2 NMDAR-dependent LTP 
It is well established that NMDARs are required for induction of LTP at the CA1-CA3 
synapse in the hippocampus. NMDARs act as coincidence detector which are only 
activated during glutamate release and the relief of Mg2+ block. This role of NMDARs 
was confirmed when antagonists, which act on the glutamate site and the glycine site, 
were shown to block LTP (Bashir et al., 1990; Collingridge et al., 1983). Following the 
relief of Mg 2+ block and depolarisation in the postsynaptic membrane, the NMDAR 
mediates the influx of Cat+. The changes in postsynaptic [Ca2+] are important in 
triggering LTP and LTD and it is required to activate a number of kinases and 
phosphotases. The expression of LTP and LTD is characterised by an increase or 
decrease in the AMPAR-mediated currents, respectively, which in turn is thought to 
affect AMPAR number or function on the postsynaptic membrane. Phosphorylation of 
AMPARs is one crucial mechanism in regulating AMPAR expression and function, and 
thus modifies the direction of synaptic plasticity. 
CaMKII is activated by the Cat+-calmodulin complex, which forms when intracellular 
[Ca2+] rises. CaMKII can phosphorylate target proteins such as the G1uR1 subunit of 
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AMPARs (Barria et al., 1997; Roche et al., 1996) and promotes synaptic incorporation 
of GluR1 during LTP, and thus increases the number of AMPAR expressed at the 
synapse and enhances the channel conductance (Shepherd and Huganir, 2007). GluRI 
subunit can also be phosphorylated by PKC and cAMP-dependent protein kinase (PKA) 
(Roche et al., 1996) which also seem to play a role in LTP. PKA is activated by cyclic 
adenosine monophosphate (cAMP), which is caused by an increase in intracellular 
[Ca2+], and its phosphorylation results in increased AMPAR-mediated transmission and 
may also promote insertion of GluRl to extrasynaptic sites, which then laterally diffuses 
across the plasma membrane into the synapse (reviewed in Sherperd & Huganir, 2007). 
NMDAR-dependent LTP has been observed in brain regions other than the hippocampus 
(Feldman et al., 1999; Watt et al., 2004) although NMDAR-independent LTP has also 
been seen (Kapur and Haberly, 1998; Wang et al., 1996; Wang et al., 1997). It has been 
a long time since induction of LTP was first shown to increase NMDAR-currents at 
synapses in the hippocampus (Asztely et al., 1992; Bashir et al., 1991; Berretta et al., 
1991). Only until recently, has the LTP expression mechanism been shown to involve 
changes in NMDAR number and/ or subunit-composition at the synapse (Grosshans et 
al., 2002). Changes in NMDAR trafficking were first shown to be involved in LTP in 
the CAI region of rat hippocampus. LTP- triggered enhancement in synaptic strength in 
neonatal hippocampal synapses was shown to be mediated by an increase in the number 
of AMPARs on the post-synaptic membrane. In contrast, LTP in adult hippocampus 
leads to an increase in surface expressed NMDARs, but not AMPARs. This increase in 
insertion of NMDARs is subunit-specific to NR2A-containing receptors and involves 
phosphorylation by PKC and Src-kinase (Grosshans et al., 2002) (Fig. 1.7a). This 
finding is consistent with previous findings showing that PKC promotes SNARE- 
dependent exocytosis of NMDARs and enhances channel opening in hippocampal 
neurones (Lan et al., 2001). 
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1.4.3. NMDAR-dependent LTD 
Like LTP induction, induction of LTD at CAI synapses in hippocampus is also 
dependent on NMDAR-triggered Ca2+ influx (Bear and Malenka, 1994). The most 
accepted model for LTD of AMPAR-currents involves PKC phosphorylation and PICK1 
binding to G1uR2 subunits, which induces dynamin-mediated clathrin-dependent 
endocytosis of AMPARs from the postsynaptic membrane (Chung et al., 2003; Hanley 
and Henley, 2005; Kim et al., 2001; Lee et al., 2002b; Leitges et al., 2004; Wang and 
Linden, 2000; Xia et al., 2000). Whereas LTD of NMDAR-currents at CAI synapses 
does not involve endocytosis of NMDARs. It was shown to be dependent on actin 
polymerisation (Morishita et al., 2005) and consistent with the finding that NMDARs 
are laterally diffused on the plasma membrane from the synapse to extrasynaptic sites 
(Fig. 1.7b). At CA3 synapses, induction of LTD between two pyramidal neurones 
requires dynamin-dependent NMDAR endocytosis (Montgomery and Madison, 2002; 
Montgomery et al., 2005). Another form of LTD that involves NMDAR trafficking is 
induced by activation of mGluRI at the CAI hippocampal synapses. It is showed in 
cultures that NMDAR endocytosis is triggered by application of mGluRI agonist 3,4- 
dihydropheylglycine (DHPG). Moreover, application of DHPG also induces chemical 
LTD of NMDAR-currents in hippocampal slices (Snyder et al., 2001) (Fig. 1.7b). It is 
known that NMDARs are crucial in induction of LTP and LTD, whereas AMPARs are 
thought to be regulators of synaptic plasticity. While a large number of studies have 
demonstrated that AMPAR trafficking in postsynaptic sites determines the directions of 
synaptic plasticity, the importance of NMDAR trafficking in regulating LTP and LTD is 
largely unknown. Continuous efforts are required to understand the roles of NMDAR 
trafficking underlying synaptic plasticity. 
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Fig. 1.7 Schematic model of NMDAR insertion or internalization during NMDAR- 
dependent LTP (a) and LTD (b), respectively. 
Adapted from Lau & Zukin, 2007, with permission from Nature Review Neuroscience. 
1.4.4. Subunit-specific regulation of NMDARs and synaptic plasticity 
Several studies suggest that NMDARs regulate LTP or LTD in a subunit-specific 
manner. It has been shown in adult rat hippocampus and perirhinal cortex that NR2A- 
containing NMDARs are required to induce LTP as blocking with the NR2A antagonist 
NVP-AAM077 (NVP) abolished induction of LTP. In contrast NR2B-containing 
receptors in perirhinal cortical neurons are thought to lead to LTD in the presence of a 
glutamate uptake blocker, suggesting that glutamate spillover onto extrasynaptic sites in 
the presence of uptake blockers is required for LTD induction (Massey et al., 2004). In 
two-week old rat hippocampus, Ro 25-6981, NMDAR antagonist which is highly 
selective for NR2B receptors, was shown to reduce only LTP, but not LTD; whereas 
NVP-AAM077 reduced both LTP and LTD in a concentration dependent manner 
(Bartlett et al., 2007). Likewise, in young hippocampus, blockade of NR2A-containing 
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receptors with NVP-AAM077 prevents LTP induction without affecting LTD induction. 
Whereas applications of NR2B antagonists, Ro25-6981 or ifenprodil, abolish the 
induction of LTD, but not LTP (Liu et al., 2004). These observations are likely due to 
the various developmental stages, brain regions and experimental conditions. These 
variabilities could also be due to localisation of NR2 subunits, with NR2A subunit 
primarily localised at the synapse (Thomas et al., 2006; Tovar and Westbrook, 1999), 
the PSD in particular, because NR2A-containing receptors have relatively fast kinetics 
and results in a more dramatic magnitude and extended timing in Ca2+ influx, which is 
essential for LTP (Malenka, 1991). In contrast, NR2B-containing receptors are thought 
to localise at extrasynaptic sites and have slower kinetics, thus generating a smaller and 
slower Ca 2+ current (Monyer et al., 1994; Rumbaugh and Vicini, 1999; Tovar and 
Westbrook, 1999), which are required for LTD induction (Artola and Singer, 1993; 
Cummings et al., 1996; Lisman, 1989). However, this hypothesis has remained 
controversial because several other groups have obtained contradictory results. Several 
groups showed that NR2A is necessary for LTP (Kohr et al., 2003; Sakimura et al., 
1995), however some were not able to impair hippocampal LTP induction using NR2A- 
type nor NR2B-type blockers (Berberich et al., 2005). Furthermore, LTP induction was 
shown to be NR2A-dependent in the dorsolateral bed nucleus of the stria terminalis 
(d1BNST). However, LTP was still inducible in dlBNST of NR2A null mice, and doubt 
was also cast on the specificity of putative NR2A-specific inhibitor NVP-AAM077 as it 
displays non-specific blocking of NR2B-containing receptors in various types of cell 
cultures (Weitlauf et al., 2005). In addition, the role for NR2B in triggering hippocampal 
LTD is also controversial. It is reported that the NR2B antagonist ifenprodil can enhance 
NMDAR-mediated LTD instead of blocking it in young hippocampal slices. Moreover, 
NR2B transgenic mice with increased NR2B expression display enhanced LTP and 
more efficient in learning in a number of behavioural tests (reviewed in Cull-Candy & 
Leszkiewicz, 2004). 
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1.5 NMDARs and schizophrenia 
Schizophrenia is a chronic, severe and disabling psychiatric disorder producing 
significant financial and emotional hardship for patients, their families and society. It 
affects approximately 1% of the global population, and equally affects men and woman. 
It occurs at similar a rate in all ethnic group around the world (Mueser and McGurk, 
2004). Unfortunately, the causes of schizophrenia and related neuropathologies are still 
unknown, which imposes extreme difficulties in prescribing medications and assigning 
treatments to cure the related symptoms observed in schizophrenic patients. 
1.5.1. Clinical symptoms of schizophrenia 
Schizophrenia is characterised by three distinct categories of symptoms. They are 
positive symptoms, negative symptoms, and cognitive symptoms (reviewed in 
Schizophrenia Revealed by Michael F. Green, Chapter 1). 
Positive symptoms are considered `positive' because they emerge with the illness onset 
and were not present to begin with. These symptoms usually involve the loss of reality, 
such as hallucination, delusion, unusual thoughts and movement disorders, and they are 
easy to spot as they are not common in healthy subjects. These psychotic symptoms 
usually appear in men in their late teen to early 20s and in woman in their mid 20s to 
early 30s. It is unusual to observe these symptoms after 45 and rarely before puberty, 
although a few cases in children have been reported. 
Negative symptoms represent the loss of certain abilities, emotions and behavioural 
states that are typically present, including loss of pleasure in everyday life, speaking 
infrequently, absence of normal emotional and facial expressions, lack of motivation and 
ability to initiate and sustain planned activity. Negative symptoms can be easily be 
confused with depression and laziness. 
Cognitive symptoms are more subtle and involve deficits in sustaining attention, in 
working memory, which is the ability to retain recent acquired memory, and to recall it 
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in a short time, disorganised speech and thoughts, and the loss of executive functioning 
which involves problem solving and the ability to analyse and interpret information and 
then making a reasonable decision base on the analysis. 
1.5.2 Neuropathology of schizophrenia 
Accumulative evidence, including in vivo human imaging results and postmortem tissue 
findings, showing significant abnormalities in human brain structure in schizophrenia. 
Most if not all schizophrenic patients appear to have significant reduction in brain 
volume and weight along with ventricular enlargement (Harrison et al., 2003; Lawrie 
and Abukmeil, 1998; Wright et al., 2000). Imaging studies indicate brain abnormalities 
particularly the volume reduction and change of shape in hippocampus (Casanova and 
Rothberg, 2002; Csemansky et al., 2002; Heckers, 2001; Nelson et al., 1998), and 
reduction in the thickness and gyrification of prefrontal cerebral cortex (Kulynych et al., 
1997; Kuperberg et al., 2003; Vogeley et al., 2000). Moreover, histological observations 
reveal aberrantly located or clustering of neurones in the entorhinal cortex and prefrontal 
cortex white matters. Notably, these brain regions are responsible for emotion regulation 
and cognitive functions that are impaired in schizophrenia. Abnormalities in these brain 
regions suggest that schizophrenia is a neurodevelopmental disorder rather than 
neurodegenerative. Thus, it is likely that schizophrenia pathogenesis are resulted from 
malfunction of proteins that are crucial in neurodevelopment which lead to the disrupted 
neuronal migration and connectivity of neurones early in development (Harrison, 1997). 
Although the precise phenotypes of disrupted neurochemical connections are not fully 
understood, it is clear that the NMDAR-mediated glutamatergic transmission in the 
hippocampus is affected in schizophrenia (Sodhi et al., 2008). 
1.5.3. NMDARs hypofunction and schizophrenia 
The hypothesis that schizophrenia might result from reduced-NMDAR activity first 
gained support from clinical data. It is shown in schizophrenic patients that 
subanaesthetic doses of non-competitive antagonists of the NMDAR, phencyclidine 
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(PCP), ketamine and MK-801, exacerbate both the positive and negative symptoms in 
patients with schizophrenia (Javitt and Zukin, 1991; Krystal et al., 1994). While in 
healthy individuals they produce an acute schizophrenic-like psychotic state (Breier et 
at., 1997). Expression studies of NMDARs from postmortem tissues of schizophrenic 
individuals reveal the role of NMDARs and highlight the different expression level of 
different NMDAR subunits in the hippocampus. These studies have reported decreased 
mRNA expression level of NR1, unchanged NR2A level and decreased NR2B 
expression, when compared to healthy controls (Gao et at., 2000; Law and Deakin, 
2001). In animal models, subanesthetic doses of non-competitive NMDAR antagonists 
produce schizophrenic-like behaviours including hyperlocomotion, enhanced stereotypic 
behaviours, cognitive and sensorimotor gating deficits, and impaired social interactions 
(Lipska and Weinberger, 2000). Which mimic the positive and negative symptoms 
observed in healthy human subjects induced by NMDAR- antagonists. Genetic modified 
mice with knockdown of NR1 and knockout of NR2A also support the findings that 
reduced NMDAR activity results in schizophrenic-like phenotypes. Mice that expressing 
5-10% of normal NR1 protein display behavioural abnormalities similar to those 
observed in pharmacologically induced mouse models of schizophrenia and these 
abnormalities can be alleviated by antipsychotic drug treatment which antagonising 
dopaminergic and serotonergic receptors (Miyamoto et al., 2001; Mohn et al., 1999). 
Moreover, NR2A knockout mouse is another animal model for schizophrenia showing 
NMDAR hypofunction. They also display schizophrenic-like behaviours such as 
hyperactivity in novel environment and impaired latent learning in finding water-source 
task, which are associated with selective attention. Similarly, hyperlocomotion in 
NR2A-null mice can be ameliorated by antipsychotic drug treatment (Miyamoto et al., 
2001). These findings implicate that altered NMDAR expression level could contribute 
to functional impairments observed in schizophrenia, which subsequently alter the 
glutamatergic synaptic transmission and synaptic plasticity throughout development. 
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1.5.4. NMDAR trafficking in schizophrenia 
The glutamatergic dysfunction and NMDAR hypofunction implicated in schizophrenia 
raised the concerns on the possibility of disrupted NMDAR trafficking and localisation 
being contributed to the neuropathologies in schizophrenia. A number of studies 
reported that neuregulin 1, a widely expressed growth and differentiation factor, is 
genetically linked to schizophrenia in humans (Stefansson et al., 2002; Tang et al., 2004; 
Williams et al., 2003). In post-mortem prefrontal cortical tissues obtained from 
schizophrenia patients, Neuregulin-1 overactivates ErbB4 receptors which suppress 
tyrosine phosphorylation of NR2A, and thus NMDAR activity (Hahn et al., 2006). 
Moreover, it is showed in rat prefrontal cortex that neuregulin decreases NMDAR 
currents and promotes rapid internalisation of NR1 via a clathrin/ dynamin- dependent 
mechanism (Gu et al., 2005). Interestingly, the neuregulin receptor, ErbB4, was shown 
to bind more tightly to PSD-95 and NR1 in postmortem brain tissues of schizophrenia 
patients compared to normal control (Hahn et al., 2006). Recently, it is reported that 
neuregulin stimulates NR2B Tyr1482 phosphorylation through Erb4 binding to Fyn, 
which promotes synaptic localisation of NMDAR on the cell surface. In neuregulin 
mutant mice (NRG +'- ), NR2B Tyr1482 is hypophosphorylated, suggesting that 
endocytosis of NR2B via binding to AP-2 is increased and this phenomenon can be 
reversed by antipsychotic drug (Clozapine) treatment (Bjarnadottir et al., 2007). These 
findings support the glutamatergic hypothesis of schizophrenia and neuregulin may play 
a role in the underlying mechanisms of NMDAR dysfunction in schizophrenia. 
1.6. Genetic basis of schizophrenia 
Pronounced evidence, including twin studies, family studies and adoption studies, 
indicates that schizophrenia is predominantly results from a combination of genetic and 
non-genetic factors, with estimates of heritability of risk upto 85% (Bjarnadottir et al., 
2007; Sullivan et at., 2003). Family studies also reveal that schizophrenia is unlikely to 
affected by single defective gene, rather it is caused by polygenic mechanisms, which 
multiple genes act together to give a complex pattern of inheritance of the illness 
(Gottesman and Shields, 1967; Shields et at., 1967). Postmortem brain research has 
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enriched tremendously the understanding of the neuropathology of schizophrenia, which 
has accelerated antipsychotic drug development which specifically targets the symptoms 
observed in schizophrenia patient. However, the ultimate goal is to unravel the complex 
pathophysiological mechanisms leading to schizophrenia and to identify genetic variants 
increase vulnerability to the illness. So as to facilitate early diagnosis and promote 
preventive measures to individuals who are at higher risk of developing the illness than 
others. 
1.6.1. Identifying schizophrenia susceptibility genes 
Screening for schizophrenia susceptibility genes has been majorly done by genome wide 
association studies (GWAS) in combination with linkage analysis or association studies 
of candidate gene strategy. It is noted that schizophrenia is certainly a complex genetic 
disorder and is not characterised by a single causative gene and not showing unified 
patterns of inheritance. Similarly, each susceptibility gene that identified is likely to 
account for a minor increment in risk, and it is also possible to be compensated by other 
protective genes, or be modified by environmental factors. The susceptibility gene 
structure is certainly polygenic and there is no certain set of genes which are 
characterised in most schizophrenic patients. Moreover, even the same causative allele 
may have different phenotypes depending on the genetic background of the sick 
individuals. Therefore, meta-analyses were performed to identify schizophrenia 
susceptibility genes by combining results of large number of GWAS, linkage analyses 
and chromosome abnormalities found in families with psychosis. And several `hotspots' 
for schizophrenia are identified within chromosomes lg2l-22,1g42,2p12-22.1,5q, 
6p22-24,8p21-22,10g25.3-26.3,13g34 and 21g11 (Owen et al., 2007). Once the 
specific loci or genes have been located, it is important to identify specific allelic 
variants, which are usually single-nucleotide polymorphisms (SNPs) within or adjacent 
to the gene. A full identification of susceptibility genes for schizophrenia cannot be 
solely coming from linkage or association studies but do also require molecular 
biological or biochemical evidence to proof the impact of the risk variant in the 
pathogenesis of the illness. 
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1.6.2. Glutamatergic genes as susceptibility genes of schizophrenia 
It is noted that several of the "hotspots" for schizophrenia contain genes influencing the 
glutamatergic system, especially various subunits of the NMDAR including NRl 
(GRIN1 on chromosome 8q24.3); NR2A (GRIN2A on 16p13.2) and NR2B (GRIN2B 
on 12pl2). Compare to the NR2A gene (GRIN2A) which was reported to be associated 
to schizophrenia in a few populations (Iwayama-Shigeno et al., 2005; Williams et al., 
2002), research in theNR2B gene (GRIN2B) has been more extensive. Which several 
studies including large scale meta-analysis involving a variety of ethnicities suggest 
possible association between the GRIN2B and schizophrenia (Li and He, 2007). 
Moreover, neuregulin, which was shown to regulate NMDAR trafficking as previously 
prescribed (Bjamadottir et al., 2007; Gu et al., 2005; Hahn et al., 2006), is reported by a 
number of studies that the neuregulin gene (NRG 1), localised on chromosome 8p22-p 11, 
is also a schizophrenia susceptibility gene (reviewed in Sodhi et al., 2008). 
1.6.3. Dysbindin as a susceptibility gene for schizophrenia 
Dystrobrevin binding protein, or dysbindin, is encoded by the gene DTNBP 1, which is 
located within chromosome 6p22.3, a region that is consistently linked to schizophrenia. 
A significant association between schizophrenia and various DTNBPI haplotypes have 
been reported in a number of populations, such as English, German, Chinese, Japanese, 
Swedish and Irish (Straub et at., 2002). DTNBPI expression is reduced in the cortex of 
human subjects who have a haplotype associated to schizophrenia (Bray et al., 2005). It 
is thus among the most promising susceptibility genes associated with a higher risk of 
developing schizophrenia. Both mRNA and protein expression levels of dysbindin have 
shown to be reduced in different brain regions including the hippocampus and prefrontal 
cortex in postmortem brain tissues of schizophrenic patients (Weickert et al.; 2004). 
Recent evidence suggests that dysbindin might contribute to the hippocampal 
glutamatergic synaptic pathology of schizophrenia (Talbot et al., 2004). However, the 
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core molecular pathway of how dysbindin contributes to schizophrenic pathologies is 
currently unclear. 
1.7. Dysbindin in protein trafficking 
Dysbindin is a 50kDa protein originally cloned from a yeast two-hybrid screen of 
binding partners of a- and ß-dystrobrevin, which are the component of dystrophin- 
associated protein complex (DPC) (Benson et al., 2001) in neuromuscular junction and 
brain, respectively. Dystrophin is a key component of dystrophin-glycoprotein complex 
(DGC), which directly links the intracellular cytoskeleton to extracellular matrix and 
serves as a scaffold for proteins involved in signal transduction (Blake et al., 2002). It is 
known that DPC is densely located in the PSD (Blake et al., 1998), thus dysbindin is 
thought to be involved in PSD functions, most likely be involved in Akt-dependent 
signal transduction, trafficking or tethering of receptors at the postsynaptic sites (Husi 
and Grant, 2001). 
1.7.1. Dysbindin as an essential component of Biogenesis of lysosome-related 
organelles complex-1 (BLOC-1) 
Dysbindin is one of the essential components of BLOC-1 (Li et al., 2003), which is a 
multi-subunit protein complex that was shown to be present on the transferring-receptor- 
positive endosomes, where it regulates membrane protein targeting to synaptic vesicles, 
lysosomes, and LROs (Ryder and Faundez, 2009). Other than dysbindin, BLOC-1 also 
includes at least seven other subunits: Pallidin, muted, cappuccino (CNO), BLOS1, 
BLOS2, BLOS3 and snapin (Dell'Angelica, 2004). Notably, mutation in dysbindin gene 
has also been reported in the pathogenesis of another genetic disease, named 
Hermansky-Pudlak syndrome (HPS). The hallmark of pathogenesis of HPS is the 
disruption of the biogenesis of a group of cell-type-specific LROs in the endosomal- 
lysosomal system. Such organelles including melanosomes, platelet dense granules, lytic 
granules and other related organelles, share in common with lysosomes and 
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characterised by having at least one transmembrane and luminal proteins (Dell'Angelica 
et al., 2000). LRO is synthesized from the Biogenesis of lysosome-related organelles 
complex (BLOC), which is associated with membranes as a peripheral membrane 
protein (Di Pietro and Dell'Angelica, 2005). Although the localisation and functions of 
different BLOCs have not been well defined, BLOC-1 has been shown to regulate 
endosomal-lysosomal trafficking through the interactions with other BLOCs or their 
sequential action. For examples, BLOC-1 regulates the sorting of selected membrane 
proeins into vesicles either by itself or in association with the AP-3: interaction between 
BLOC-1 and the adaptor protein (AP)-3 complex (Di Pietro et al., 2006) serves in the 
endosomal trafficking pathway from early endosomes to late endosomes or lysosomes in 
a clathrin-dependent manner (Peden et al., 2004), moreover BLOC-1 was also shown to 
interact with BLOC-2 to facilitate protein trafficking in an unknown mechanism that is 
independent to AP-3/clathrin (Di Pietro et al., 2006). 
1.7.2. The role of dysbindin in neurones 
Dysbindin is widely expressed in the brain and located both pre- and postsynaptically 
(Benson et al., 2001). Dysbindin was shown to bind directly to both a- and ß- 
dystrobrevin within the DPC in the PSD (Benson et al., 2001), which suggests a 
postsynaptic function of dysbindin. Several groups proposed a presynaptic role of 
dysbindin. For examples, in primary cortical neurones, overexpression of dysbindin led 
to an increase in SNAP-25 and synapsin-1 expression, and subsequently increases 
glutamate release at the presynaptic sites (Numakawa et al., 2004). Moreover, in vivo 
studies showed that dysbindin assembled into BLOC-1 does not interact with 
dystrobrevin and is exempt from the DPC (Nazarian et al., 2006). Therefore, it is likely 
that dysbindin is located at both pre- and postsynaptic sites and is responsible in playing 
distinct roles when assembled in different complexes. It is noted that apart from 
glutamatergic hypothesis, dysregulation of dopaminergic signalling is also involved in 
neuropathologies in schizophrenia. In rat pheochromocytoma cell line, PC-12 cells, 
siRNA suppression of dysbindin results in an increase in dopamine release (Kumamoto 
et al., 2006). Which seems to be correlated to the finding in dysbindin-null mice (sandy 
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mice) that there is a decrease in dopamine level in the cortex, possibly due to the 
increased dopaminergic transmission and dopamine turnover rate (Murotani et al., 
2007). In the prefrontal cortex, over stimulation of dopamine receptor 2 (D2R) 
signalling pathway, or understimulation of dopamine receptor I (D1 R) signalling 
pathway leads to a reduction in cortial excitation and subsequent inhibition via 
stimulation of inhibitory GABA interneurones (Seamans et al., 2001). Such changes are 
expected to trigger neurophysiological and cognitive dysfunction in schizophrenia. 
Interestingly, a recent study showed that siRNA knockdown of dysbindin in primary 
cortial neurones increases surface expression level of D2R, but has no effect on DIR 
(Iizuka et al., 2007). Suggesting that dysbindin, as a schizophrenia susceptibility gene, 
functionally affects dopamine receptor trafficking in a subunit-specific pathway, a 
mechanism that has long been implicated in schizophrenia. The sandy mice, which arose 
from spontaneous mutation in a DBA/2J strain and carry a DTNBP 1 allele encoding a 
protein with an inframe 22-residue deletion (Li et al., 2003). In cultured hippocampal 
neurones derived from the sandy mice, it displays morphologically abnormalities of the 
actin cytoskeleton in the growth cone, suggesting the role of dysbindin in intracellular 
trafficking in neurones and in neurodevelopment (Kubota et al., 2009). In addition, 
sandy mice also exhibit defective synaptic structure and function in the hippocampal 
CAI neurones (Chen et al., 2008). Because it is known that dysbindin is a stable 
component of BLOC-1 and HPS is a result of defective protein trafficking along the 
endocytic/ lysosomal pathway. Thus, it is possible that genetic variations in the 
dysbindin gene disrupt normal protein trafficking which contribute to the pathogenesis 
observed in schizophrenia. 
1.7.3. Behavioural characterisation of dysbindin-null mice 
Sandy mice have a spontaneous mutation on chromosome 13 that arose in the DBA/2J 
strain (Swank et al., 1991). This mutation is a 38kb in-frame deletion in the DTNBPI 
gene which led to the loss of amino acid 119-172 and causes a reduction of dysbindin in 
heterozygous mice (Dys+/-) and a total loss in homozygous mice (Dys-/-). Thus, sandy 
mice serve as an animal model of dysbindin function and there is emerging evidence 
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showing that sandy mice exhibit schizophrenia-related behavioural abnormalities 
(Bhardwaj et at., 2009). Homozygous sandy mice (Dys -/-), both in DBA/2J and 
C57BL/6J strains, are shown to be hyperactive in the open-field and on the elevated zero 
maze, and the hyperactivity in homozygous (Dys-/-) mice is not the consequence of 
increased anxiety as they showed no motor co-ordination impairment. Moreover, Dys-/- 
mice also show reduced habituation to novel environment and increased sensitisation to 
amphetamine, suggesting abnormalities in dopaminergic activity (Cox et al., 2009). In 
addition, homozygous (Dys-/-) mice in C57BL/6 strain also display spatial learning and 
memory deficit in the Morris water maze, reflecting defects in hippocampal functions 
(Cox et al., 2009). These behavioural abnormalities observed in sandy mice may model 
cognitive deficits related to altered dybindin gene expression which are associated to the 
pathophysiologies of schizophrenia. 
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Chapter 2. 
Materials and Methods 
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2.1. Bacteria strains 
The bacterial strains used in transformation include: 
-Escherichia Coli TOP10 (Invitrogen) 
F- mcrA A(mrr-hsdRMS-mcrBC) cp801acZAM15 OlacX74 nupG recA1 araD139 
0(ara-1eu)7697 galE15 ga1K16 rpsL(StrR) endA1 ?; 
-DH5a (homemade) 
huA2 A(argF-lacZ)U169 phoA gin V44 080 A(lacZ)M15 gyrA96 recAl relAl 
endAl thi-1 hsdR17 
2.1.1. Bacterial growth media and plate preparation of chemically competent 
bacteria 
Bacteria were grown in the following media: 
Luria-Bertani (LB) Medium: 
1Og/L Bacto-tryptone (Gibco) 
5h/L Bacto-yeast extract (Gibco) 
10/L Sodium Chloride 
Superbroth (KD medical) 
100mg/L ampicillin (Stratagene) or 30mg/L kanamycin added as appropriate 
prior to pouring 
For growth on plate, 16g/L agar were added prior to autoclaving 
Or, 
SOC medium (Invitrogen) 
2.1.2. Preparation of chemically competent bacteria 
500 ml of LB were inoculated with 5ml of bacteria culture and grown at 37°C with 
shaking until an ODD reached 0.5-0.6, the cells were cooled on ice for 5 min and 
centrifuged at 5000 rpm for 10 min at 4°C. The pellet was resuspended by gentle 
pipetting in 50 ml of Buffer 1 (30 mM Potassium acetate, 100 mM RbC12,1 mM CaC12, 
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5 mM MnC12,15% glycerol, pH5.8), cooled on ice for 5 min and then recentrifuged as 
previously. The pellet was resuspended in 5 ml Buffer 2 (10 mM MOPS, 7.5 mM CaC12, 
1 mM RbC12,15% glycerol, pH6.5), chilled on ice for 15 min and divided into 200 µl 
and fast freeze in liquid nitrogen and then stored at -80 °C. 
2.1.3. Transformation of chemically competent bacteria 
For each transformation, 50 µl of competent cells were thawed on ice and mixed gently 
with up to1-5µg of plasmid DNA. The cell mixture was placed on ice for 15 min and 
then heated in a 42 °C waterbath for 45 sec before being returned to ice for 2 min. 950 µl 
of SOC medium was added to the mixture and incubated at 37 °C for 1 hour with 
shaking. The cell mixture was centrifuged at 2000rpm for 30 sec, 75011 of medium was 
removed and the pellet was resuspended in the remaining 250 µl SOC. Cell mixture was 
plated out onto a LB agar plate containing an appropriate antibiotic and incubated 
overnight at 37 °C. 
2.1.4. Storage of bacteria 
Bacterial colonies were stored on agar plates for up to one month at 4 T. For long term 
storage, glycerol stocks of bacteria were made. 700 µl of a saturated bacterial culture 
was mixed with 300 µl of 70% sterile glycerol and frozen immediately at -80 °C. 
2.2. DNA manipulation 
2.2.1. Plasmids Used 
f pcDNA3.1 (Invitrogen) 
f pCDM8 
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2.2.2. Site-directed mutagenesis 
Site-directed mutagenesis involves creating a mutation on the defined site of a known 
plasmid DNA using short oligonucleotide primers containing the desired base change. 
QuikChange® Site-Directed mutagenesis kit was used, the two mutagenic primers were 
selectively designed using the software PrimerX. Both primers contained the desired 
mutation and annealed to the same sequence on opposite strands of the plasmid, both 
primers were also between 25 to 45 bases in length, with a melting temperature >75 °C. 
Sample reaction was prepared and kept on ice (5 µl l OX reaction buffer; 5-50 ng 
template plasmid DNA; 125 ng of each primer; 250 nM dNTP mix; ddH2O to a final 
volume of 50 µl), then added 1 µl (2.5U) of Pfu Turbo DNA polymerase. The reaction 
mixtures were then transferred directly from ice to a DNA engine PCR machine (BD 
bioscience) preheated to 96 °C. 
2.2.3. Agarose gel electrophoresis 
Agarose gels electrophoresis was performed to analyse DNA by isolating DNA 
fragments according to their sizes. Agarose gels used were of 0.8-2% agarose, which 
were made by dissolving low melting agarose powder (Invitrogen) in TAE buffer. 
Microwave mixtures until agarose dissolved and cool down to lurk warm before 
ethidium bromide (EtBr) (50 ng/ml) was added to the gels. The cast gels were 
submerged into TAE buffer and DNA samples were mixed with 5X sample loading 
buffer with dye before loading into the wells of the agarose gels, molecular markers 
were loaded alongside. DNA samples were separated by electrophoresis at 60-110V 
depending on the size and percentage of the agarose gels. DNA fragments were 
visualised under UV light on a transilluminator. 
2.2.3. Enzyme digestion of vector DNA . 
Restriction enzymes cleave DNA samples into fragments at specific nucleotide 
sequences. Enzyme recognition sites on DNA sequence 'are usually 4 to 6 base pairs in 
length, which allow restriction enzymes to digest into fragments of different sizes. 
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Approximately 10 units (-1 µl) of enzyme (New England Biolab, NEB) was used to 
digest 1 µg of vector DNA in the presence of appropriate buffer and BSA if necessary 
depending on the restriction enzyme. Vector DNA was digested for 2 hours or more at 
37°C to allow thorough digestion. 1 gl of Calf Intestinal Alkaline Phosphatase (CIP) 
(NEB) was added to each reaction and the digestion continued for 1 hour to reduce self- 
ligation. The digested fragments could be separated by DNA electrophoresis and 
purified by gel excision. 
2.2.4. DNA extraction from agarose gels 
DNA was recovered using a QlAquick gel excision kit (Qiagen). The desired DNA 
fragments, visualised using a transillumilator, were excised from agarose gels using a 
clean razor blade. The sliced gel fragments were weighed and 2 volumes of QG buffer to 
1 volume of gel was added and heated at 42 °C waterbath for 20 min or until the gel was 
visibly dissolved. To bind DNA, the sample was centrifuged on a spin column for 1 min 
and the flow through decanted. The spin column was washed with 750 µl PE buffer and 
centrifuged for 1 min. Decant the flow through and centrifuged the column at maximum 
speed for 1 min. The spin column was transferred to a clean 1.5 ml eppendorf tube. 
DNA was eluted by adding 30 µl EB buffer or ddH2O to the centre of the spin column, 
let stand for 3 min and then centrifuged at maximum speed for 1 min. 
2.2.5. Polymerase Chain Reaction (PCR) 
PCR is a general technique in molecular biology used to amplify specific regions of 
DNA fragments and to create mutations in DNA sequences. It rapidly amplifies a single 
DNA fragment into numerous copies. To specifically amplify the desired fragment of 
DNA, short oligonucleotide primers were designed and synthesized (Operon). Both 
primers were short single-stranded DNA fragments, which were between 18 to 25 base 
pairs in length and had annealing temperatures of 50 -70 °C. The primers bound 
specifically to complementary DNA sequences at the target site of the denatured 
template DNA. PCR reaction mixture were set up on ice with 100 ng of template DNA, 
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polymerase buffer, 2.5 pM each of forward and reverse primer, 250 nM dNTPs (a 
mixture of the four deoxynucleotide triphosphates - dATP, dCTP, dTTP and dGTP), and 
1µl or IOU of suitable heat-stable DNA polymerase (Taq or Pfu turbo). All of the 
reaction samples were directly transferred to a PCR thermal cycler (BD bioscience) and 
preheated to 95 T. At 95 °C double stranded DNA was denatured, at the annealing 
temperature (calculated as 2 °C per purine residue and 4 °C per pyrimidine residue in the 
primer) the primers anneal to the single-stranded DNA template and at 72°C, the 
polymerase catalyses the addition of nucleotides to the primers. Each newly synthesized 
DNA strand can act as a template for further DNA synthesis. Therefore, after 25 cycles 
of DNA synthesis, the PCR product will include approximately 105 copies of the target 
DNA fragment. 
A standard protocol of cycles was started with initial denaturing step at 95 °C for 5 min, 
followed by 24-30 cycles of the following: 30 sec denaturation at 95 °C, 30 sec 
annealing at appropriate temperature, and extention at 72°C (time at 72°C was 
determined by the length of fragment to be amplified). The final step involved an 
incubation at 72°C for 10 min ensuring that all incomplete PCR extensions were 
finished. The samples were kept at 4 °C until collection. 
2.2.5. PCR product purification 
Raw PCR products were purified using QlAquik PCR purification kit (Qiagen) prior to 
enzyme digestion. To purify PCR product, 5 volumes of PB buffer were added to 1 
volume of the PCR sample and mixed. To bind DNA to the spin column, samples were 
applied to the spin column and centrifuged for 1 min. The flow-through was decanted 
and the column was washed with 750 µl PE buffer, and centrifuged for 1 min. The 
column was transferred to a clean Eppendorf tube and the DNA was eluted by applying 
30 µl of ddH2O to the centre of the column. After 3 min it was centrifuged at maximum 
speed for 1 min. 
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2.2.6. Enzyme digestion of insert DNA 
PCR products containing the insert DNA were first purified using QlAquik PCR 
purification kit or QlAquik gel excision kit before enzyme digestion. The purified DNA 
(30 µ1) were separated into 3 reactions with 10 t1 each. For each reaction, 1 µ1(10U) of 
each restriction enzyme was added with the appropriate buffer and BSA depending on 
the enzymes, and then digested for 2 hours at 37°C. The digested fragments were then 
separated by DNA electrophoresis and purified by gel excision. 
2.2.7. Ligations 
Relative quantities of vector and insert DNA fragments were assessed by running 
aliquots of the obtained PCR purified products on an agarose gel. Ligations were set up 
with approximately 1: 5 to 1: 20 ratios of vector to insert DNA with 1 unit of T4 ligase 
(NEB), ligase buffer and ddH2O in a total volume of 20 µl. Ligations were performed at 
16 °C overnight or at room temperature for 2 hours, bacteria were transformed with 
portions of ligation mixture as described above. 
2.2.8. Screening bacterial colonies by PCR 
As an initial screen of transformed bacteria colonies from ligation products, PCR was 
used if the appropriate primers of vector were available to determine whether the desired 
DNA fragment was present. The reaction mixture was prepared as described above for 
the PCR mixture except Taq polymerase was used instead of Pfu turbo. A bacterial 
colony was picked with a plastic pipette tip and mixed with the reaction mixture, the tip 
was then streaked onto a LB plate with appropriate antibiotics and incubated at 37°C 
overnight. The reaction mixture was allowed to proceed in the PCR machine with the 
standard protocol as previously described. The PCR products were visualised using gel 
electrophoresis. 
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2.2.9. Small scale purification of plasmid DNA from bacteria (Mini-prep) 
Bacteria colonies confirmed by PCR were picked from plates using plastic pipette tips 
and transferred to 4 ml LB medium containing an appropriate antibiotic. The cultures 
were allowed to grow at 37°C overnight with shaking. The bacterial cells were harvested 
by centrifugation at 3000 rpm for 10 min at 4°C. DNA was extracted from these 
bacterial cultures using a QlAprep spin mini-prep kit (Qiagen). Briefly, the bacteria 
pellet was resuspended in 250 µl of buffer P1 and transferred to an eppendorf tube. 250 
gl of buffer P2 was added and mixed thoroughly to lyse the bacterial cell walls and 
disrupt the cell membranes. 350 µl of buffer N3 was then added to neutralise the alkaline 
medium from P2 buffer so as not to additionally disrupt the plasmid DNA and to give 
acidic medium for DNA binding to the spin column. The mixtures were then centrifuged 
at maximum speed for 10 min to pellet the cell debris, the supernatant was loaded onto a 
spin column and was centrifuged at maximum speed for 1 min to allow DNA binding. 
The columns were then washed with 750 µl PE buffer, decanted flow through and 
centrifuged again to drain remaining wash buffer. The spin column was transferred to a 
clean 1.5ml Eppendorf tube, DNA was eluted by applying 50 µl dd112O to the centre of 
the spin column, let stand for 3 min, then centrifuged at maximum speed in 14,000 rpm 
for 1 min. 
2.2.10. Large scale purification of plasmid DNA from bacteria (Maxi-prep) 
Large scale purification of plasmid DNA was essentially performed in a larger scale of 
the previous protocol using QlAprep maxi-prep kit (Qiagen). Maxi-preps yield up to 500 
µg of plasmid DNA. The procedures were followed according to the protocol in the 
Qiagen handbook. 250 ml of bacterial cultures were started a night before with 
appropriate antibiotic and allowed to grow overnight at 37°C with shaking. For certain 
constructs (Tac), bacteria was first grown overnight in 20 ml of Superbroth with 
appropriate antibiotic, which was then transferred to 500 ml of Superbroth the next 
morning and allowed to grow for 3 hrs. Chloremphenicol (170mg/L) was added to the 
bacterial culture and continued to grow overnight. RNase A solution and Lyse-Blue 
were first added to P1 buffer and P3 buffer was pre-chilled at 4°C. Bacterial cells were 
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harvested by centrifugation at 3000 rpm for 15 min at 4°C and pellet was homogenously 
resuspended in 10 ml of P1 buffer then transferred to a clean 50 ml falcon tube. Cells 
were lysed with 10 ml of P2 buffer by vigorously inverting the tube for 5-6 times and let 
stand for 5 min at room-temperature. 10 ml of ice-cold P3 buffer was added to neutralise 
the mixture and was incubated on ice for 20 min before centrifugation at 10,000 rpm for 
30 min at 4°C to remove the bacterial cell debris and genomic DNA. The supernatant 
was filtered with miracloth (Chemicon) to remove any remaining debris and then 
transferred to a Qiagen spin column previously equilibrated with 10 ml of buffer QBT 
and allowed to pass through the column by gravity flow. The column was washed twice 
with 30 ml of buffer QC and transferred the column to a clean 50 ml falcon tube. DNA 
was eluted by applying 15 ml of buffer QF to the centre of the column and allowed to 
flow through by gravity flow. DNA was precipitated by 10.5 ml of (0.7 volume) 
isopropanol and harvested by centrifugation at 10,000 rpm for 30 min at 4°C. 
Supernatant was carefully decanted not to disturb the pellet and the pellet was 
transferred to a 1.5 ml Eppendorf tube and washed 5 times with 1 ml of 70% ethanol and 
allowed to air dry prior to resuspension in ddH2O of pH 8.0 TE buffer. 
2.2.11. DNA sequencing 
All DNA sequencing was performed on an automatic ABI PRISM® Genetic Analyzer 
(Applied Biosystems) by Dr. James Nagel at the DNA sequencing facility (NINDS, 
NIH). The sequencing reactions were performed using 250 ng of template DNA and 
25nM sequencing primers. 
2.2.12. Computerised analysis of plasmid DNA 
DNA sequences were mapped using the software MacVector (MacVector, Inc). 
Unknown DNA sequences were screened and sequence alignments were performed 
against a number of databases using the NCBI BLAST program 
(http: //blast. ncbi. nlm. nih. govBlast. cgi). 
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2.2.13. DNA quantification 
DNA quality and quantity were measured by UV spectrophotometer absorption. 
Spectrophotometer was warmed up for 15 min before reading the DNA samples. DNA 
concentration can be quantified by measuring the absorbance of the sample at 260 nm, 7 
µl of DNA sample was mixed with 693 µl of ddH2O in a quartz cuvette. The absorption 
measurement was multiplied by dilution factor (1: 100) then by 50 (the absorption 
coefficient for double stranded DNA) for the final concentration in µg/µ1. The ratio of 
absorption at 260 mit to 280 nm represents the DNA purity of the sample. Pure DNA 
sample should give a range of reading in between 1.4- 1.8. 
2.2.14. Genotyping of mouse tissue 
Genotyping of knockout mice were performed using the Extract-N-AmpTM Tissue PCR 
Kits (Sigma), which provide all the reagents necessary to rapidly extract DNA from 
tissues and amplify targets of interest by PCR. The procedures were followed the same 
as the protocol provided in the product information. Basically, to extract genomic DNA 
from mouse tails, the scissors and mouse tail were sterilised with 70% ethanol and 
approximately 0.5 cm of mouse tail was cut into a clean 1.5 ml Eppendorf tube. 
Premixed solution containing 50 µl of Extraction solution and 12.5 . tl of Tissue 
Preparation solution for each reaction was added to the mouse tail and mixed thoroughly 
by vortexing and pipetting. The sample was incubated at room temperature for 10 min 
and then transferred to a heat block to boil for 3 min at 95 T. The sample was 
neutralised by adding 50 µl of Neutralization Solution B and mixed by vortexing. The 
neutralised tissue was then used for PCR or stored at 4°C for up to 6 months. Each PCR 
reaction included 4 gl of tissue extract, 10 µl of Extract-N-Amp PCR reaction mix, 2.5 
pM each of forward and reverse primer, and appropriate volume of dd112O to give a total 
volume of 201i1. Thermal cycling was performed as previously described and PCR 
samples were loaded onto an agarose gel with loading dye and appropriate molecular 
markers. 
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2.3. Protein Biochemistry 
2.3.1. Membrane protein extraction from brain 
A Dounce homogenizer was chilled on ice, the dissected brain was weighed, and at least 
5 volume of solubilisation buffer (5mM EDTA, complete protease inhibitor cocktail 
(Roche, Indianapolis, IN), 50mM Tris-HCI p117.5) was added to the homogenizer. The 
dissected brain were placed into the homogenizer and slowly homogenised with 12 
strokes. The brain lysate was then transferred to a 15 ml conical tube and was sonicated 
on ice for 15 sec, which was then centrifuged at 40,000 rpm for 30 min at 4°C. The 
pellet containing the membrane fraction was then solubilised in 1% SDS for 30 min at 
37 T. 10 volumes of 1% TX-100 lysis buffer (1% TX-100,5 mM EDTA, complete 
protease inhibitor cocktail, PBS) was added and mixed thoroughly by vigorously 
pipetting up and down until all the precipitates were not seen. The brain lysate was then 
centrifuged for 20 min at 14,000rpm to remove insoluble cell organelles. The 
supernatant containing membrane protein fraction was removed and was measured using 
Bradford protein assay kit (Bio-Rad). Lysates were either immediately used'in 
experiment or were stored at -80 T. 
2.3.2. Protein quantification assay 
Protein concentrations of samples were determined using the Bio-Rad protein assay kit 
(Bio-Rad) which is based on the Braford method. The actual amount of protein was 
assessed by correlation with a series of Bovine serum albumin (BSA) standards. The dye 
reagent was prepared by diluting lvolume of dye in 4 volume of ddH2O and filtered 
through Whatman filter paper to remove particulates. A standard protein curve was 
plotted by serial dilution of BSA from 2 mg/ml to 0.2 mg/ml. 100 µl of BSA or samples 
were added to the diluted dye reagent in polystyrene cuvettes with 1 cm path length 
(Bio-Rad) and incubated at room-temperature for 5 min before measuring the 
absorbance at 595nm on a spectrophotometer. A correlation between absorbance and 
concentration for the BSA standards was plotted and the protein concentration for the 
test samples could be determined from the standard curve. ' 
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2.3.3. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The gel was prepared in two stages. For resolving gel (acrylamide/bis solution (Bio- 
Rad), 0.375M Tris (pH8.8) (Bio-Bad), 0.1% SDS, polymerised by adding 0.05% 
ammonium persulfate (APS) and 0.00 1% TEMED (Bio-Rad)) was poured into a mold 
between two 1.5 mm cleam glass plates (Bio-rad). The percentage of gel was made 
dependent on the sizes of the blotted proteins. In general, it is between 6% to 14% of 
polyacrylamide. A thin layer of ddH2O or butanol was added to cover the resolving gel 
to remove any bubbles and to give a smooth and flat surface in between resolving gel 
and stacking gel. After 30 min, the ddH2O or butanol was poured off and the gel was 
rinsed with ddH2O thoroughly. The resolving gel was covered by a stacking gel (4% 
acrylamide/bis, 0.125M Tris (pH6.8), 0.1% SDS, polymerised by addition of 0.05% 
APS and 0.002% TEMED) which was allowed to set for 30 min. The apparatus (Bio- 
rad) was filled with SDS-PAGE running buffer (0.2M glycine, 25mM Tris HCI, 0.1% 
SDS, pH 8.3) (Bio-rad). 
Protein samples were prepared by addition of 5X sample loading buffer (250 nM Tris 
pH6.8,10% SDS, 50% glycerol, 0.02% bromphenol blue, 10% b-mercaptoethanol) and 
boiled at 97 °C for 3 min to denature protein prior to running on a polyacrylamide gel. 
For each gel, 5gl of Precision molecular weight markers (Bio-rad) were also loaded 
alongside to assess the size of proteins on the gel. Samples and markers were carefully 
loaded into the wells and ran the gel was run at a constant voltage of 85 mV until 
samples ran past stacking gel layer, then the voltage was increased to run the gel at 
125mV until loading dye ran off the bottom of the gel. Gels were removed from the 
apparatus and proceed to western blotting. 
2.3.4. Western blotting 
Western blotting requires the transfer of proteins from SDS-polyacrylamide gels onto 
Polyvinylidene Difluoride (PVDF) membranes where they can be detected with the use 
of antibodies. Immobilion P membranes (Milipore) were prepared by soaking in 
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methanol for 1 min prior to equilibration in transfer buffer (0.4 M glycine, 25 mM Tris, 
10% methanol) for 10 min. Proteins on the acrylamide gel were transferred onto the 
PVDF membrane for 1 hr at a constant ampere of 400 amp or 40 amp overnight in 
transfer buffer. The membrane was removed and blocked in 20 ml of blocking buffer 
(10% dried fat-free milk powder in TBST buffer: 50mM Tris, 150 mM NaCl, 0.1% 
polyoxyethylenesorbitan monolaurate (Tween20), pH7.5) for 1 hour at room- 
temperature or overnight at 4 °C with shaking. The membrane was then incubated with 
primary antibody diluted in TBST buffer for 1 hour at room-temperature or overnight at 
4 °C with shaking. Antibodies used are listed below: 
f Anti-NR2A (Rabbit polyclonal IgG antibody; Upstate Biotechnology, 
1: 2500 dilution) 
f Anti-NR2B (Rabbit polyclonal IgG antibody; Sigma, 1: 2500 dilution) 
f Anti- NRl (Mouse monoclonal IgG antibody; BD Pharmingen, 1: 2500 
dilution) 
f Anti- a tubulin (Mouse monoclonal IgG antibody; Upstate Biotechnology, 
1: 10000 dilution) 
The membrane was washed twice in TBST buffer for 5 min followed by one wash in 
blocking buffer for 5 min at room temperature. The membrane was then incubated in a 
1: 5000 dilution of peroxidise conjugated anti-rabbit or anti-mouse IgG secondary 
antibody (Amersham Bioscience) in blocking buffer for 30 min with shaking. It was 
then washed for 30 min with changes of TBST buffer every 5 min. The proteins were 
visualised using an enhanced chemiluminescence (ECL) kit (Pierce), after the ECL 
reagent was added the membrane was immediately exposed to Kodak MR/MS film or 
Fuji blue-films for periods between 5 sec to overnight. Films were developed using 
Kodak developer. 
2.3.5. Western analysis on dissected-mouse brain 
Appropriated brain regions were dissected from mice and homogenized in buffer (0.32M 
Sucrose; 20 mM HEPES, pH7.4,5 mM EDTA, complete protease inhibitor cocktail). P2 
crude synaptosomes were extracted, which were first lysed in 1%SDS for 30 min at 
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37°C and then in 1% TX-100 at 4°C, both in PBS with 5 mM EDTA and complete 
protease inhibitor cocktail. The lysate was centrifuged at 40,000 rpm for 30 min and 
protein concentrations were determined by BCA protein assay (Pierce) as previously 
described. Same amount of protein was loaded onto each lane and were separated on 
SDS-PAGE gels and then immunoblotted with appropriate antibodies. 
2.3.6. Surface biotinylation assay 
Cell cultures were washed three times with ice-cold PBS containing I MM M9029 0.1 
mM CaC12 and 5 mM EDTA (PBS+), and incubated with 1 mg/ml EZ-Link Sulfo-NHS- 
LC-biotin (Pierce) in PBS+ with protease inhibitors for 20 min at 4°C with gentle 
agitation. Cells were washed 3 times with ice-cold quenching buffer (50 mM glycine in 
PBS+) for 5 min each. The cells were then sonicated for 10 sec and centrifuged at 
40,000 rpm for 20 min at 4°C to obtain a crude membrane fraction. The crude membrane 
fraction was first lysed in 1% SDS for 30 min at 37°C and then in 1% TX-100 at 4°C, 
both in PBS with 5 mM EDTA and complete protease inhibitor cocktail (Roche, 
Indianapolis, IN). The lysate was centrifuged at 14,000 rpm for 20 min and then 
incubated with streptavidin-Sepharose beads (Pierce) for 2 hr at 4°C with constant 
rotation. Beads were washed four times in washing buffer and then twice in PBS. Bound 
proteins were eluted in 50µl of 2X sample buffer and immunoblotted with appropriate 
antibodies including anti- a-tubulin as control. 
2.3.7. Co-immunoprecipitation 
Membrane protein fraction was prepared as previously described. Brain or cell lysate 
were precleared by incubating with G-Sepharose beads (Sigma) for 2 hours with rotating 
at 4 °C. 60 p1 Protein A beads for each reaction (1: 1 slurry in ethanol) were washed 
twice in washing buffer (5 mM EDTA, 1% TX-100, PBS) and resuspended the beads in 
500 pl lysis buffer. 1/10 volume of lysate was retained as control. Suitable amount of 
antibody was added to the solution and allowed to couple to the beads for overnight at 4 
°C with constant rotation. The next day, all immunoprecipitated samples were washed 
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four times with washing buffer, with shaking at each wash. To elute 
immunoprecipitated protein, 50 µl of 2X sample loading buffer was added to each tube, 
the samples were then boiled for 3 min and were loaded onto polyacrylamide gels for 
SDS-PAGE. 
2.4. Cell biology 
2.4.1. Cell culture 
The only cell line used was HeLa cells, which was derived from cervical cancer cells 
taken from Henrietta Lacks. 
2.4.2. Growth and passaging of HeLa cells 
HeLa cells were grown in Dulbecco's modified Eagle medium (DMEM, Gibco) 
supplemented with 10% Fetal Bovine Serum (FBS) (Hyclone or Gibco), 2 mM L- 
glutamine (Gibco), and 0.0 1% gentamycin (Gibco). Cells were grown as monolayers in 
petri-dishes by incubation at 37°C in humidified incubators maintaining 5% CO2. Cells 
were passaged when they were 70% - 95% confluent, the medium was removed by 
aspiration, cells were washed for 1-2 times with PBS; 1 ml of trypsin-EDTA (1.5% 
trypsin, 0.2% EDTA, Gibco) was added and left covering the cells and incubated at 37°C 
5 min to allow cells to detach from the surface of the culture dishes. 10 volumes of fresh 
culture media was added to the trypsinised cells and cells were dispersed by gentle 
pipetting for several times. A suitable fraction of cells was transferred to new petri- 
dishes to give a confluency of 10% to 50%. For other purposes and experiments, a 
proportion of cells were transferred to 15 mm glass coverslips (Diagger) or 35 mm 
dishes (Falcon). 
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2.4.3. Transient transfection of HeLa cells 
Cells were plated at a density of approximately 30% confluency one day prior to 
transfection on a 35 mm dish containing 3 15 mm glass coverslips which were immersed 
in absolute ethanol and were flamed to sterilise. On the day of transfection, cells were at 
a density of approximately 70% confluency. Culture medium was removed by aspiration 
and fresh culture medium was replaced 2 hours prior to transfection. Transfection of 
HeLa cells were performed using CalPhos Mammalian Transfection kit (Clontech). The 
procedures were followed according to the protocol provided. For each transfection, an 
appropriate amount of plasmid DNA (generally 4 µg per 35 mm dish) was mixed with 
12.4 µl calcium phosphate solution to give a final concentration of 125 mM, and the 
final volume was made up to 100 µl with sterilised water. This mixture was added 
dropwise to an equal volume of 2X HBS with aeration to mix the solution thoroughly. 
Fine precipitates were allowed to form by incubation at room temperature for 20 min. A 
total volume of 200 µl was added dropwise to the cells, the cells were returned to the 
incubator overnight. Approximately 16 hours later, transfection medium was removed 
and cells were washed three times in MEM with Hanks (Gibco) which was pre- 
equilibrated in a 37 °C incubator containing 5% CO2 for 30 min, cells were allowed to 
incubate at 37 °C for 5 min at each wash. Fresh culture medium was replaced and cells 
were placed back in the incubator for an additional 48 hours before use. 
2.4.4. Storage of eukaryotic cells 
Cells were grown in 10 cm petri-dishes to 80-90% confluency and washed and 
trypsinised as described above. Cells were resuspended in 10 ml of culture medium and 
centrifuged at 1000rpm for 5 min at room-temperature, pellet was resuspended in 2 ml 
of freezing medium (10%DMSO, Sigma, 5%FBS, 40% DMEM) and was transferred to 
a cryovial (Comings). The vials were frozen at -80 °C overnight and transferred to liquid 
nitrogen for long-term storage. To multiply cells from frozen stocks an aliquot was 
thawed at 37 °C and the cells were added to 10 ml of prewarmed culture medium in a 10 
cm petri-dish and grown at 37 °C in an incubator maintaining 5% CO2. The medium was 
replaced 24 hr later to remove the remaining DMSO. 
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2.4.5. Dissection and culturing of cortical and hippocampal neurones 
Time pregnant mouse with embryos aged between E16-18 were anaesthetised and 
decapitated as close to the brain stem as possible. Embryos were taken out and soaked in 
dissection medium (500 ml HBSS w/v phenol red, Gibco, 5 ml 1M HEPES, Gibco, 5 ml 
Pen/strep, Gibco), which were then decapitated and cerebrums were removed then 
transferred to new 35 mm dishes containing dissection medium. Occipital lobes and 
meninges were removed, hippocampi and cortices were then dissected out under a 
dissection microscope (Zeiss) and placed in fresh ice cold dissection medium. The brain 
tissues were transferred to 15 ml Falcon tube and briefly minced with forceps prior to 
centrifugation at 1000 rpm for 5 min. Dissection medium was removed as much as 
possible and the pellet was resuspended in 5 ml of papain solution (Hanks without 
phenol red, Gibco, Papain, Worthington, DNase, Worthington) and incubated at 37 °C 
for 30 min to allow enzyme digestion, the tube was inverted to mix every 10 min. The 
cells were mechanically dispersed using a fire polished glass Pasteur pipette by titrating 
10-15 times, which were then centrifuged at 1000 rpm for 5 min. Papain solution was 
carefully removed with a5 ml pipette, the pellet was resuspended in 5 ml of STOP 
solution (Hanks without phenol red, Gibco, DNase, Worthington, ovomucoid protease 
inhibitor with BSA, Worthington) and was allowed to settle for 10 min at room 
temperature. STOP solution was carefully removed using a5 ml pipette without getting 
the settled substance, which was then folded into 10 ml of 10/10 solution and 
centrifuged at 1000 rpm for 10 min (Hanks, G ibco, 100 mg trypsin inhibitor, Sigma, 
100 mg BSA, Sigma) to wash. Cell pellet was resuspended in 10 ml of prewarmed 
plating media (Neurobasal media, Gibco, 2% B-27, Gibco, 1% L-Glutamine, Gibco, 1% 
Penicillin/Streptomycin). Density of cells was counted by making an appropriate 
dilution, cells were plated in pre-coated 18 mm glass coverslips orlO cm petri-dishes. 
Cells were incubated at 37 °C in an incubator maintaining 5% CO2. For long-term 
cultures, half of the volume of plating media was replaced on a weekly basis after 
dissection. 
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2.4.6. Transfection of hippocampal neurones 
Hippocampal neurones were transfected using Lipofectamin 2000 (Invitrogen). 
Transfection was performed on 9-12 days in-vitro (DIV), and half of the plating media 
was replaced 2 hours prior to transfection. For each well in the 12-well plate, 1 µg of 
plasmid DNA was pipetted into 25 µl of neurobasal medium, 0.5 µl of Lipofectamin 
2000 in 25 µl of neurobasal medium was then added to the DNA solution. The mixture 
was left at room-temperature for 20 min, which was then added dropwise to the cells and 
incubated for 48-72 hours in the incubator before the cells were used. 
2.5. Immunocytochemistry 
2.5.1. Primary antibodies 
f Anti- Tac : Mouse monoclonal IgG2A antibody (antisera) recognising an N-terminal 
epitope of Tac (IL2) (1: 5 dilution) 
f Anti- MHCII ß monomer: Mouse monoclonal IgG2A antibody (antisera)(1: 3 
dilution) 
f Anti-MHCII ap dimer (L243): Mouse monoclonal IgG2A antibody (antisera)(1: 3 
dilution) 
f Anti- GFP: Rabbit (Molecular Probe) (1: 750 dilution) 
f Anti -HA: Mouse monoclonal IgG1 antibody (Covance) (1: 1000 dilution) 
2.5.2. Secondary antibodies 
All secondary antibodies used for immunostaining are obtained from Molecular Probe 
unless specifically stated. 
(1: 500 dilution was used unless specifically stated) 
f Anti-rabbit IgG Alexa Fluor®488- conjugated 
f Anti-rabbit IgG Alexa Fluor®568-conjugated 
f Anti-rabbit IgG Alexa Fluor®647-conjugated 
f Anti-mouse IgG Alexa Fluor® 488-conjugated 
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f Anti-mouse IgG Alexa Fluor® 568-conjugated 
f Anti-mouse IgG Alexa Fluor® 647-conjugated 
f Anti-mouse IgG2A Alexa Fluor® 488-conjugated 
f Anti-mouse IgG2A Alexa Fluor® 568-conjugated 
f Anti-mouse IgGi Alexa Fluor® 647-conjugated 
f Anti-rabbit IgG unconjugated (Sigma) 
f Anti-mouse IgG unconjugated (Sigma) 
2.5.3. Immunostaining 
Cells on glass coverslips were removed from the incubator and culture medium was 
gently removed by aspiration. PBS at room temperature was gently washed onto the 
cells and repeated for 3 times. Cells were then fixed with 500 µl 4% paraformaldehyde 
in PBS for 15 min on ice and washed 3 times with PBS before permeabilised with 0.25% 
TX-100 in PBS for 5 min at room temperature. Cells were blocked with 1 ml of 10% 
Normal Goat Serum (NGS) for 1 hour and 100 µl of primary antibody diluted in 10% 
NGS was added onto the cells on coverslip and incubated for 1 hour. Primary antibody 
was removed by washing with PBS for 2 times, 100 pl of secondary antibody was added 
onto the cells and incubated for 30 min at room temperature. The cells were then washed 
an additional 4 times in PBS and the coverslips were mounted with Prolong Antifade kit 
(Invitrogen). 
2.5.4. Antibody feeding assay 
HeLa cells grown on glass coverslips were transfected using Calcium Phosphate 
Transfection Kit (Clonetech) as previously described and analysed 36 hours later. 
Transfected cells were washed once with PBS at room-temperature and incubated with 
350 p1 of primary antibody diluted in conditioned media for 5 to 30 min at 37 °C in an 
incubator maintaining 5% CO2. After 3 washes in PBS, the cells were fixed in 4% PFA 
in PBS for 15 minutes at room temperature. The cells were then permeabilised in 0.25% 
TX-100 in PBS for 5 minutes at room-temperature and blocked in 10% (NGS) (Vector 
Laboratories) in PBS for 1 hour. The cells were then labelled with appropriate secondary 
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antibody for 30 min at room temperature. After multiple washes in PBS, the coverslips 
were mounted. 
2.5.5. Surface receptor labelling in HeLa cells 
Transfected cells were washed once with ice-cold PBS and labelled with primary 
antibody live on ice for 1 hour. After 3 washes in ice-cold PBS, the cells were fixed, 
permeabilised and then blocked for 1 hour. The cells were then labelled with appropriate 
secondary antibody for 30 minutes at room temperature. After multiple washes in PBS, 
the coverslips were mounted. 
2.5.6. Internalisation assay in HeLa cells and primary neurones 
Transfected HeLa cells or neurones were incubated live with primary antibody on ice 
(HeLa cells) for 1 hour or at room-temperature for 15 min (neurones) before cells were 
returned to 37°C for 30 min or indicated time points to allow internalisation. The cells 
were then washed in PBS for 3 times, fixed, permeabilised and then blocked for 1 hour. 
The cells were then labelled with secondary antibody for 30 min at room temperature. 
After multiple washes in PBS, the coverslips were mounted. 
2.5.7. Recycling assay in HeLa cells 
Transfected HeLa cells were incubated with primary antibody on ice for 1 hour before 
cells were returned to 37°C for 30 min to allow internalisation. The cells were washed 
multiple times to remove primary antibody remaining on the cell surface and then 
labelled with excess unconjugated secondary antibody on ice for 1 hour to block all 
surface receptors. Cells were then incubated at 37°C for 30 min to allow recycling or 
kept on ice to prevent protein trafficking. The cells were washed 3 times in PBS, fixed, 
and blocked before being incubated with Alexa 568 secondary antibody for 30 min to 
label the surface receptors (Red). Cells were then permeabilised and blocked before 
incubated with Alexa 488 secondary antibody for 30 min to label internalised receptors 
that had not recycled back to the plasma membrane (green). The level of recycling was 
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plotted as the ratio of the average fluorescence intensities of recycled receptors (red) 
versus the total of surface and internalised receptors (red + green) fluorescence 
intensities. 
2.5.8. Surface to total labelling in primary cultured neurones 
Transfected cultured neurones were surface labelled with primary antibody for 10 min at 
room temperature in conditioned media. After 3 washes with PBS, neurones were fixed 
for 15 min in 4% paraformaldehyde with sucrose and incubated with Alexa-568- 
conjugated (red) secondary antibody. Following permeabilisation in 0.25% TX-100 for 5 
min, cells were blocked in 10% normal goat serum (NGS) for 30 min. The cells were 
then incubated 45 min with primary antibody again as indicated to label the intracellular 
populations of transfected receptors. The cells were labelled with Alexa 488- (green) or 
Alexa- 647 (blue) conjugated secondary antibodies, and were mounted. 
2.5.9. Recycling assay in cultured primary neurones 
Transfected neurones were incubated with primary antibody at room temperature for 10 
min before cells were returned to 37°C for 30 min to allow internalisation. The cells 
were gently washed 3 times to remove primary antibody remaining on the cell surface 
and were then labelled with excess unconjugated secondary antibody for 20 min at room 
temperature to block all surface receptors. Cells were then incubated at 37°C for 30 min 
to allow recycling or kept at room temperature to stop protein trafficking. The cells were 
washed 3 times in PBS, fixed in 4% PFA with sucrose, and blocked in 10% NGS before 
incubated with Alexa-568 secondary antibody for 30 minutes to label the surface 
receptors (Red). Cells were then permeabilised and blocked before incubated with 
Alexa-647 secondary antibody for 30 min to label internalised receptors that had not 
recycled back to the plasma membrane (green). The level of recycling was plotted as the 
ratio of the average fluorescence intensities of recycled receptors (red) versus the total of 
surface and internalised receptors (red+green) fluorescence intensities. 
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2.5.10. Confocal microscopy and image acquisition 
Cells stained with antibodies then labelled by fluorescent tracers or transfected with GFP 
were visualised by using a LSM5 10 confocal laser-scanning microscope (Zeiss). 
Confocal imaging gives high resolution and eliminating out-of-focus light by 
introducing a pinhole on the detector side by automatically setting the diameter of the 
detection pinhole to the optimal value of 1 Airy unit. The immunostained cells were 
scanned through their thickness at 0.34 µm intervals by using a 40X or 63X oil 
immersion objection, 1.5-3x zoom factor, and 0.8 µs pixel time. Laser wavelengths for 
the green, red and blue channels were 488nm, 568nm and 647nm, respectively. Stacks 
of 512 x 512 (for measuring fluorescent intensities in surface labelling, internalisation 
assay and recycling assay) or 1024 x 1024 (for colocalisation analysis) pixel serial 
optical images, with a pixel size of 0.1 µm in the x- and y- axes were collected and were 
used to create maximum projection images in Zeiss software. The images were exported 
in TIFF format into various softwares for data analyses (see 2.5.11) or exported into 
Photoshop CS2 (Adobe Systems) for graphical optimisation including adjustment of 
brightness and contrast, and finally composed in Illustrator CS2 (Adobe Systems). 
2.5.11. Image analysis with computer software 
Images were viewed using LSM image browser (Zeiss) or volocity (Improvision ®Perkin 
Elmer). Images were analysed using Image) (NIH) or MetaMorph 7.0 softwares 
(Universal Imaging Corp. ) for co-localisation analysis and integrated fluorescent 
intensities measurement (in surface labelling, internalisation assay and recycling assay), 
respectively. The values of integrated fluorescent intensities were obtained and applied 
in statistics. 
2.5.12. Statistical analysis 
Colocalisation analysis in HeLa cells and hippocampal neurones 
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To quantify colocalisation of endosomal markers (Rab-9 or Rab- 11) with Tac-NR2A, - 
NR2B, -CHI, -CH2, aNR2AßNR2A, aNR2B3NR2B and aNR2AßNR2B, the red and 
green dual-channel of the stack confocal images were splited in the software ImageJ 
(NIH) and exported as 8-bit grayscale images for each channel and saved as TIFF files. 
The whole cell for HeLa cell and 3-5 secondary dendrites for hippocampal neurone were 
selected as Region Of Interest (ROI) in ImageJ to analyse. Background noise was 
removed using the auto-threshold application in ImageJ. Colocalisation between red and 
green channels was measured using a global statistic approach that performs intensity 
correlation coefficient-based (ICCB) analysis to assess the pixel-based overlap between 
red and green fluorescence intensities. The Overlap coefficient plug-in in ImageJ (NIH), 
which is based on the Pearson's coefficient was applied to calculate colocalisation. 
The overlap coefficient method is with the mean intensity value of both channels 
being taken out of the expression. Therefore, it is an estimate of the association strength 
between the two proteins considered. Here is the algorithm of overlap coefficient: 
r2=k,. k2 with k1= X; (A;. B. )l E (A; )2 & k2= i; (A;. B; )/ E (B; )2 
It splits the value of colocalisation into the two separate parameters, k, and k2 
coefficients depending on the sum of the products of the intensities of the two channels, 
k, being related to the first channel (A) total intensity, k2 being related to the second 
channel (B) total intensity. Thus, they are sensitive to the differences in the intensities of 
signals and represent the true degree of colocalisation. 
The coefficient is always positive or null, ranging from 0 to 1, corresponding to 
no of full colocalisation, respectively. Similar to Pearson's coefficient, it has three major 
pitfalls (Bolte and Cordelieres, 2006): 
1. The quantitative relationship between the localisation and colocalisation may not 
be distinguished, therefore measurements should be restricted to a ROI for 
unique association rate. 
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2. Poor signal to noise ratio: try to optimise highest signals during sample 
preparation and image acquisition, alternatively try to isolate and/or take into 
account the noise from the image. 
3. Bleedthrough from one channel to another or background: if it does not take 
away too much signal, the coefficient might be calculated after use of a 
threshold. 
Student's t-test was applied in this thesis to assess whether the means of two groups of 
samples are statistically different from each other. Two-Tailed tests were applied to test 
the significance of the difference in two sets of samples. Results are represented as the 
p-value and statistical significance was set to the p-value of 0.05. 
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Chapter 3. 
Defining sequence determinants in the distal C- 
termini of NR2A and NR2B that regulate NMDAR 
post-endocytic sorting and recycling 
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3.1. Hypothesis and aims 
Previous studies in our lab showed that the distal C-termini of NR2A and NR2B contain 
sequence determinants that regulate the trafficking of NMDARs through differential 
endocytic pathways (Lavezzari et al., 2004). Endogenous NMDARs undergo robust 
endocytosis that decreases as synapses develop and neurones mature (Roche et al., 
2001). I therefore hypothesised that the developmental changes in the expression of NR2 
subunits result in differential regulation in sorting and recycling of NMDARs. 
In the cortex and hippocampus, endogenous NMDARs are composed of NR1, NR2A 
and NR2B subunits. NR2B expression is predominant early in development, whereas 
NR2A is primarily expressed in mature neurones (Stocca and Vicini, 1998). In this 
chapter, my aim is to determine if this developmental pattern of NR2 expression 
regulates the surface stability of NMDARs, I specifically aim to identify specific 
sequence determinants within NR2A and NR2B that regulate NMDAR surface 
expression and post-endocytic sorting. 
3.2. Rationale 
3.2.1. Tyrosine 1472 regulates NR2B-mediated endocytosis in heterologous cells 
and neurones 
At immature glutamatergic synapses early in development, NR2B-containing NMDARs 
are highly mobile in the membrane and undergo rapid internalisation (Roche et al., 
2001). Previously, our lab identified a consensus tyrosine-based 'internalisation motif 
encoded in the distal carboxy-terminus (CT) of the NR2B subunit, (1472YEKL1475)" 
Using Tac-NMDAR chimeras, we showed that a chimera containing the CT of the 
NR2B subunit (TacNR2B) induced endocytosis of Tac protein. A mutant containing an 
11 amino acid truncation, with the YEKL motif and the PDZ binding motif deleted, 
dramatically reduced the internalisation level of TacNR2B. In contrast, overexpression 
of a mutant with only the PDZ binding motif truncated, showed unaffected 
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internalisation in neurones (Lavezzari et al., 2003). These results suggest a critical role 
of Y1472 in NR2B-CT-dependent endocytosis. 
3.2.2. Tyrosine 1472 in the distal C-terminus of NR2B binds to the adaptor 
medium chain, µ2 
It is previously showed that co-expression of TacNR2B with a dominant negative form 
of dynamin in heterologous cells abolished the internalisation of Tac-NR2B, consistent 
with internalisation of TacNR2B being clathrin-dependent (Roche et al., 2001). 
Endocytosis via clathrin-coated vesicles requires the interaction of plasma membrane 
endocytic cargo proteins with the clathrin adaptor complex, AP-2 (Bonifacino and 
Dell'Angelica, 1999; Bonifacino and Traub, 2003). The plasma membrane adaptor 
complex AP-2 directly binds to internalised cargo proteins via their medium chain, µ2 
(Ohno et al., 1995), thus linking internalised protein to the clathrin coated pits. By using 
the yeast-2-hybrid assay, it was determined that co-expression of the distal CT of NR2B 
and µ2 resulted in robust interaction; however, point mutations of the tyrosine (Y1472F 
or Y 1472A) in the YEKL motif of NR2B disrupted this interaction (Lavezzari et al., 
2003). These data are consistent with the immunofluorescent observations of TacNR2B 
trafficking. These results suggest that the distal C-terminus of NR2B contains the 
tyrosine-based motif (YEKL), which is sufficient to promote clathrin-dependent 
endocytosis. 
3.2.3. The NR2A CT contains a di-leucine-based endocytic motif, and NR2A and 
NR2B display differential binding to adaptor medium chains 
Like NR2B, NR2A contains a PDZ binding domain (-ESDV) at the extreme C-terminus. 
Also, NR2A contains several potential internalisation motifs, including a putative ._ 
tyrosine-based endocytic motif and several dileucine motifs. Both tyrosine-based motifs 
and dileucine motifs are consensus endocytic motifs that can regulate clathrin-mediated 
endocytosis (Bonifacino & Dell'Angellica, 1999; Bonifacino & Traub, 2003; Ohno et 
al., 1996). Our lab found that NR2A and NR2B possess distinct endocytic motifs and 
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sorting information within their distal C-termini. TacNR2A chimeras also contain the 
region corresponding to the YEKL endocytic motif in NR2B CT, YKKM (Y1454), 
which is a conserved tyrosine-based motif, yet this motif in NR2A was not essential for 
the internalisation of TacNR2A. Instead, the internalisation of TacNR2A was shown to 
be regulated by a di-leucine motif (L1319, L1320) localised further upstream in the C- 
terminus of NR2A (Lavezzari et at., 2004). However, mutation of this di-leucine motif 
still only inhibited approximately 25% of endocytosis (Lavezzari et al., 2004). 
Using the yeast two-hybrid assay, our lab tested if the conserved tyrosine in the 
distal CT of NR2A also binds to p2. Although the C-terminus of NR2A and NR2B both 
interact directly with clathrin adaptor proteins, they interact with different adaptor 
medium chains (p1-4) with different affinities. Importantly, the µ2 chain of the AP-2 
complex interacts robustly with NR2B, but not with NR2A (Lavezzari et al., 2003). This 
is consistent with the YKKM motif in NR2A not playing a critical role in internalising 
Tac-NR2A from the plasma membrane. 
3.2.4. Differential endocytic pathways of NR2 subunits 
It is known that after endocytosis, some membrane proteins are delivered to late 
endosomes for degradation. For many integral membrane proteins, including AMPARs 
and G-protein-coupled receptors, post-endocytic sorting is regulated by specific 
endocytic motifs or intracellular signals (Ehlers, 2000; Bonifacino & Traub, 2003). In 
the case of NMDARs, the post-endocytic pathways are not well understood. Our lab has 
demonstrated that the internalisation of NMDARs is dependent on different combination 
of NR2 subunits, including the trafficking to distinct intracellular pathways. Due to the 
lack of specific antibodies that recognise the N-terminal domains of NR2A and NR2B, 
full-length NR2A and NR2B subunits containing an extracellular FLAG epitope were 
expressed in hippocampal neurones. Our lab found that after internalisation, these two 
subunits are immediately delivered to early endosomes. Interestingly, thereafter the two 
subunits are sorted into distinct compartments, such that FLAG-NR2B preferentially 
sorts into recycling endosomes. On the other hand, FLAG-NR2A is delivered to late 
endosomes with notably progressive loss of FLAG-NR2A signal observed (Lavezzari et 
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at., 2004), the most parsimonious explanation for this degrading signal being that 
FLAG-NR2A was entering the degradation pathway. Moreover, in mature neurones, 
FLAG-NR2A consistently internalised less well than FLAG-NR2B (Lavezzari et at., 
2004). These data support the idea that NR2A and NR2B have distinct endocytic sorting 
in neurones, with NR2B preferring the recycling pathway, consistent with NMDARs 
being more mobile early in development and also in mature neurones at extrasynaptic 
sites. 
3.3. Experimental approaches and results 
3.3.1. Generation of Tac chimeras containing part of both the NR2A and NR2B C- 
termini 
According to the data obtained previously in our lab, tyrosine Y1472 was identified as 
an endocytic motif that on the NR2B CT. However, the analogous tyrosine residue in 
NR2A (Y1454) was not shown to regulate NR2A endocytosis, instead NR2A 
internalisation was regulated by a dileucine motif (1320-1321 a. a. ) on the NR2A CT 
(Lavezzari et al., 2004). In this chapter, I designed my studies set out to dissect out the 
precise sequence determinants in the C-termini of NR2A and NR2B that regulate the 
differential NMDAR endocytic pathways. I generated two chimeric proteins, Tac-CH1 
and Tac-CH2 (Fig. 3.1). Tac-CH1 contains the first 120 amino acids of the distal CT of 
NR2A (1304-1400 a. a. ) and the last 60 amino acids of the NR2B CT (1420-1482 a. a). In 
contrast, Tac-CH2, contains the first 120 amino acids of the distal CT of NR2B (1315- 
1410 a. a. ) and the last 60 amino acids of the NR2A CT (1401-1464 a. a. ) (Fig. 3.1). 
Therefore, Tac-CH 1 contains several dileucine motifs on NR2A and the tyrosine based- 
endocytic motif (YEKL) on NR2B, whereas Tac-CH2 contains the NR2A tyrosine- 
based motif (YKKM) corresponding to YEKL on NR2B. 
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Tac-CH1 Tac " NR2A(1304-1400a. a) 
Il tI LL YE L 
Tac-CH2 Tac 
Fig. 3.1 Schematic diagrams of the Tac-NR2A/NR2B subunits chimeras. 
Tac-CH 1: contains the first 120 amino acids of the distal CT of NR2A (1304-1400 a. a. ) and the last 60 
amino acids of the NR2B CT (1420-1482 a. a. ) 
Tac-C112: contains the first 120 amino acids of the distal CT of NR2B (1315-1410a. a) and the last 60 
amino acids of the NR2A CT (1401-1464a. a). 
TM: Transmembrane domain; LL: dileucine motifs; YEKL/ YKKM: The putative tyrosine-based 
endocytic motifs on NR2B and NR2A respectively. 
3.3.2. Optimisation of internalisation and quantitative colocalisation assays in 
HeLa cells 
To evaluate the intracellular sorting of Tac-CH I and Tac-CH2, compared to the 
previously characterised sorting of TacNR2A and TacNR2B, I expressed these chimeric 
proteins in HeLa cells, and examined the effect of endocytosis and intracellular sorting 
over time (5 min and 30 min) by performing an internalisation assay and subsequent 
immunofluorescence microscopy as previously described in Chapter 2. In order to 
examine the subcellular localisation of the two chimeras, I co-expressed them with the 
recycling endosomal marker (Rab 11) and the late endosomal marker (Rab9) 
respectively. Consistent with the previous study in our lab (Lavezzari et al., 2004), after 
5 min, TacNR2A was localised on the cell surface (Fig. 3.2,3.4) and in early endosomes 
(Lavezzari et al., 2004), but by 30 min we found almost total colocalisation with GFP- 
Rab9-positive late endosomes in the perinuclear compartment (Fig. 3.2; upper panel), but 
not with the GFP-Rabl l positive late recycling endosomal marker (Fig. 3.2; lower 
panel). 
In contrast to TacNR2A, we found very little colocalisation of TacNR2B with GFP- 
Rab9 after 30 min (Fig. 3.3; upper panel), indicating that the distal CT of NR2B did not 
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regulate sorting to late endosomes. Most of the internalised TacNR2B was distributed 
throughout the cell, with some accumulation in the cell edges. Coexpression of 
TacNR2B and GFP-Rabl l revealed that, after 30 min of internalisation, there was a 
significant colocalisation of internalised TacNR2B with GFP-Rabl I (Fig. 3.3; lower 
panel). These data are consistent with previous findings that NR2A and NR2B contain 
different endocytic motifs, differentially interact with the endocytic machinery, and 
undergo differential post-endocytic sorting. 
3.3.3. Tac-CH1 shows a similar post-endocytic sorting pattern to TacNR2A 
We then compared the internalisation and endocytic sorting events of Tac-CH 1 and Tac- 
CH2 to TacNR2A and TacNR2B. Interestingly, coexpression of Tac-CH1 and GFP- 
Rab9 revealed a similar expression pattern to TacNR2A at both the 5 and 30 min 
internalisation time points. After 30 min, Tac-CH1 distributed to the perinuclear region 
and colocalised significantly with GFP-Rab9 (Fig. 3.5; upper panel; Fig 3.7A). 
Moreover, coexpression of Tac-CHI and GFP-Rab1 l also revealed a strong perinuclear 
distribution of Tac-CH 1 and notably lack of colocalisation with GFP-Rab1 l after 30 min 
of internalisation (Fig. 3.5; lower panel; Fig 3.7A). This suggests that the endocytic 
motif(s) on the NR2A CT that regulates the sorting from early endosomes to late 
endosomes is present in the first 2/3 of the distal C-terminus of NR2A. These findings 
confirm our previous findings that the tyrosine-based endocytic motif in NR2A does not 
play an important role in plasma membrane endocytosis and the subcellular sorting from 
early endosomes to late endosomes. 
3.3.4. Tac-CH2 shows robust internalisation and intermediate phenotypes in post- 
endocytic sorting 
However, surprisingly, although Tac-CH2 does not contain either the dileucine motifs 
on NR2A or the tyrosine-based endocytic motif (YEKL) on NR2B, it was internalised 
robustly (Fig. 3.7,3.8B) and appeared to sort to both late endosomes and recycling 
endosomes at a low level (Fig. 3.7; 30' lower panel; Fig. 3.8B). In addition, after 30 min 
97 
of internalisation, colocalisation with GFP-Rab9 was observed at a low level, and Tac- 
CH2 was no longer accumulated in the cell edges but re-distributed to the perinuclear 
region (Fig. 3.6). Notably, coexpression with GFP-Rab11 also revealed localisation of 
Tac-CH2 in two distinct patterns after 30 min of internalisation. There was a 
subpopulation of cells redistributed to the perinuclear region (Fig. 3.6; 30' upper panel), 
whereas in a number of cells Tac-CH2 appeared to localise at the cell edges (Fig. 3.6, 






Fig. 3.2 TacNR2A is sorted to late endosomes but not recycling endosomes over time 
Cells were incubated with Tac polyclonal antibody on ice for 1 hour and then returned to conditioned media 
for 30 minutes at 37°C. The cells were fixed and permeabilised, and the immunoreactivity of TacNR2A was 
visualised using Alexa-568-conjugated (red) anti-mouse antibodies. GFP-Rab9 and GFP-Rabl I were 
visualised with Alexa-488 (green). Merge shows the level of colocalisation of the TacNR2A and GFP-Rab9 
/ GFP-Rab 11. The images shown were representative of 2 individual experiments. 
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Fig. 3.3 TacNR2B preferentially traffics through recycling pathways but not to 
degradation pathway over time. 
TacNR2B was visualised using Alexa-568-conjugated (red) anti-mouse antibodies. GFP-Rab9 
and GFP-Rabl I were visualized with Alexa-488 (green). Merge shows the level of 
colocalisation of the TacNR2B and GFP-Rab9 / GFP-Rabl 1. The images shown were 
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Fig. 3.4 Statistical analysis of the amount of colocalisation between (A)'t'ac-NR2A and 
(; FP-Rab9; (13) Tac-NR213 and GFP-Rabl I after 5 or 30 min of internalisation in 
transfected lieLa cells. 
('olocalisation analysis was measured with the software Nil I Image) Overlap coefficient plug- 
in. Values represent the mean +/ - SEM of overlap coefficient. (n K cells, N=2 individual 







Fig. 3.5 Tac-CHI shows a similar trafficking pattern to TacNR2A and sorts to late 
endosomes over time. 
Tac-CH I was visualised using Alexa-568-conjugated (red) anti-mouse antibodies. GFP-Rab9 
and GFP-Rab 1I were visualised with Alexa-488 (green). Overlay shows the level of 
colocalisation of the Tac-CH I and GFP-Rab9 / GFP-Rab l 1. The images shown were 
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Tac-CH2 GFP-Rabl1 Merge 
Fig. 3.6 Tac-0112 shows intermediate trafficking patterns. 
Tac-C112 was visualised in red whereas GFP-Rab`) and GFP-Rabl I were visualized in green. Overlay 
shows the level of colocalisation of the Tac-CI 12 and (iFP-Rab9 / GFP-Rah 11. (bexpression with GFP- 
Rab II after 30 min of internalisation revealed the localisation of Tac-CI 12 in two distinct patterns: a 
suhpopulation ot'cells redistributed to the perinuclear region (30' upper panel), whereas in a number of 
cells Tac-('I12 appeared to redistributed to the cell proximal region (30' lower panel) The images 
shown were representative of 2 individual experiments. 
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11g. 3.7 Statistical analysis of the amount of colocalisation between (A)Tac-('11 I and (: FI'- 
Rah9 or -Rah 11; (13) "I'ac-0112 and ('. Fl'-Rah9 or -Rab II after 5 or 30 min of internalisation 
in transfected IIcLa cells. 
('olocalisation analysis was measured with the software NIII Image) Overlap coefficient plug-in. 
Values represent the mean P- SEM of overlap coefticient. (n= 4-9 cells, N-2 independent 
experiments); two-tailed 1-test performed, * p<0.02; n. s = Non-specific, p> 0.3. 
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3.3.5. Both Tac-CH1 and Tac-CH2 are moderately recycled back to the plasma 
membrane 
It is reported that NR2B is primarily trafficked through the recycling pathway 
(Lavezzari et al., 2004), I therefore performed an antibody-based recycling assay to 
more precisely quantitate the level of recycling of TacNR2A, TacNR2B, Tac-CH 1 or 
Tac-CH2 in HeLa cells. To examine the level of recycling to TacNR2A or TacNR2B, 
live HeLa cells expressing TacNR2A, TacNR2B, Tac-CH1 or Tac-CH2 were labelled 
with anti-Tac antibody, and returned to conditioned media at 37°C for 20 min to allow 
internalisation. Remaining surface proteins were blocked with unconjugated secondary 
antibody on ice for 30 min, followed by either a second incubation at 37°C to allow 
receptor trafficking to continue (Fig. 3.9), or a continued incubation on ice as a negative 
control (Fig. 3.8). I observed no surface-expressed aß-NR2 dimers when cells were kept 
on ice and the second 37°C incubation was omitted confirming that the unconjugated 
secondary antibody effectively blocked any labelling of dimers that remained on the cell 
surface (Fig. 3.8; 3.10). Interestingly, for the cells that were incubated for the second 
time at 37°C to allow recycling, I observed almost no recycled TacNR2A, whereas 
TacNR2B showed a significant amount of recycling back to the cell surface (Fig. 3.9; 
3.10), supporting a dominant role for NR2B in receptor recycling. However, I observed 
both Tac-CH 1 and Tac-CH2 showed a moderate level of recycling although 
quantification showed that the level of Tac-CH 1 recycling is not significantly different 
from TacNR2A. Suggesting that Tac-CH 1 possesses a recycling motif or the motif(s) 
that regulates degradation in TacNR2A is absent in TacCH1. Furthermore, the level of 
recycled Tac-CH2 on the cell surface was shown to be significantly different from both 
TacNR2A and TacNR2B. Again, these results reflect an intermediate phenotype in the 


















Fig. 3.8 Surface expressed Tac-chimeras that do not undergo endocytosis are 
effectively blocked by unconjugated secondary antibody. And, internalised chimeras do 
not traffic back onto the cell surface when kept on ice as shown in the left column. 
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Fig. 3.9 Both Tac-CH I and Tac-CH2 show a moderate level of recycling back to the 
cell surface of HeLa cells. 
TacNR2A shows a minute amount of recycling back to the plasma membrane after 30 min 
of internalisation, whereas cells expressing TacNR2B recycle back to the cell surface 
robustly (left column). 















TacNR2A TacNR2A TacNR2B TacNR2B Tac-CH1 Tac-CH1 Tac-CH2 Tac-CH2 
Ctrl recycled Ctrl recycled Ctrl recycled Ctrl recycled 
Fig. 3.10 Quantification of the level of recycling of various 'Inc chimeras expressed in IIeLa cells. 
Noted that fac-CI II recycling is not significantly different from I'acNR2A whereas Tac-C112 shows a 
significantly higher level of'recycling than TacNR2A. 
Ctrl = Cells kept on ice; Recycled= Cells internalised at 37° C. Images were quantified with Metamorph 
software (n-- 28- 51, N=3). Data represent means +/- SEM of the recycled/ internalized fluorescence 




In this chapter, I generated two Tac chimeras, each containing chimeras of parts of 
both NR2A and NR2B C-terminal domains (Tac-CH 1 and Tac-CH2), in an attempt to 
identify the precise sequence determinants in regulating differential post-endocytic 
sorting of NR2A and NR2B subunits. The Tac chimera has widely been used in studying 
receptor trafficking, in particular to identify trafficking motifs in the intracellular C- 
terminal domain of NMDARs, owing to its robust and stable expression on the cell 
surface (Standley et al., 2000; Roche et al., 2001; Hawkins et al., 2002; Lavezzari et al., 
2004; Scott et al., 2004). In the current study, a chimeric approach was chosen because 
there are clear differences in NR2A and NR2B trafficking; however, it is not a good 
approach and too time consuming to individually mutate each amino acid residue in the 
distal C-termini of NR2A and NR2B subunits due to their large number of amino acid 
residues, so I decided to swap a relatively larger regions between NR2A and NR2B and 
then gradually narrow down the critical domains, and eventually target the precise motif 
(if one exist) responsible for regulating NR2A degradation and NR2B recycling. 
It is surprising to see both Tac-CH1 and Tac-CH2 chimeras undergoing robust 
internalisation when incubated at 37°C. Given that Tac-CH 1 contains the portion of 
NR2B that includes the YEKL endocytic motif NR2B, the -ESDV PDZ binding domain 
and several dileucine (LL) motifs from NR2A, which were shown to regulate NR2A 
endocytosis; whereas Tac-CH2 only contained the YKKM conserved tyrosine-based 
endocytic motif from NR2A and the -ESDV, PDZ binding domain, which is known to 
regulate the trafficking of NMDARs. These findings suggest that additional endocytic 
motifs could be present in Tac-CH2, localised within the first 120 amino acids of the 
distal CT of NR2B (a. a 1315-1410) and the last 60 amino acids of the NR2A CT(a. a 
1401-1464). Alternatively, the -ESDV PDZ binding motif localised in the extreme CT 
of Tac-CH2 might play the major role in internalising Tac-CH2 in the absence of other 
endocytic motifs. This suggests a possible compensation mechanism in regulating 
NMDARs endocytosis and could explain the reason of having multiple endocytic motifs 
localised in the CTs of NR2 subunits. To verify this hypothesis, a Tac-CH2 mutant can 
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be generated with truncation of the -ESDV motif followed by measuring the level of 
internalisation to total expression of Tac-CH2 and Tac-CH2-ESDV mutant. 
Interestingly, Tac-CH1 is shown to sort to late endosomes like TacNR2A, 
whereas Tac-CH2 is colocalised slightly to recycling endosomal markers, but not to late 
endosomal markers, however it also reveals intermediate phenotypes between TacNR2A 
and TacNR2B. Moreover, in recycling assay, even though the level of recycled Tac-CH I 
trafficked back on the cell surface is not significantly different from TacNR2A (Fig 
3.10), Tac-CH 1 appears to be quite readily recycled back to the cell surface in a 
subpopulation of cells (Fig. 3.9). Again, Tac-CH2 shows intermediate level of recycling 
back on the cell surface, which is not as robust as TacNR2B while it shows significantly 
higher level of recycling than TacNR2A (Fig. 3.9; 3.10). The ambiguity of these 
observations makes it very difficult to draw any conclusion from the experiments 
performed in this chapter. Due to the intermediate phenotypes observed with the Tac- 
CH1 and Tac-CH2 chimeras, I concluded that using the chimeric approach may not be 
appropriate in determining the precise trafficking motifs localised in the C-termini of 
NMDARs. There are several reasons why the chimeric receptors failed to reveal definite 
phenotypes: 
  Previous studies reported that the Tac chimeras generated by appending the 
entire C-termini of NR2A and NR2B to Tac were not able to reach the 
plasma membrane and were retained in the ER (Hawkins et al., 2002; 
Lavezzari et al., 2004), possibly due to the large size of the NR2 
intracellular domains. The last 170 a. a. of the NR2A and NR2B CTs were 
shown to express well on the plasma membrane and internalised well and 
sorted into distinct pathways. I therefore focused on this distal C-terminal 
domain and swapped parts of NR2A and NR2B CTs within this region. 
However, it is likely that the exact choice of boundaries chosen is crucial in 
determining whether the chimeras were able to fold into the correct 
structural orientation. Therefore it is possible that Tac-CHI and Tac-CH2 
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chimeras were unable to fold into correct conformations and thus unable to 
traffic correctly within the cell. 
  It is also possible that the post-endocytic motifs are coincidently fall on the 
junctions where NR2A and NR2B are connected in Tac-CHI and Tac-CH2. 
Thus the correct sorting patterns were not achieved. Further work can be 
done to generate more chimeras with alternative boundaries between NR2A 
and NR2B sequences being chosen, but we wanted a robust assay and this 
approach did not give us that advantage. 
Thus, based on these and other unknown reasons, these generated chimeras are unable to 
give us clear insight to successfully identify where the potential sorting motifs are 
localised in the NR2A and NR2B C-termini. More approaches may be taken to continue 
this work, but it is too time consuming. Therefore, I dropped this approach to focus on 
my other two projects that will be discussed in the next two chapters. 
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Chapter 4. 
Use of a novel approach to study glutamate 
receptor dimerisation and trafficking 
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4.1. Introduction 
As mentioned earlier, NMDARs are tetramers, most probably composed of two 
copies of NR1 and NR2 subunits. Functional diversity of NMDAR is generated by 
differential incorporation of various types of NMDAR subunits (reviewed in Dingledine 
et at., 1999). In the cortex and hippocampus, regions that are crucial in synaptic 
plasticity and responsible for learning and memory, besides NR1/NR2A and NR1/NR2B 
diheteromeric NMDARs, triheteromeric NMDARs containing NR1/NR2A /NR2B have 
also been consistently observed (Didier et at., 1995; Luo et at., 1997; Sheng et al., 1994). 
Whereas the contributions of NR2A and NR2B subunits in regulating diheteromeric 
NR1/NR2 NMDARs trafficking have been extensively studied both in vivo and in vitro 
(reviewed in Lau & Zukin, 2007), the functional characterisation and the properties of 
NR2A and NR2B assemblies in triheteromeric NMDARs are unable to study due to the 
fact that currently there is no specific antibody or other approach to distinguish NR2A or 
NR2B subunits containing in triheteromeric receptor complexes from the diheteromeric 
receptor complexes. 
In this chapter, I have set out to optimise an approach to investigate the 
trafficking of multimeric membrane proteins, and to identify the corresponding 
trafficking motifs encoded in the C-terminal tails of the protein. Since several motifs 
have been identified in the C-terminal domains of NR2 subunits which regulate 
NMDARs trafficking and sorting (Roche et al., 2001; Lavezzarri et al., 2003; 2004; 
Scott et al., 2004; Chung et al., 2004), suggesting that the C-terminal tails of NMDARs 
play a vital role in receptor function and channel properties. I have chosen a novel 
approach based on several unique features of human class II histocompatibility 
molecules (MHCII), namely HLA-DRa and HLA-DRß chains. First, a and ß chains 
form dimers and traffic to the plasma membrane. Secondly, there are reagent that 
specifically recognises dimerised aß chains. This approach is especially useful in 
studying the endocytic sorting of dimers of chimeric proteins containing NMDAR tails, 
which may provide some insight into answering the questions regarding NR2A and ,ý. 
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NR2B assemblies that mentioned above. Moreover, beside NMDARs, this approach is 
also applicable in studying receptor trafficking of other multimeric proteins. 
4.2. Expression and characterisation of MHCII a and ß chains as 
dimers 
The protein Tac has been used as a plasma membrane reporter molecule, and Tac- 
glutamate receptor chimeras have been instrumental tools in defining trafficking and 
sorting motifs encoded within the C-termini of glutamate receptor subunits. (Lavezzari 
et al., 2004; Scott et al., 2004; Standley et al., 2000). The a and ß chains must 
oligomerise to reach the plasma membrane. However, Tac chimeras are expressed as 
monomers whereas NMDARs are tetramers. Thus, in order to characterise the 
endocytosis of dimers of chimeric proteins containing NMDAR tails further, I am using 
an approach based on the unique features of the human MHC II proteins, which are 
heterodimers consisting of an a and ß chain (HLA-DRa and HLA-DRß chains). The 
MHCII a and ß chains must form heterodimers in order to exit the ER and reach the 
plasma membrane. This dimerisation allows us to coexpress various a- and ß-NMDAR 
subunit C-terminal chimeras in heterologous cells and neurones, and evaluate receptor 
expression on the cell surface, endocytosis and post-endocytic sorting. 
4.3. Results 
4.3.1. MHCII a chain dimerises with ß chain and is expressed on the plasma 
membrane 
I obtained constructs encoding truncated human MHCII a and ß chains (HLA-DRa: a. a. 
1-244; and HLA-DR3: a. a 1-255), from Dr. Paul Roche's laboratory (NCI, NIH). I also 
obtained two specific antibodies which recognise MHCII ß chain (XDS. A11) and 
chain only when dimerised with a chain (L243) (Lampson and Levy, 1980), 
respectively. As mentioned above, MHCII a and ß chains must form a heterodimer in 
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order to exit the ER and reach the plasma membrane, meaning that all immunoreactivity 
observed with MIICII aß chain (L243) antibody represent dimeric complexes. In 
addition, the antibody recognises and extracellular epitope and therefore can specifically 
label surface-exposed dieters. To test this approach, I co-expressed a and (3 chains or 13 
chain alone in l leLa cells, which are ideal for confocal microscopy and highly 
transfectable. The cells were then labelled with antibodies that recognize ul3 dimers 
(L243) or ß chain (XDS. A I I) by surface labelling and immunofluorescent microscopy. I 
found that when the P chain was expressed alone, it was not expressed on the cell 
surface (Fig 4.11 A), whereas coexpression of c4 chains led to dimerisation and the a 
complexes were robustly expressed on the cell surface (Fig. 4. Iß). 
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Fig. 4.1 11-chain is not cxpresscd (III the cell surface (A) unless it is dinicriscd ýsilh IIIV u 
chain (13). 
I IeLa cells were transiently transfected with human MI I('ll- (i chain or MI ICII- cc and ji chains. For 
surface labelling, live cells were first fixed and blocked, then labelled with anti- human MI I('II-ý 
chain or MI ICII a4i dinier antibodies for I hour. Surface receptors were visualised with anti-mouse 
Ig(12A Alexa 56X- conjugated secondary antibody. Images were collected using a 63X objective. 0- 
chain is not expressed on the cell surface when expressed alone, whereas coexpression of a and ß 
chains reveals robust surface expression of aß- dimmers. 
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4.3.2. Truncated human MHCII aß dimers were stably expressed on the cell 
surface 
Next, I tested these constructs for their stability of surface expression, these mutants 
were reported to be internalised rapidly but levelled off with majority of the molecules 
remaining at the cell surface, because of the truncation of most of the cytoplasmic 
domain (Pinet et al., 1995). I also compared these human mutants to their mouse 
counterparts (Mus IA and IE from Dr. Paul Roche, NCI, NIH) to see if there is a species 
difference. Therefore, I co-expressed human and mouse MHCII a and ß chains in HeLa 
cells, respectively. Then, I performed an antibody feeding assay and 
immunofluorescence microscopy as described in Chapter 2. However, I found that a 
certain level of intracellular localisation of aß dimers was observed in a subpopulation 
of cells, and the level of residual endocytosis in the cells expressing mouse MHCII a 
and ß mutants was more significant than the human mutants (Fig. 4.2A; Original aß 
dimer). I therefore reviewed the amino acid sequences of all mutants and noticed that 
each mutant contains 5 a. a. in the C-terminal tail right after the transmembrane domain. I 
therefore truncated the residual amino acids in the C-terminal tail of each mutant (HLA- 
DRa: a. a. 1-239; and HLA-DRß: a. a 1-250) and tested their surface stability again with 
the same approach described above. Interestingly, as shown in Fig. 4.2B (Mouse aß- 
dimer), internalised aß dimers were still visible in cells expressing truncated mouse 
MHCII a and ß mutants but were no longer seen in cells expressing truncated human 
MHCII a and ß mutants, as revealed by the robust surface expression Fig. 4.2B (human 
aß-dimer). I therefore focused on further characterising the truncated human a and ß 
chains by testing if these tailless constructs would undergo endocytosis. I performed an 
internalisation assay over a range of time points from 0 to 30 min. HeLa cells expressing 
aß dimers were labelled on ice for 1 hour with anti-aß dimer-specific antibody (L243) 
and returned to conditioned media for different periods of time (0 min, 15 min, and 30 
min) to allow internalisation. Strikingly, robust steady-state surface expression of ap 
dimers (Stack images) with negligible internalised protein (single-slice images) was 
observed at all tested time points (Fig. 4.3). These data demonstrate a similar steady 
surface expression of truncated human MHCII a and ß mutants as the surface integral 
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membrane protein Tac, which our lab has used previously to define endocytic motifs 
(Lavezzari et al., 2004). The truncated human MHCII a and 0 chains are now well 
characterised and shown to be stably expressed on the cell surface, allowing me to 
proceed and use them to generate chimeras to study NMDAR trafficking. 
A Human Mouse 





Fig. 4.2 A) HeLa cells expressing human or mouse ap dimers containing 5 a. a. of the C-terminal 
tails reveal residual endocytosis. B) Human aß dimers with the entire C-termini truncated are 
robustly expressed on the cell surface with no residual endocytosis observed, whereas cells 
expressing the truncated mouse aß chains still show residual endocytosis. 
HeLa cells were transiently transfected with partially truncated or truncated human or mouse MHCII- aß 
chains. Live cells were labelled with anti- human or mouse MHCII aß dimer antibodies for 30 min at 
37°C. Cells were than fixed, permeabilised, blocked and incubated with anti-mouse IgG, A Alexa 568- 
conjugated secondary antibody. Images were collected using a 63X objective at intervals of 0.34 µm. 
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Fig. 4.3 Human aß dimers are robustly expressed on the cell surface at steady state and 
there is negligible endocytosis over all tested internalisation time points. 
HeLa cells were transiently transfected with truncated human a and ß chains and was labelled with 
anti- human aß dimer antibody on ice for I hour. Cells were returned to conditioned media for 
different time points as specified (0,15, or 30 min) at 37°C to allow internalisation. Images were 
collected using a 63X objective at intervals of 0.34 µm. Images are shown as single slice and 
projection stack images. 
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4.4. Investigation of differential endocytosis and post-endocytic 
sorting of diheteromeric and triheteromeric NMDARs 
In more mature neurones (DIV 12) compared to younger neurones (DIV5), surface- 
expressed NR2B undergoes more robust endocytosis than NR2A. Moreover, it is 
reported that NR2A and NR2B subunits have distinct post-endocytic sorting pathways 
(Lavezzari et al., 2004). Internalisation of surface NR2B was identified to be mediated 
by a tyrosine- based YEKL endocytic motif encoded within the distal C-terminus of 
NR2B. This site is localised just upstream of the PDZ-binding domain, and PDZ binding 
proteins can inhibit NR2B endocytosis (Roche et al., 2001). Subsequently, our lab found 
that this YEKL motif regulates surface NR2B internalisation through binding to the 
clathrin adaptor protein, AP-2, which internalises cargo proteins into clathrin-coated- 
pits. Internalisation of surface NR2A was not tyrosine- dependent but was partially 
regulated by a dileucine (LL) motif encoded in NR2A C-terminal tail; however, 
disruption of this motif did not affect the endocytosis of NR2A, suggesting that another 
NR2A endocytic motif may be localised at an alternative site, or NR2A-containing 
NMDAR use this LL endocytic motif less efficiently in NR2A endocytosis (Lavezzari et 
al., 2004). However, it is unclear how complexes containing both NR2A and NR2B 
subunits might behave. As mentioned above, NR2 dimers exist in a functional NMDAR 
complex and can be composed of identical or different NR2 subunits, which would also 
give rise to triheteromeric (NR1/NR2A/NR2B) assemblies. Whereas diheteromeric 
NR1/NR2 receptors have been extensively studied both in vivo and in vitro, the 
characterisation of triheteromeric NMDARs are more complicated and therefore less 
studied. It is known that after endocytosis, NR2A is sorted to late endosomes for 
degradation, whereas NR2B preferentially traffics through the recycling pathway 
(Lavezzari et al., 2004). It is not known whether co-expression of NR2A and NR2B in 
the same NMDAR complex would shift the post-endocytic sorting pathway to either the 
NR2A-preferred or NR2B-preferred route. 
Here, I have applied a new approach using the dimeric MHCII constructs that were 
already characterised, to study the subcellular sorting pathways of the NR2 subunits 
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present in diheteromeric as well as triheteromeric NMDARs. Again, the MHCII a and ß 
chains must form heterodimers in order to exit the ER and reach the plasma membrane. 
This dimerisation allows us to coexpress various NMDAR subunit C-terminal chimeras 
in heterologous cells and neurones, and evaluate endocytosis and sorting. 
4.4.1. Results 
The distal C-termini of NR2A and NR2B have been shown to regulate NMDAR 
trafficking (Lavezzari et al., 2004; Lavezzari et al., 2003; Roche et al., 2001; Scott et al., 
2004; Steigerwald et al., 2000). Therefore, I have constructed chimeras of human MHC 
II a or ß chain containing the distal (the last 175 a. a. ) NR2A (a. a. 1304-1464) or NR2B 
(a. a. 1315-1482) C-terminal domains (Fig. 4.4). 
MHCII a and ß-NR2 chimeras 
a, 'T MI NR2A (a. a. 1304-1464) 
1 
TM NR2A (a. a. 1304-1464) 
a Mýýý 
PT Mýýý 
Fig. 4.4 Schematic diagrams of the human MHC11 aß- NMDA receptor (NR2 subunit) 
chimeras. 
The distal C-terminus of NR2A (amino acids 1304-1464) or NR2B (amino acids 1315-1482) was 
appended to the plasma membrane reporter molecules, MHCII a and ß chains. 
4.4.1.1. aß-NR2A/NR2B dimers undergo internalisation 
Our lab has previously shown that the distal C-termini of NR2A and NR2B subunits 
were able to induce internalisation of the plasma membrane protein Tac (Roche et al., 
2001; Lavezzari et al., 2004), which is a monomer. To analyse if NR2A and NR2B C- 
120 
termini drive endocytosis of surface-expressed aß dimer effectively, I expressed 
aNR2A-3NR2A or aNR2B-ßNR2B homodimers in HeLa cells. Transfected cells were 
surface labelled on ice with anti-aß dimer antibody (L243) and immediately fixed (0' 
internalisation) or incubated at 37°C for 30 min to allow internalisation. Both aNR2A- 
ßNR2A or aNR2B-ßNR2B were primarily expressed on the cell surface before 
internalisation (Fig. 4.5 A-B, 0' internalisation, Stack) and no endosomes were labelled 
intracellularly (Fig. 4.5 A-B, 0' internalisation, Single slice). Robust endocytosis was 
observed for both NR2A and NR2B homodimers after 30 min of internalisation, with 
aNR2B-4NR2B homodimers trafficking to endosomes, but also demonstrating residual 
pronounced surface expression (Fig. 4.5 B, 30' internalisation), whereas aNR2A- 
ßNR2A homodimers showed a reduced surface expression and distinct endosomal 
distribution mainly in the peri-nuclear region (Fig 4.5A, 30' internalisation). These 
observations were remarkably similar to findings with TacNR2A and TacNR2B 
(Lavezzari et al., 2004). Therefore, dimers of the distal C-termini of NR2A or NR2B 
were able to induce internalisation of surface-expressed aß chains, with NR2A and 
NR2B homodimers having distinct post-endocytic sorting patterns. 
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Fig. 4. S Ilomodimcric \122: (: \) and \12213 (13) chimeras are primarily expressed on the 
cell surface before internalisation (0 min) and are ýýcll internalised with distinct endocytic 
sorting patterns as shown in the single slice and stack images of transfected IIcLa cells. 
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4.4.1.2. Homomeric NR2A dimers traffic through late endosomes, whereas 
homomeric NR2B dimers preferentially traffic through the recycling pathway 
Following endocytosis, NMDA receptors traffic to early endosomes, and are then either 
sorted to recycling endosomes for reinsertion into the plasma membrane or traffic to late 
endosomes, and are subsequently degraded in lysosomes. Our lab previously 
demonstrated that the post-endocytic sorting of NMDA receptors is differentially 
regulated by the NR2A and NR2B subunits. Monomeric TacNR2A and TacNR2B traffic 
to distinct compartments, with TacNR2B preferentially sorting into recycling 
endosomes, whereas TacNR2A is sorted to late endosomes for degradation (Lavezzari et 
al., 2004). To examine the localisation of homomeric aNR2A-ßNR2A or aNR2B- 
INR2B dimers, I evaluated internalised proteins using immunofluorescence microscopy. 
I incubated the cells on ice for 1 hour with anti-aß dimer antibody (L243) and returned 
the cells to conditioned media at 37°C for various amounts of time (5 min, 15 min and 
30 min) to allow internalisation. I quantitated the colocalisation of homomeric aNR2A- 
INR2A and aNR2B-INR2B dimers with the late endosomal marker GFP-Rab9 or the 
recycling endosomal marker GFP-Rab1 I (Fig 4.6; Fig 4.8) (data not shown for 15 min 
internalisation). At 5 min, both aNR2A-3NR2A and aNR2B-INR2B chimeras were 
still robustly expressed on the cell surface and did not colocalise well with either the late 
endosomal marker GFP-Rab9 or the recycling endosomal marker GFP-Rabl I (Fig. 4.6; 
Fig. 4.8,5' internalisation). At 15 min, aNR2A-3NR2A and aNR2B-3NR2B dimers 
showed moderate colocalisation with GFP-Rab9 and GFP-Rabl l respectively (data not 
shown), most notably by 30 min, aNR2A-ßNR2A was shown to be almost completely 
colocalised with GFP-Rab9 in the perinuclear regions, whereas aNR2B-ßNR2B was 
shown to be heavily colocalised with GFP-Rab1 l in the cell surface proximal regions 
(Fig. 4.6,4.8; 4.9). Statistical analyses reveal that the colocalisation of aNR2A-ßNR2A 
with GFP-Rab9 increases over time but decreases with GFP-Rabl l over time (Fig. 4.7), 
whereas aNR2B-fNR2B dimers were preferentially colocalised with the recycling 
endosomal marker GFP-Rabl 1 at all tested internalisation time points (Fig. 4.9). These 
results show that homomeric NR2A dimers preferentially traffic to late endosomes 
whereas the homomeric NR2B dimers preferentially traffic through the recycling 
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pathway. Strikingly, these data are indistinguishable from our previous findings for 
trafficking of the monomeric TacNR2A vs. TacNR2B. 
4.4.1.3. Heteromeric aNR2A-ßNR2B dimers preferentially sort to recycling 
endosomes 
The trafficking of di-heteromeric and triheteromeric NMDA receptors has been 
impossible to evaluate, due to the lack of specific tools to monitor particular 
subpopulations of receptors with defined stoichiometry. Based on my findings that 
homomeric aNR2A-ßNR2A and aNR2B-ßNR2B dimers sort to distinct subcellular 
compartments following endocytosis, I next evaluated the post-endocytic itinerary of 
heteromeric aNR2A-ßNR2B dimers. I quantitated the colocalisation between aNR2A- 
ßNR2B and GFP-Rab9 or GFP-11 over time (5' and 30') (Fig. 4.10; Fig. 4.11). At S 
min, similar to both homomeric aNR2A-ßNR2A and aNR2B-INR2B dimers, aNR2A- 
PNR2B dimers were still expressed constitutively on the cell surface and did not 
colocalise well with either late endosomal marker GFP-Rab9 or recycling endosomal 
marker GFP-Rab11. By 15 min, aNR2A-PNR2B dimers showed a higher level of 
colocalisation with GFP-RabI l than with GFP-Rab9 (data not shown). Interestingly, by 
30 min, the colocalisation of heteromeric aNR2A-PNR2B dimers with GFP-Rab9 or 
GFP-Rabl l was indistinguishable from homomeric aNR2B-ßNR2B dimers. 
Specifically, aNR2A-PNR2B heterodimers colocalised less with GFP-Rab9 than GFP- 
Rab 11, showing robust overlap with Rab 11, particularly on the cell surface along the 
distal edges of the cells, which is typical of recycling endosomes (Fig. 4.8; Fig. 4.10). I 
also tested aNR2B-INR2A heterodimers as a control for any effect that might depend 
on the a or ß chain. I observed the same sorting pattern for these heterodimers as 
aNR2A-PNR2B heterodimers (data not shown). These data show that the heteromeric 
aNR2A-PNR2B dimers preferentially enter the recycling pathway following 






















Fig. 4.6 (A-B) Homomeric aNR2A-ONR2A dimers do not colocalise with the recycling 
endosomal marker GFP-Rabl I but increasingly colocalise with the late endosomal marker 
GFP-Rab9 in the perinuclear region over time (5 or 30 min). 
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Fig. 4.7 Statistical analysis of the amount of colocalisation between aNR2A-ßNR2A dimers 
with CFP-Rab9 or GFP-Rabt I after 5 or 30 min of internalisation in transfected Ile La cells. 
Colocalisation analysis was measured with the software NIII Image. ) Overlap coefficient plug-in. 
Values represent the mean +/ - SEM of overlap coefficient. (n 15-20, N=4; n= number of cells, N= 


















Fig. 4.8 (A-B) Homomeric aNR2B-ONR2B dimers colocalise extensively with the recycling 
endosomal marker GFP-Rabll rather than with the late endosomal marker GFP-Rab9. 
Colocalisation increases in the cell surface proximal regions over time (5 or 30 min). 
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Fig. 4.9 Statistical analysis of the amount of colocalisation between aNR2B-ßNR2B 
dieters with GFP-Rab9 or GFP-Rabl I after 5 or 30 min of internalisation in transfected 
IIcLa cells. 
Colocalisation analysis was measured with the software NI11 Image) Overlap coefficient plug-in. 
Values represent the mean -/- SEM of overlap coefficient. (n- 15-20, N- 4) ; two-tailed /-test 




























Fig. 4.10 (A-B) of ctNR2A-ßNR2B heterodimers are preferentially sorted to recycling 


















Internalization time (min) 
Fig. 4.1 1 Statistical analysis of the amount of colocalisation between ct N R2A-0 N R2 It 
dieters with (FP-Rab9 or (: FI -Rabl I after 5 or 30 min of internalisation in transfected 
IIcLa cells. 
('olocalisation analysis was measured with the sotlware Nil I Image) Overlap coefficient plug- 
in. Values represent the mean +/ - SEM of overlap coefficient. (n= I5-20, N"4); two-tailed t- 
test performed, * p--0.01. 
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4.4.1.4. aNR2B- f NR2A and aNR2A-3NR2B heterodimers are robustly recycled 
to the plasma membrane, in contrast to NR2A homodimers 
I next performed an antibody-based recycling assay. Live HeLa cells expressing 
aNR2A-f3NR2A, aNR2B-ßNR2B, aNR2A-ßNR2B or aNR2B-ßNR2A dimers were 
labelled with anti-aß dimer (L243) antibody, and returned to conditioned media at 37°C 
for 20 min to allow internalisation. Remaining surface proteins were blocked with 
unconjugated secondary antibody on ice for 30 min, followed by either a second 
incubation at 37°C to allow receptor trafficking to continue (Fig. 4.13), or maintained on 
ice as a negative control (Fig. 4.12). Strikingly, for the cells that were incubated at 37°C 
to allow internalisation, I observed almost no recycled homomeric aNR2A-ßNR2A 
dimers, whereas homomeric aNR2B-INR2B dimers, heteromeric aNR2A-INR2B and 
aNR2B-ßNR2A dimers showed a significant amount of recycling back to the cell 
surface (Fig. 4.13; 4.14), supporting a dominant role for NR2B in receptor recycling. I 
observed no surface-expressed aß-NR2 dimers when cells were kept on ice and the 
second 37°C incubation is omitted confirming that the unconjugated secondary antibody 
effectively blocked any labelling of dimers that remained on the cell surface (Fig. 4.12; 
4.14). These results are consistent with the results using colocalisation analyses 
demonstrating that NR2B homo- and hetero-dimers preferentially sort to recycling 










Fig. 4.12 All surface remaining aß-labelled NR2 dimers are effectively blocked by unconjugated 
secondary antibody when incubated on ice 
Cells expressing aNR2A-f NR2A, aNR2B- ßNR2B, aNR2A-ßNR2B or aNR2B-ONR2A were labelled with 
aß dimer (L243) antibody on ice and returned to conditioned media at 37°C. Remaining surface receptors 
were blocked with unconjugated secondary antibody and kept on ice. Recycled receptors were labelled with 
Alexa-568 conjugated (red) secondary antibody. Internalised receptors were labelled with Alexa 488- 
conjugated (green) secondary antibody after permeabilisation. 
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Fig. 4.13 The distal C-terminus of NR2B regulates the recycling of homomeric aN11211- 
ßNR2B dimers, as well as heteromeric aNR2A-ßNR2B and aNR2B-ßNR2A dimers in HeLa 
cells 
The majority of homomeric aNR2A-ßNR2A dimers do not recycle back to the plasma membrane 
after internalisation, whereas cells expressing homomeric aNR2B-ßNR2B dimers, heteromeric 
aNR2A-ßNR2B or heteromeric aNR2B-ßNR2A show significant amount of recycled receptor 
accumulating on the cell surface after the second incubation period at 37°C. 
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Fig. 4.14 Quantification of recycling of various combinations of dimers in IIeLa cells. 
Not-recycled = Cells kept on ice after incubation with unconjugated secondary antibody; Recycled= 
Cells allowed to recycle at 37°C after incubation with unconjugated secondary antibody. Images were 
quantified with Metamorph software (n= 20, N=4). Data represent means +/- SEM of the recycled/ 
internalised fluorescence intensities ratios. Student t-test performed. *<0.02 relative to not-recycled 
cells; ** <0.02 relative to cells expressing recycled aNR2A-INR2A homodimers. 
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4.4.1.5. Differential post-endocytic sorting pathways of aNR2A-ßNR2A, aNR2B- 
ßNR2B and aNR2A-f NR2B dimers in hippocampal neurones 
After characterising the post-endocytic sorting pathways of aß-NR2A/2B homo- and 
hetero-dimers in HeLa cells, I next examined the post-endocytic trafficking of these aß- 
NR2 dimers in neurones. I transfected dissociated rat hippocampal neurones with 
aNR2A-INR2A, aNR2B-3NR2B or aNR2A-PNR2B and either GFP-Rab9 or GFP- 
Rabl lat 9 -10 DIV. Five days after transfection, I quantified the amount of 
colocalisation between aNR2A-ßNR2A, aNR2B-3NR2B or aNR2A-PNR2B dimers 
and various endosomal markers (GFP-Rab9 or GFP-Rab 11) after internalisation. By 30 
min of internalisation, aNR2A-ßNR2A strongly colocalised with the late endosomal 
marker GFP-Rab9, and to a lesser degree with the recycling endosomal marker GFP- 
Rabl 1 (Fig. 4.15; 4.16). In contrast, trafficking of aNR2B-(3NR2B homodimers and 
aNR2A-PNR2B heterodimers was indistinguishable, with both showing some 
colocalisation with GFP-Rab9, but an even higher degree of overlap with the recycling 
endosomal marker GFP-RabI 1 (Fig. 4.15; 4.16), suggesting that both homomeric 
aNR2B-ßNR2B and heteromeric aNR2A-INR2B dimers preferentially sorted to 
recycling endosomes in neurones. These data demonstrate that the distal C-terminal tail 
of NR2B regulates the recycling of homomeric aNR2B-ßNR2B as well as heteromeric 





















Fig. 4.15 lieteromeric aNR2A-ßNR2B dimers are preferentially sorted to recycling endosomes in 
hippocampal neurones 
Hippocampal neurones were transiently transfected at DIV9/10 with ctNR2A-ßNR2A, aNR2B-ßNR2B, or 
aNR2A-INR2B and GFP-Rab9 or GFP-Rabl 1.5 days after transfection (DIV 14), cells were labelled with 
anti- aß-dimer antibody for 15 min at room temperature then returned to conditioned media and incubated 
at 37°C for 30 min to allow internalisation. Neurones were fixed and permeabilised, and immunoreactivity 












Fig. 4.16 Statistical analysis of the amount of colocalisation between various aß-NR2 dimers 
and the endosomal marker GFP-Rab9 or GFP-Rab11 in neurons. 
Series of optical sections were collected at 0.34 µm using a Zeiss LSM 510 confocal microscope. 
Colocalisation analysis was measured with the software Image) Overlap coefficient plug-in. Values 
represent mean +/ - SEM of overlap coefficient. (n=14-20, N=3-4), *p <0.01, student t-test. 
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Fig. 4.17 GFP-NR2B is robustly internalised (A) and all remaining surface receptors are 
effectively blocked by unconjugated secondary antibody In hippocampal neurones derived from 
both WT and NR2A-/- mice 
Cultured hippocampal neurones prepared from WT and NR2A-/- E 18 embryos were transfected with 
GFP-NR2B at DIVI 1-12. After 3 days, live neuroneneurones were incubated with anti-GFP antibody for 
10 min at room temperature to label surface-expressed receptors. The antibody was removed, and the 
neurones were incubated in conditioned media at 37°C to allow internalisation. The neurones were fixed 
at this point for cells showed in (A). For cells showed in (B), the cells were incubated with unconjugated 
secondary antibody for 20 min at room-temperature. The cells were then labelled with Alexa-568- 
conjugated secondary antibody to label the surface pool of receptors (Red). Neurones were then 
permeabilised and incubated with Alexa-647-conjugated secondary antibody to label the internalised pool 
(green). 
4.4.1.6. Recycling of NR2B is unaffected in NR2A-/- hippocampal neurones 
The data presented thus far strongly suggest that in vivo heteromers containing 
NR2B will preferentially recycle at synapses. In order to characterise the role of NR2B 
in regulating the recycling of NMDARs, and to conclusively demonstrate that the NR2B 
sorting motif is dominant I analysed NMDAR recycling in NR2A-deficient neurons. I 
expressed full-length NR2B containing an N-terminal GFP epitope tag in hippocampal 
neurons derived either from wild-type (WT) or NR2A knockout mice (NR2A-/-), and 
examined NMDAR recycling. Due to the limitations on specific antibodies that 
recognise the N-terminal domain of NR2 subunits, the use of a GFP tag in the N- 
terminal domain of NR2B enabled the analysis of NR2B trafficking in neurones. On 
DIV 14, neurones were labelled with anti-GFP primary antibody live at room- 
temperature which were then returned to conditioned media and incubated at 37°C for 30 
min to allow internalisation. GFP-NR2B was shown to undergo robust internalisation in 
both WT and NR2A-/- neurones (Fig. 4.17A). The cells were then labelled with 
unconjugated secondary antibody to block all the primary antibody bound-receptors 
remained on the cell surface. It is revealed that after 20 min of incubation with 
unconjugated secondary antibody, labelling of all remaining surface receptors were 
abolished (Fig. 4.17B). The cells were then warmed up at 37°C for 30 min again to 
allow further trafficking to continue. Cells were fixed at this point and recycled 
receptors on the cell surface were labelled with Alexa-568 conjugated secondary 
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antibody under a non-permeabilised condition. After permeabilisation and blocking, 
intracellular receptors were probed with Alexa 647-conjugated secondary antibody. 
Quantitative analysis revealed that the amount of NR2B recycled back onto the cell 
surface in NR2A-/- neurons was not significantly different from that seen in WT neurons 
(Fig. 4.18). These data suggest that trafficking of NR2B was not affected by loss of 
NR2A, which also confirmed the findings from HeLa cells as described previously in 
this chapter that NR2B is dominant in regulating NR2 trafficking. Alternatively, it is 
possible that NRl/NR2AINR2B triheteromeric NMDARs are a minor population of total 
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Fig. 4.18 Recycling of internalised NR2B is not affected in NR2A-/- hippocampal neurones 
(A) Not significantly different levels of recycled NR2B receptors were detected in WT and NR2A-/- 
neurones. 
(B) Quantification of NR2B recycling in WT and NR2A-/- neurones. Fluorescence intensities were 
measured using Metamorph software. (n= 43-46 cells; N= 3 independent experiments). The ratios of 
recycled receptors (red) to total (red plus green) of GFP-NR2B in WT and NR2A-/- neurones are 
presented. The error bars represent mean +/- SEM; n. s (non-specific) =p>0.4. 
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4.5. Investigation of ER-retention and surface expression of different 
NR1 splice variants combinations 
It is well established that both NR1 and NR2 subunits are required for proper 
assembly and receptor egress from the ER as functional receptor complex. As a control 
mechanism, any unassembled and non-functional NRl/NR2 subunits are ER-retained by 
an ER-retention motif, and only fully assembled NMDARs are targeted to the 
postsynaptic membrane. NR1 subunits do not form functional receptors alone, but their 
surface expression depends on the splice variants generated in the C- terminus. NR1 has 
4 splice variants that differ in their C-terminal tails (Fig. 1.4), and trafficking motifs are 
encoded within the C-termini of NR1 subunits (Standley et al., 2000; Horak et al., 2008; 
Horak & Wenthold, 2009). The isoform with the longer C-terminal tail (NR1.1) is 
mostly ER-retained due to the presence of ER-retention motifs (RRR and KKK) in the 
alternatively spliced Cl cassette (Standley et al., 2000; Horak & Wenthold, 2009), 
whereas the shorter C-terminal tail isoforms (NR1.2 and NR1.4) are more efficiently 
expressed on the postsynaptic membrane due to the lack of the C1 cassette (Standley et 
al., 2000; (Okabe et al., 1999). The ER-retention signal in the Cl cassette of NR 1.3 is 
suppressed by the presence of a C2' cassette which includes a PDZ-interacting domain 
(Standley et al., 2000). Moreover, a recent study reported that the C2 cassette has an 
additional inhibitory effect on the forward trafficking of NR1 whereas CO and C2' 
cassettes had an enhancing effect on the trafficking of NR1 subunits to the cell surface 
(Horak & Wenthold, 2009). Although it is widely recognised that NR1 subunits are 
dimerised upon assembly of functional channels, and it is known that homomeric NR I 
receptors do not exist on the surface of neurones. However, it is not known whether the 
precise splice variant stoichiometry would affect the ER-retention and forward 
trafficking of NMDARs. 
Having validated the use of MHCIIaß dimers as reporter molecules in NR2 
trafficking, I am now extending our investigation to explore the trafficking of the dimers 
of NRl splice variants. 
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4.5.1. Results 
To begin the characterisation of aß chimeras containing different spice variants of NRI 
full-length C-termini, I have generated the chimeras of truncated a and ß chains 
containing the full-length C-terminal tail of NR1.1 and NR1.2 splice variants. I first 
tested if the homomeric dimers of NRl. 1 and NR1.2 chimeras were able to exit the ER 
and traffic to the plasma membrane. I co-expressed aNR1.1 and ßNR1.1 or aNR1.2 and 
ßNR1.2 in HeLa cells, and then performed surface labelling and immunofluorescent 
microscopy as previously described in Chapter 2. I found that homomeric 
aNR1.1 ßNR1.1 did not reach the plasma membrane, and the morphology revealed 
under permeabilised conditions suggested that aNR1. Ij3NR1.1 was heavily retained in 
the ER, whereas aNR1.20NRI. 2 expressed robustly on the cell surface (Fig. 4.19), these 
results are consistent with previous findings of monomeric Tac chimeras, TacNR1.1 and 
TacNR1.2 (Standley et al., 2000). I next tested the surface and total expression of the 
heteromeric aNR1.1 fNR1.2 dimers. Surprisingly, a moderate level of surface 
expression was detected upon dimerisation of aNR1.1 and pNR1.2 (Fig. 4.19). I found 
that the level of surface expression of aNR1.1ßNR1.2 heterodimer was approximately 
half as much as that of aNR1.2ßNR1.2 homodimers, suggesting that when NR1.2 forms 
a dimer with NR1,1, it partially masks the ER-retention motif located in the C-terminus 
of NR1.1. This finding reveals that differential assemblies of NR1 splice variants play a 




















Fig. 4.19 Homomeric aNR1. I-ßNR1.1 chimeras are ER-retained, whereas homomeric 
aNRl. 2-ßNR1.2 and heteromeric aNR1.1-ONRI. 2 chimeras express on the cell surface. 
HeLa cells were transiently transfected with different combinations of aNRI. 1; ßNR1.1, aNRI. 2, or 
3NRI. 2. For surface staining, live cells were incubated with aß-dimer antibodies on ice for I hr. 
Cells were then fixed and immunoreactivity was visualised using Alexa 568-conjugated (red) 
secondary antibodies. For total expression staining, cells were first fixed, permeabilised and stained 
with aß-dimer antibodies. Immunoreactivity was visualized using Alexa 568-conjugated (red) anti- 
mouse secondary antibodies. 
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Fig. 4.20 Quantification of surface expression for different combinations of ap-NR1.1/ 
NR1.2 dimers in IIeLa cells. 
Fluorescence intensities were measured using ImageJ software. (n= 12-14 cells; N= 2 
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4.6. Discussion 
In this chapter, I have truncated and characterised human MHCII a and ß chains to 
study the effect on NMDAR trafficking upon dimerisation of various NMDAR subunits. 
I developed an approach based on the unique feature of MHCII that a and ß chains must 
dimerise to reach the plasma membrane. Furthermore, and the availability of a specific 
antibody that recognises aß- dimers makes precise study of dimers possible. I examined 
the relative contribution of the distal C-termini (last 175 a. a. ) of NR2 subunits in 
targeting receptors to the post-endocytic sorting pathways. I compared of homomeric 
(NR2A- or NR2B- homodimers) versus heteromeric assemblies (NR2A/NR2B 
heterodimer) of NR2 subunits by generating chimeras of a and ß chains with the NR2A 
/NR2B distal C-termini and expressed them both in heterologous cells and neurones. I 
found that the endocytic trafficking of NMDA receptors is dependent on different 
combinations of NR2 subunits. Homodimeric NR2A chimeras enter the degradation 
pathway and colocalise with late endosomal markers, whereas the homomeric NR2B 
chimeras predominantly traffic through the recycling pathway and colocalise with 
recycling endosomal markers, consistent with our previous results using monomeric 
chimeras of NR2 C-termini (TacNR2A and TacNR2B). Interestingly, heteromeric 
aNR2AßNR2B chimeras preferentially sort to recycling endosomes. Moreover, 
heteromeric NR2A/NR2B chimeras and homomeric NR2B, but not NR2A, chimeras 
expressed in HeLa cells also show a similar level of recycling back onto the cell surface 
in quantitative recycling assays. These data support a dominant role for the NR2B C- 
terminus in regulating the trafficking of NR2A/NR2B complexes towards the recycling 
pathway. The dominant role of NR2B in subcellular sorting of NMDAR complexes is 
supported by my data showing the absence of NR2A does not affect NR2B recycling in 
hippocampal neurones derived from NR2A-/- mice comparing to the wild-type control. 
Apart from NR2 trafficking, I also generated chimeras of MHCII a or ß chains with 
NR1.1 and NR1.2, two of the splice variants of the NR1 subunit. I showed that 
homomeric NR1.1 dimers are ER-retained whereas homomeric NR1.2 dimers are 
robustly expressed on the cell surface. Intriguingly, upon dimerisation of aNR1.1 and 
fNRI. 2 chimeras in heterologous cells, the heteromeric NR1.1-NR1.2 complexes are 
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expressed on the cell surface. This suggests the ER-retention motif(s) localised in NR1.1 
C-terminus is/are overridden or hindered by certain domain(s) or motif(s) localised in 
the C-terminus of NR1.2. These findings shed some light on how assemblies of various 
NMDAR subunits determine the differential trafficking and subcellular sorting of 
NMDARs. It is noted that, in this chapter, I have developed a novel approach to study 
the role of oligomerisation of NMDAR trafficking, which may be useful and applicable 
in studying the trafficking of other multimeric membrane receptors. 
A variety of techniques have been utilized to identify molecular determinants 
within proteins that regulate intracellular trafficking and sorting. One molecular 
approach that has been exploited successfully has been to use of Tac as a plasma 
membrane reporter protein. Tac is a transmembrane protein that contains no endocytic 
motifs in its cytosolic domain, and is expressed at high levels on the plasma membrane 
at steady-state. Cell biologists and immunologists have utilized Tac for many years, and, 
by appending the cytosolic domains of transmembrane proteins (such as CD3E and 
HLA-DM), have revealed the presence of dominant endocytic sorting signals in each 
proteins' cytosolic domains. More recently, neuroscientists have adopted this approach 
to identify signals responsible for the trafficking of neurotransmitter receptors. For 
example, Tac-NMDA receptors chimeras have been used effectively to define subunit- 
specific contributions to NMDA receptor trafficking (Standley et al., 2000; Roche et al., 
2001; Lavezzari et al., 2004; Scott et al., 2004). Although this strategy is useful it suffers 
from the limitation that Tac itself is a monomer, and thus this approach can only be used 
to study one receptor subunit at a time. 
The trafficking of NMDARs is critical in regulating the number of functional 
NMDARs expressed at the synapse. This process is tightly regulated by a series of 
trafficking events including proper folding and retention of receptor in the ER, 
exocytosis, endocytosis, degradation and recycling of receptors. NMDARs are 
tetrameric complexes and it is well recognised that functional diversity of NMDAR is 
generated by differential incorporation of various types of NMDAR subunits 
(Dingledine et al., 1999). Without assembly with NR1, both NR2A and NR2B are not 
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able to reach the plasma membrane (Mcllhinney et al., 1998), therefore NR1 is thought 
to deliver NR2-containing NMDAR complexes to the cell surface. The intracellular C- 
terminal domains of both NR1 and NR2 have been shown to be crucial in regulating 
NMDAR trafficking, particularly ER-egress and endocytosis, respectively (Prybylowski 
et al., 2005). 
NMDAR endocytosis is developmentally regulated in neurons such that NMDARs 
undergo robust endocytosis and rapidly recycle back to the postsynaptic membrane early 
in development (Standley et al., 2000; Roche et al., 2001; Scott et al., 2001; Washbourne 
et at., 2002). At this stage of development endogenous NMDA receptors contain NR2B 
and the dynamic recycling endogenous NMDA receptors fits very well with the ability 
of the NR2B C-terminus to induce endocytosis of Tac followed by sorting to recycling 
endosomes (Lavezzari et al., 2004). However, endogenous NMDA receptors become 
more stable as synapses develop. This stabilisation corresponds with the increased 
expression of NR2A and the corresponding diversity in NMDA receptor subunit 
composition. In adult cortex, NMDA receptors are some combination of NR1/NR2B, 
NRI/NR2A, and NR1/NR2A/NR2B. It is therefore difficult to individually assess the 
contributions of individual subunits to endogenous NMDA receptor trafficking. The 
current study expands on the widely used approach of using reporter molecules to assess 
dominant trafficking motifs by using chimeras that assemble as heteromeric dimers. I 
find that I can measure trafficking of homodimers and heterodimers efficiently and 
quantitatively. This has allowed me to directly assay a heterodimer of the NR2A and 
NR2B tail. 
By taking advantage of the fact that MHCII surface expression requires assembly 
of both a- and ß- chains, I was able to evaluate the trafficking of dimeric complexes of 
NMDAR C-termini and thereby compare the role of different NR2 subunits; as well as 
the differential ER-retention or surface expression of homomeric NR1.1 or NR1.2 
chimeras versus heteromeric NR1.1/NR1.2 chimeras. Furthermore, I anticipate this 
approach will be a valuable tool to dissect out domains and motifs that are important in 
the trafficking of multimeric-protein complexes. 
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It is noted that the a and ß chain chimeras with the entire C-termini of NR2A and 
NR2B cannot reach the plasma membrane and are ER-retained (data not shown), which 
is consistent with the Tac-chimeras including the entire C-termini of NR2A and NR2B 
reported previously (Hawkins et al., 2004; Lavezzari et al., 2004). I therefore focused on 
the distal portion of the NR2A and NR2B C-termini, which have been shown to contain 
distinct trafficking motifs, which regulate endocytosis and subcellular sorting of the 
NR2 subunits (Roche et al., 2001; Lavezzari et al., 2003; 2004; Prybylowski et al., 
2005). I generated a and ß chain- chimeras including the last 175 a. a. of the NR2A or 
NR2B C-termini and showed that they are able to reach the plasma membrane and 
internalise from the cell surface. This is consistent with previous studies that major 
endocytic motifs of NR2A and NR2B are localised in the distal C-termini (Roche et al., 
2001; Lavezzari et al., 2004). I then examined the trafficking of homomeric versus 
heteromeric assemblies of the C-termini of NR2A or NR2B in both heterologous cells 
and hippocampal neurons. Although either homodimers or heterodimers of NR2A and 
NR2B induced endocytosis, there were subunit-specific differences in the post-endocytic 
sorting of these chimeras. Whereas homodimeric NR2A chimeras enter the lysosomal 
degradation pathway following endocytosis, homodimeric NR2B chimeras 
predominantly recycle to the cell surface through Rab 11 -positive endosomes. 
Interestingly, I now show that NR2A/NR2B heterodimers, like NR2B homodimers, 
preferentially traffic to recycling endosomes. These data demonstrate that the sorting 
motif in NR2B is dominant in heteromeric complexes. 
Although it would be best to look at colocalisation between endogenous 
endosomes and dimeric aß -NR2 chimeras, exogenous expression of GFP-tagged 
endosomal markers were used due to the lack of high quality antibodies against 
endogenous recycling endosomes and the well established reliability of these GFP- 
endosomal markers that were also used in other studies (Lavezzari et al., 2004; Rzomp 
et al., 2003). 
150 
To evaluate the relative importance or dominance of NR2A vs. NR2B, I began 
by performing a robust trafficking assay in heterologous cells to specifically quantify the 
level of recycling of homomeric NR2A or NR2B chimeras and heteromeric 
NR2A/NR2B chimeras. Heteromeric NR2A/NR2B chimeras show a robust level of 
recycling, similar to homomeric NR2B chimeras, but not homomeric NR2A chimeras, 
which reinforces the findings obtained in the colocalisation experiments in both 
heterologous cells and neurones. 
There is the possibility that the expression of aß -NR2 chimeras in primary 
hippocampal neurones would interfere the trafficking of endogenous NR2 subunits, by 
interrupting protein-protein interactions that regulate NMDAR trafficking. This effect 
may also mutually affect the trafficking of exogenous aß -NR2 chimeras expressed in 
neurones, and thus the colocalisation with endosomal markers. However, quantification 
of colocalisation between different a(3 -NR2 chimeras and various endosomal markers in 
neurones reveals a similar result as observed in heterologous cells. These data may not 
precisely reveal the ratio of colocalisation of homomeric chimeras or heteromeric 
chimeras to various endosomal markers, but it at least implies that the distal C-termini of 
NR2A and NR2B regulate the differential post-endocytic sorting in homomeric- versus 
heteromeric chimeras, which may reflect the actual trafficking and sorting pathways in 
diheteromeric and triheteromeric NMDARs. Unfortunately, up-to-now there is no 
approach or technique available to verify this differential trafficking and post-endocytic 
sorting pattern of diheteromeric and triheteromeric NMDARs in neurones, which is the 
significance of my design of current chimeric approach. 
Furthermore, I hypothesised that if NR2A was dominant, in triheteromeric 
NMDARs there would be a change in the amount of recycling, thus the preferred post- 
endocytic sorting of NR2B towards the recycling pathway would not be affected in 
NR2A-/- neurones, given that NR2B is dominant in heteromeric NR2A/NR2B chimeras. 
To investigate if NR2B plays 'a dominant role in NMDAR recycling in vivo, I examined 
NMDAR recycling in neurons isolated from NR2A-deficient mice and showed that 
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recycling of NR2B-containing NMDARs is not affected, supporting the dominant role of 
NR2B in regulating post-endocytic sorting of triheteromeric NMDARs 
(NR 1 /NR2A/NR2B) in vivo. 
To verify the dominant role of NR2II in NMDAR trafficking, RNAi knockdown 
of NR2B in WT neurones can be performed, follow by measuring the changes in NR2A 
surface expression at steady-state or in the presence or absence of leupeptin (degradation 
inhibitor) to block protein degradation in NR2B knockdown or WT neurones. The idea 
is that, since NR2B is dominant in NMDAR post-endocytic sorting, knockdown of 
NR2B may affect the intracellular sorting of both NR1/NR2B and triheteromeric 
NR1/NR2A/NR2B NMDARs, by shifting more NMDARs towards the lysosomal 
pathways. In addition, it would be most ideal to develop specific and high quality 
antibodies against the extracellular (N-terminal) domains of the NR2A and NR2B 
subunits, such that the endocytosis and post-endocytic sorting pathways of endogenous 
NR2A and NR2B could be more precisely studied in neurones, both in fixed and in live 
cells. 
Compared to NR2 subunits, the NR1 splice variants have received less attention, 
partly due to the lack of reagent to differentiate NR1 spice variants and it is unclear 
about their roles in neurones. There is a large excess of NR1 in neurones and thus it is 
not the limiting factor to generate functional NMDARs. This pool of excess NR1 
primarily is retained in the ER, which would be rapidly degraded if not assembled into 
functional receptors (reviewed in Wenthold et al., 2003). However, it is noted that 
whether or not NR1 can reach the plasma membrane is literally determined by 
alternative splicing in the C-terminal domain. It is known that NR1.2, but not NR1.1, 
does express on the cell surface due to the absence of the Cl cassette, although they do 
not form functional receptors when expressed in heterologous cells (Standley et al., 2000; 
Scott et al., 2001). It is generally agreed that two NR1 subunits form a dimer when 
assembled into a tetrameric NMDAR complex together with an NR2 dimer. However, is 
it not known whether certain combinations of NR1 splice variants are required to 
dimerise when assembled in NMDAR complexes. In this study, using chimeras of aß - 
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chains appended to the entire C-terminus of NR1.1 or NR1.2, I was able to study the 
dimerisation of NR1 splice variants in regulating NR1 ER-retention and surface 
expression. Consistent with previous findings, homomeric NR1.1 chimeras are retained 
in the ER, whereas homomeric NR1.2 chimeras are robustly expressed on the cell 
surface. Intriguingly, NR1.1 chimeras dimerised with NR. 1.2 chimeras to form 
heteromeric NR1.1/NR1.2 chimeras which were shown to readily express on the cell 
surface. The precise mechanism is unknown, but it is possible that the ER-retention 
motif(s) in NR1.1 C-terminus were masked by NR1.2 C-terminus upon dimerisation. 
One explanation is that there are certain motif(s) in NR1.2 C-terminal domain that can 
override the effect exerted by ER-retention motif(s) localised in the NR 1.1 C-terminal 
domain. Alternatively, dimerisation of NR 1.1 and NR 1.2 may change the quaternary 
folding structure that occludes the ER-retention motif(s) in NR1.1. In summary, these 
data on NR1 splice variants reflect that assemblies of various NR1 splice variants 
regulates NR1 ER-retention and surface expression, which may also play a role in 
regulating differential NMDARs trafficking, 
The findings in this chapter reveal a multitude of possibilities as to the roles of 
NR1 or NR2 dimerisation and thus NMDAR subunits assemblies. What remains unclear 
and would be interesting to further investigate is the property of various NR1 splice 
variants assemblies in regulating the trafficking of NMDARs. Future directions include 
performing experiments to determine whether dimerisation of & -NR1.1 chimera with 
other a/ß-NR1 splice variants (NR1.3 and NR1.4) chimeras would show a similar effect 
in masking the ER-retention of NR1.1 and increasing expression on the cell surface as 
heterodimers. Following the same line of investigation, experiments could be performed 
to determine whether dimerisation of different combinations of NR1 splice variants with 
various NR2 subunits play a role in regulating NMDAR trafficking. Further studies will 




Investigation of the role of dysbindin in regulating 
LTP by controlling NMDAR trafficking as a 
potential neuropathology leading to schizophrenia 
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5.1. Introduction 
The DTNBPI gene, which encodes dybindin at chromosome 6p. 22.3, is a 
susceptibility gene for schizophrenia (Straub et at., 2002). In schizophrenic patients, 
dysbindin mRNA and protein is reduced in the hippocampus (Talbot et al., 2004) and 
the prefrontal cortex (Weickert et al., 2004), areas known to contribute to cognitive 
deficits in schizophrenia. A recent study also reported a reduction in dysbindin mRNA 
in the hippocampal formation of schizophrenic patients (Weickert et al., 2008). 
Dysbindin is a key component of BLOC-l, which regulates the trafficking of proteins in 
the lysosomal pathway (Di Pietro et al., 2006; Setty et al., 2007). Dysbindin has been 
shown to regulate cell surface expression of the dopamine receptor D2, but not D1 
(Collingridge et al., 2004; lizuka et al., 2007). It is interesting to note that D1 is recycled 
to the plasma membrane after endocytosis, whereas D2 is trafficked to the lysosomal 
pathway and degraded (Ariano et al., 1997; Bartlett et al., 2005; Jeziorski and White, 
1989; von Zastrow, 2003). However, how aberrant dysbindin expression contributes to 
the pathophysiology of schizophrenia has remained elusive. 
Abnormal NMDAR function in hippocampus has also been implicated in 
schizophrenia (Moghhadam et al., 2003). As previously mentioned, NMDARs are 
tetrameric receptors consisting of two obligatory NR1 subunits and two NR2 subunits 
(Mcllhinney et al., 1998). NR2A and NR2B are the major NR2 subunits expressed in the 
hippocampus (Monyer et al., 1994), with expression patterns that change during 
development. In cortex and hippocampus, NR2B is predominantly expressed early in 
development and gradually decreases. In contrast, NR2A expression is low at birth but 
gradually increases during development (Monyer et al., 1994; Sheng et al., 1994; Kew et 
al., 1998; Sans et al., 2000). In adult cortical and hippocampal neurones, NR2A subunit 
is preferentially localized in synaptic sites, whereas NR2B subunit is expressed in both 
synaptic and extrasynaptic membranes (Brickley et al., 2003; Li et al., 1998; Thomas et 
al., 2006). It is widely recognised that NMDAR trafficking plays an important role in the 
regulation of synaptic plasticity, and trafficking of NMDAR is subunit-specific (Roche 
et al., 2001; Barria & Malinow, 2002; Lavezzari et al., 2004; Scott et al., 2004; Kim et 
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al., 2005). For example, NR2A and NR2B sort to different intracellular pathways 
following endocytosis. Specifically, NR2A is sorted to the lysosomal pathway, whereas 
NR2B preferentially traffics to recycling endosomes (Lavezzari et al., 2004). Currently, 
very little is known about the potential corresponding post-transcriptional molecular 
mechanisms of defective NMDAR trafficking in relating to the illness. Therefore, it is 
logical to postulate that defective NMDAR trafficking plays a role in the 
pathophysiology underlying the cognitive behavioural impairments in schizophrenia. 
In this chapter, in collaboration with Dr. Bai Lu's laboratory (NIMH/NICIID, 
NIH), we asked whether dysbindin may differentially regulate the trafficking of 
NMDAR subunits in hippocampal neurones, given that it is thought to be involved in 
protein trafficking in the lysosomal pathway. Using dysbindin null mice (Dys-/-), we 
were able to investigate the correlations between the loss of function of dysbindin and its 
effects in NMDAR function in the hippocampus and the corresponding trafficking 
mechanisms in a subunit-specific manner, which could contribute to the glutamatergic 
imbalances observed in schizophrenia. 
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5.2. Results 
5.2.1. Expression of endogenous NR2A and NR2B in Dys-/- hippocampus was not 
affected 
Dysbindin is known to be involved in regulating trafficking of proteins implicated in 
pigmentation, and melanosomes in Dys-/- mice are markedly reduced such that Dys-/- is 
phenotypically distinct from its WT littermates as shown by the pale fur coat colour and 
decreased pigmentation in the retina (Fig. 5.1). We initially determined the total 
expression of endogenous NR2A and NR2B in the hippocampi of four-week old Dys-/- 
mice compared to WT control mice. I dissected out WT or Dys-/- hippocampi, and 
extracted protein from the crude synaptosomes (P2 fraction). Equal amounts of protein 
extracted from WT and Dys-/- hippocampi were resolved by SDS-PAGE and transferred 
onto a PVDF membrane. The membrane was then probed with primary antibodies (a- 
tubulin, NR2A ' NR2B , NR1 or G1uR1) and the appropriate secondary antibodies. 
Blotting of a-tubulin confirmed that same amount of protein in each sample was loaded. 
It is demonstrated that the expression of NR2A , NR2B , NRI or G1uR1 was not 
affected in the hippocampus of Dys-/- mice (Fig. 5.2). 
5.2.2. Increased NR2A surface expression in hippocampal neurones derived from 
Dys-l- mice 
To determine if disruption of the dysbindin gene affects the trafficking of NR2A, and to 
evaluate the effect of exogenous expression of epitope tagged-NR2A and NR2B, we 
compared the surface expression of NR2A and NR2B expressed in cultured - 
hippocampal neurones derived from Dys-/- or WT mice. Primary hippocampal cultures 
derived from embryonic (E16-18) WT and Dys-/- mice were transfected on DIV 9 or 10 
with exogenous NR2A or NR2B containing a GFP tag in the extracellular N-terminal 
domain. On DIV 14, I performed surface to total staining as previously described in 
Chapter 2 to separately label the surface-expressed (red) or the intracellularly-expressed 
(green) GFP-NR2A or NR2B with distinct Alexa-conjugated secondary antibodies. We 
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quantified the steady-state level of surface NR2A and NR2B using an antibody against 
GFP. Surface NR2A was markedly increased as shown in Fig 5.3A; C (red panel) and 
quantitative analyses revealed an approximate 50% increase in surface NR2A in Dys-/- 
neurones. In comparison, surface levels of NR2B were not changed (Fig. 5.3 B; Q. 
5.2.3. Surface biotinylation revealed increased NR2A surface expression in 
cortical neurones derived from Dys-/- mice 
To evaluate if surface levels of endogenous NMDARs are also increased by loss of 
dysbindin, Dr. Bo-Shiun Chen in the laboratory performed surface biotinylation assays 
as previously described in Chapter 2 to measure the amount of endogenous NR2A and 
NR2B on the cell surface of both cultured cortical neurones. Biotinylated proteins in the 
membrane crude lysates were extracted, pulled-down with streptavidin-Sepharose beads, 
resolved by SDS-PAGE, and blotted with various antibodies (Fig. 8.1A). In neurones 
prepared from Dys-/- mice, we observed a substantial increase in NR2A surface 
expression, consistent with our imaging studies. However, we also found that surface 
NR2B was reduced in Dys-/- cortical neurones (Fig. 8. IA-B). 
WT +lf Dys -/- 
Fig. 5.7 The pale coat colour (left) and eye malpigmentation phenotype (right) of the 4 weeks old (left 
panel) and P1 (right panel) Dys-/- mice compared to the WT littermate control strain (C57BL/6J). 
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Fig. 5.2 NR2A and NR211 expression is unchanged in the hippocaºmpus of I)ys-/- juice. 
I lippocampi were dissected from 4-week old WT or Dys-/- mice. P2 crude synaptosomes were extracted, 
and 25 pg of protein were loaded in each lane. Expression of NR2A, NR213, NR I, GluR I and u-tuhulin 
was detected by Western blotting using antibodies as indicated. (A) Representative Western blots of 
hippocampal lysates from WT or Dys-/- mice. (13) Quantification of Western blots. Relative intensities 
of ECI_ bands were quantified by NII I Image) software. Immunoreactivities of NR2A, NR26, NRI and 
GluR I were normalized to that of (L-tubulin in the same sample, and the signals from Dys-1- 
hippocampul neurones were compared to that from WT control. N 4. Error bars represent mean t 
SEM; * Non-specific, p> 0.4, Student's 1-Test. 
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Fig. 5.3 Increased surface expression of NR2A (A), but not N11211 (B), in Dys-/- hippocampal 
Henrones. 
Cultured hippocampal neurones prepared from WT and Dys-/- EIK embryos were transtcrted with 
GFP-NR2A or GFP-NR213 at DIV9-10. Atter 5 days, live neurones were incubated with an anti- 
GFP antibody (red) to label surface-expressed receptors. "file neurones were fixed, permeabiliserl 
and labelled again with anti-GFP antibody to detect intracellular NR2A or NR2B (green). 
(C) Quantilication of (. Fl'-NR2A and CFP-NR2B surface to total expression in W'I' and t)ys-/- 
hippocampal neurones 
Fluorescence intensities were measured using Metamorph software. (n 27-36 cells; N4 
independent experiments) and the ratios of surface (red) to total (red + green) fluorescence fier WT 
and l)ys-/- neurones are presented. The error bars in this and all other figures represent mean -1 /- 
SF: M. *: p< 0.02, Student t-test. 
5.2.4. Exogenous expression of dysbindin reduced NI12A surface expression in 1)ß's 
-/- hippocampal neurones 
To vcriiy whether the increase in surface NR2A in Dys-/- neurones is due to the 
disruption ofdishiiidin, I performed rescue experiments by introducing Jvshincli#i into 
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WT or Dys-/- neurones. I transfected WT or Dys-/- hippocampal neurones with GFP- 
NR2A or GFP-NR2B and HA-dysbindin or HA vector alone on DIV 9 or 10 and 
performed surface and total immunostaining on DIV 14. I measured the steady-state 
level of surface- expressed NR2A and NR2B in the transfected neurones, and I found 
that expression of exogenous HA-dysbindin significantly reduced the surface expression 
of NR2A in Dys-/- neurones, compared with expression of HA alone (Fig. 5.4A). 
Quantitative analyses of fluorescence images revealed a 25% reduction in surface NR2A 
in Dys-/- neurones (Fig. 5.5) confirming that the reduction in dysbindin directly leads to 
increased surface expression of NR2A. Furthermore, expression of exogenous 
dysbindin also reduced surface NR2A in WT neurones, compared to the HA control 
(Fig. 5.4B; 5.5). In addition, I tested if exogenous expression of dysbindin in Dys-/- 
hippocampal neurones has an effect in NR2B trafficking. I found that overexpression of 
HA-dysbindin or HA-alone resulted in indistinguishable surface expression level of 
GFP-NR2B in Dys-/- neurones (Fig. 5.6). These results demonstrate that NMDAR 
surface expression is regulated by dysbindin in a subunit-specific manner, and 
specifically the level of NR2A surface expression is modulated by changes in the 
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Fig. 5.4 Expression of exogenous dysbindin reduces NR2A surface expression in both WT 
and Dys-/- hippocampal neurones. 
Representative images showing surface and intracellular NR2A in transfected (A) WT and (B) Dys- 
/- neurones, respectively. Note that transfection of HA-dysbindin, but not HA alone, rescued WT 
levels of NR2A surface expression in Dys-/- neurones expressing exogenous NR2A, and reduced 
surface expression of NR2A in WT neurones. Images were collected using 63X objective at 0.34 
µm. 
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Fig. 5.5 Quantification of surface NR2A in I1A-I))shindin transfected Dys-/- and W'I' 
hippocampaf neurones. 
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Fig. 5.6 Expression of exogenous dysbindin has no effect on NR2B surface expression in 
Dys-/- hippocampal neurones. 
(A) Representative images show surface and intracellular NR2B in transfected Dys-/- neurones. 
Note that NR2B surface expression in cells transfected with EIA-dysbindin shows no significant 
difference from those cells transfected with I IA (Control). Images were collected using 40X 
objective at 0.34µm. Scale bars represent 25 µm. (B) Quantification of surface NR2B in (A). 
NR2B surface expression in Dys-/- neurones expressing HA-dysbindin is not significantly different 
from HA control. n= 34 cells; N= 2. The error bars in this figure represent mean +/- SEM; Non - 
specific (n. s. ) p>0.4 , students' t-test. 
5.2.5. Increased NR2A-mediated synaptic currents in Dys-/- CAI pyramidal 
neurones 
Our imaging and biochemical analyses demonstrated a consistent increase in surface 
expression of NR2A in Dys-/- neurones. However, the surface biotinylation assays also 
revealed a decrease in surface NR2B in Dys-/- cortical neurones (Fig. 8.1). It was not 
clear whether this subunit-specific change was specific to synaptic NMDA receptors. 
These conflicting findings prompted us to directly examine the function of synaptic 
NMDARs in hippocampal slices. Dr. Feng Yang in Dr. Bai Lu's laboratory performed 
whole-cell, voltage-clamped recordings from CA1 pyramidal neurones of hippocampal 
slices derived from adult (26-31 days old) WT and Dys-/- mice. Excitatory postsynaptic 
currents (EPSCs) were evoked by stimulating Schaffer collaterals in the presence of the 
GABAA receptor antagonist bicuculline (10 µM) (Fig. 8.2 A, Q. When membrane 
potentials were held at -80 mV (Vh = -80 mV), the EPSCs were predominantly mediated 
by AMPA receptors. Input-output curves, derived by plotting peak AMPA current 
amplitudes against the intensities of presynaptic stimulation, were indistinguishable 
between WT and Dys-/- mice (Fig. 8.2C). Evoked NMDAR-mediated currents were 
then recorded at a holding potential of +50 mV (Vh = 50 mV) in the presence of the 
AMPA receptor antagonist CNQX (50µM) (Fig. 8.2B, D). The NMDAR-mediated 
synaptic currents recorded from the Dys-/- neurones were greater with faster decay time, 
compared with those from the WT control (Fig. 8.2B). Input-output curves revealed 
consistent differences in NMDAR currents between genotypes in the entire range of 
stimulation intensities (Fig. 8.2D). We then further confirmed the increase in NMDAR- 
mediated current by measuring the NMDA to AMPA ratio in Dys-/- neurones. Evoked 
NMDAR-mediated currents were recorded at +5OmV whereas AMPAR-mediated 
currents were recorded at -80mV (Fig. 8.2A), NMDAR-mediated currents in Dys-/- 
neurones were appeared to be significantly higher than in the WT control (Fig. 8.3). 
We next investigated the relative contributions of NR2A or NR2B to the changes 
in NMDAR synaptic currents. Application of the selective NR2B antagonist, ifenprodil 
(3 µM), significantly reduced NMDAR currents in both WT and Dys-/- neurones (Fig. 
166 
8.4A). Likewise, a more specific NR2B antagonist Ro25-6981 (1 µM) elicited a similar 
decrease in NMDAR-EPSCs in CAI pyramidal neurones from both genotypes (Fig. 
8.3). Given that both antagonists provide a maximal and selective inhibition of 
NR1/NR2B diheteromeric receptors and that the majority of NMDARs in CAI are 
NR2A and/ or NR2B, the remaining (non-NR2B) currents reflected those mediated by 
NR2A-containing receptors. We found that hippocampal CAI synapses in Dys-/- mice 
exhibited a much greater proportion of NR2A-mediated currents, compared with WT 
mice (Fig. 8.4 B, D). The normalized NMDAR currents decreased within a few minutes 
following perfusion of NR2B antagonists onto the slices (Fig. 8.4 C, E). Quantitative 
analyses revealed a significant increase in the total NMDAR currents (averaged from the 
first 2.5 min of recording before ifenprodil/ Ro25-6981 application) in Dys-/- neurones 
(Fig. 8.5A, C, left columns). Further, NR2A-mediated EPSCs, obtained by averaging 
the last 2.5 minutes of the currents recorded in the presence of NR2B antagonists, also 
exhibited a big difference between WT and Dys-/- neurones (Fig. 8.5A, C, middle 
columns). In contrast, when the NR2A-mediated currents were subtracted from the total 
NMDA-EPSCs for each neurone, no significant difference was found in the ifenprodil/ 
Ro25-6981 -sensitive, NR2B-mediated currents between WT and Dys-/- neurones (Fig. 
8.5A, C, right columns). Given that NR2A-mediated currents usually decay faster than 
NR2B-mediated currents (Cull-Candy & Leszkiewicz, 2004), we further analysed the 
decay time constants of NMDAR currents. Indeed, there was a significant decrease in 
the decay time of NMDAR-EPSCs in Dys-/- neurones, both before and after ifenprodil 
application (Fig. 8.5B). Taken together, these results suggest that the increase in 
NMDA-EPSCs in Dys-/- neurones is due largely to elevated NR2A at the hippocampal 
CAI synapses. 
5.2.6. Elevated LTP at CA1 synapses , 
To investigate whether the changes in synaptic NR2A could alter synaptic plasticity in 
the hippocampus, Dr. Yuan Lu in Dr. Bai Lu's laboratory performed field recordings of 
excitatory postsynaptic potentials (fEPSPs) in hippocampal slices. Because long-term 
depression (LTD) is prominent earlier in development, 2 week-old WT or Dys-/- mice 
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were used. Conventional LTD, induced by low frequency stimulation (LFS, 1 Hz, 900 
pulses), was not affected in the Dys-/- slices (Fig. 8.6 A, E). Control experiments 
showed no change in input-output of fEPSPs or paired-pulse facilitation (PPF) in Dys-/- 
mice at this age (Fig. 8.6 C, D). Long-term potentiation (LTP), induced by a single 
tetanus (1 sec, 100 Hz) was investigated in slices derived from 8 week old mice. We 
found that LTP was significantly increased in Dys-/- mice compared to WT control (Fig. 
8.6 E, F). The fEPSP was 151 ± 5% in wild-type, but 125±5% in Dys-/-, respectively 
(p<0.003). However, input-output curves were normal in Dys-/- mice (Fig. 8.6 G). PPFs 
were virtually identical over a wide range of interpulse intervals for Dys-/- and WT 
slices (Fig. 8.6 H). These data suggest that the observed change in LTP in Dys-/- mice is 
due to a postsynaptic rather than presynaptic mechanism. 
5.3. Discussion 
Although dysbindin has been implicated in schizophrenia (Straub et al., 2002), 
little is known about its cellular function in neurones. Using a dysbindin null mutant 
mouse line (Dys-/-) on C57BL/6J strain, we have uncovered an unexpected role of 
dysbindin in NMDAR trafficking. Using a variety of techniques, we demonstrated a 
specific enhancement of NR2A expression on the surface of neurones and at synapses. 
Extensive imaging experiments revealed that disruption of the dysbindin gene increases 
NR2A surface expression in hippocampal neurones. This dramatic increase in NR2A 
surface expression was mitigated by introducing exogenous dysbindin in Dys-/- 
hippocampal neurones, suggesting that dysbindin directly regulates NR2A trafficking, 
rather than indirectly by regulating neuronal development. Moreover, biotinylation 
assays in cortical neurones confirmed the result obtained from our imaging experiments 
that there was a dramatic increase in endogenous NR2A surface expression. 
Furthermore, in hippocampal slices from Dys-/- mice, NMDA-, but not AMPA- 
mediated synaptic currents were dramatically increased, and this effect is due largely to 
an elevated expression of NR2A at the excitatory synapses of CA 1 pyramidal neurones. 
We have also observed a marked increase in LTP, but not LTD, at CAI synapses in 
Dys-/- slices. Together, our data provide a previously unexpected link between 
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dysbindin and NMDARs. These results have implications in synaptic plasticity and 
perhaps schizophrenia. 
Post-mortem brain studies also reveal significant reduction in dysbindin 
transcripts in the hippocampus and prefrontal cortex of schizophrenic patients (Talbot et 
al., 2004). Moreover, it is well recognized that the NR2A and NR2B expression are 
predominant in the hippocampus and cortex. We therefore examined the surface 
expression of NR2A and NR2B in cultured hippocampal neurones derived from WT and 
Dys-/- mice. In order to label the surface expressed NR2A or NR2B, it is critical to have 
specific antibodies against the N-terminal domain of NR2A or NR2B, however such 
specific antibodies are not available, which has been a long time problem in the field of 
NMDAR trafficking. We therefore did not examine surface expression of endogenous 
NR2A or NR2B in our imaging experiments, instead we expressed in cultured 
hippocampal neurones with full-length NR2A or NR2B subunits which had GFP-tagged 
to the extracellular domain. We observed a dramatic increase in the surface expression 
of NR2A, but not NR2B, while the total expression of both endogenous NR2A and 
NR2B detected by western blotting in adult Dys-/- hippocampus is not different from its 
WT littermate. Which implies that dysbindin directly regulates NR2A trafficking, and 
this regulation is independent to NR2A expression throughout the development. 
Moreover, when we restored the expression of dysbindin by exogenous expression of 
dysbindin in Dys-/- neurones, the surface expression of NR2A was significantly 
reduced. Interestingly, exogenous expression of dysbindin in WT also reduced the 
surface expression NR2A, suggesting that dysbindin plays a role in regulating surface 
expression of NR2A. 
We also performed surface biotinylation assays to examine endogenous NR2A 
and NR2B surface expression in primary cultured neurones and to verify the results 
obtained in our imaging experiments. It is noted that we did not use hippocampal 
neurones for biotinylation experiments due to the limited number of Dys-/- embryos that 
we were able to obtain at one neuronal preparation, we therefore used cortical neurones 
instead. Our surface biotinylation assays demonstrated that disruption of dysbindin 
169 
resulted in more endogenous NR2A on the surface of cortical neurones. However, we 
also observed a reduction in endogenous NR2B on the surface of Dys-/- neurones. 
Whereas surface staining of GFP-NR2B in hippocampal neurones showed no difference 
between WT and Dys-/- neurones. This difference could be due to the exogenous 
expression of GFP-NR2B in neurones could potentially alter the balance of protein- 
protein interactions given that NR2B is overexpressed, which would subsequently affect 
pre-existing network of receptor trafficking. It is also likely that NR2B surface 
expression in cortex may be different from that in hippocampus. 
We further investigated what are the changes of NR2A surface expression would 
influence NMDAR-mediated synaptic function. Electrophysiological recordings 
revealed an increase in NR2A-mediated synaptic currents in Dys-/- mice pyramidal 
neurones, suggesting that more endogenous NR2A has been incorporated into excitatory 
synapses. Moreover, we are concerned that our biotinylation experiments showed a 
reduction in NR2B on the surface of Dys-/- neurones, unexpectedly, consistent with our 
imaging experiments in hippocampal neurones, our electrophysiology data showed no 
change in NR2B-mediated synaptic currents was observed in Dys-/- CAl pyramidal 
neurones. Apart from the possible difference between hippocampal and cortical 
neurones, this inconsistency could also be accounted by the fact that NR2B is largely 
expressed in extra-synaptic sites (Barria and Malinow, 2002; Rumbaugh and Vicini, 
1999; Thomas et al., 2006; Tovar and Westbrook, 1999), thus it is possible that 
biotinylation assays revealed a decrease in extrasynaptic but not synaptic NR2B in Dys- 
/- neurones. 
Using specific NR2B antagonists, ifenprodil and Ro25-6981, we were able to 
show that the increase in NMDAR currents in Dys-/- CAI neurones was primarily 
mediated by NR2A subunits. It is noted that ifenprodil and Ro25-6981 are known to be 
most effective in blocking NR2B in NR1/NR2B diheteromeric NMDARs but less 
effective in blocking triheteromeric (NR1/NR2A/NR2B) NMDARs (Hatton and Paoletti, 
2005), thus the possibility of an increase in triheteromeric NMDA receptor in Dys-/- 
neurones cannot be excluded. 
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It would be interesting to determine whether the increased surface expression of 
NR2A in Dys-/- hippocampal neurones is due to an increase in insertion or a decrease in 
endocytosis of NR2A. Our lab has previously showed that NMDARs undergo a subunit- 
specific post-endocytic sorting, with NR2A being sorted to the lysosomal pathway, 
whereas NR2B preferentially traffics to recycling endosomes (Lavezzari et al., 2004). 
Interestingly, knockdown of dysbindin in rat cortical neurones has been shown to 
increase the surface expression of D2R, a subtype of dopamine receptor known to traffic 
to the lysosomal pathway (Ariano et al., 1997; Bartlett et al., 2005; von Zastrow, 2003). 
Moreover, it is intriguing that a number of studies have implicated the role of dysbindin 
in regulating protein trafficking in the endosomal network and have recently been shown 
to play a role in the delivery of membrane proteins to the cell surface (Bonifacino, 2004; 
Zhang et al., 2007), particularly through its interaction with the adaptor protein-3 
complex (AP-3) which interaction has been shown in CAI and CA3 of mouse 
hippocampus and melanocytes (Di Pietro et al., 2006; Setty et al., 2007; Taneichi- 
Kuroda et al., 2009). Consistent with the role of AP-3 in regulating trafficking of 
proteins from early endosomes to lysosomes or lysosome-related organelles (Cowles et 
al., 1997; Stepp et al., 1997). This led to a model suggesting that in Dys-/- neurones, 
reduction in dysbindin disrupts its interaction with AP-3 and thus may interrupt the post- 
endocytic sorting of NR2A from early endosomes to late endosomes or lysosomes by 
diverting its trafficking back to the cell surface. Consistent with this idea, we found an 
enhancement in NR2A surface expression in neurones lacking dysbindin, whereas 
NR2B was not affected. Furthermore, expression of exogenous dysbindin also reduced 
NR2A surface expression in both WT and Dys-/- neurones. We also observed an 
increase in NR2A-mediated NMDAR currents in Dys-/- neurones, suggesting that 
dysbindin regulates the number of NR2A- containing NMDARs at synaptic sites. 
Together these results support a model in which dysbindin controls the amount of NR2A 
at excitatory synapses by regulating post-endocytic sorting of NR2A from early' 
endosomes into lysosomes or LROs. To verify this hypothesis, further experiments 
including a variety of imaging and biotinylation techniques can be performed to 
k, 
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determine NR2A insertion and endocytosis in cultured hippocampal neurones which can 
address the mechanism underlying the increased surface expression of NR2A in Dys-/- 
neurones. For example, we could attempt a cursory characterization using sucrose to 
block clathrin-dependent endocytosis and measure the accumulation of NR2A on the 
cell surface of Dys-/- and WT neurones. However, sucrose is problematic because it 
dramatically increases transmitter release. So if changes were observed, it would be 
unclear if they were due to an increase in synaptic transmission or blocking of 
endocytosis. Alternatively, we could express full-length NR2A with a pHluorin tagged 
to the N-terminal domain and real-time imaging could be performed to monitor the 
insertion of NR2A from the cytosol to the cell surface. 
Activation of NMDARs is required for both LTP and LTD in hippocampal CAI 
synapses. Several studies suggest that NR2A-containing NMDARs are preferentially 
involved in LTP whereas NR2B-containing NMDARs are critical for LTD (Liu et al., 
2004; Massey et al., 2004; Collingridge et al., 2004). Although this model remains 
controversial (Morishita et al., 2007; Weitlauf et al., 2005), our findings revealed an 
increase in LTP in adult Dys-/- CAI pyramidal neurones, whereas there is no change in 
LTD. It is conceivable that an increase in the number of NR2A-containing NMDARs 
present in Dys-/- synapses leads to an enhancement in LTP without interfering with 
LTD. 
Our finding that a reduction in dysbindin leads to increased NR2A expression at 
synapses brings a new twist to our understanding of the pathogenesis of schizophrenia. 
Several lines of evidence have pointed to a hypo-function of NMDAR in schizophrenia 
brains (Moghaddam, 2003). In situ hybridization of postmortem brains revealed a 
reduced level of NMDARs, particularly NRI in the hippocampus of schizophrenic 
patients (Clinton et al., 2003; Gao et al., 2000). Moreover, administration of NMDAR 
antagonists such as PCP or ketamine to healthy volunteers produces hallucination and 
psychosis (Krystal et al., 1994) and exacerbates both the positive and negative 
symptoms in patients with schizophrenia (Javitt and Zukin, 1991). These results at first 
glance appear at odds with our findings. However, methods used to detect NMDARs in 
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the postmortem brains cannot distinguish whether changes in NMDARs occur at 
synaptic or extra-synaptic sites. It is also unclear if systemic administration of NMDAR 
antagonists act on hippocampus or other brain regions to achieve their effects. 
Furthermore, whether and how impairments in hippocampal synaptic plasticity 
contribute to the pathogenesis of schizophrenia have not been established. We here show 
a specific increase in NR2A surface expression in Dys-/- hippocampus, most likely at 
excitatory synapses in pyramidal neurones, leading to a selective increase in LTP but not 
LTD. The increase in surface NR2A unavoidably changes the NR2A/NR2B ratio, which 
is thought to be important for regulating the critical period in the visual cortex as well as 
the threshold for bidirectional synaptic plasticity (Cho et al., 2009). An imbalance 
between NR2A and NR2B in the brain should therefore be considered as a potential 
factor involved in schizophrenia. Thus, our findings that dysbindin controls NR2A 




Summary and general discussion 
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6.1 Data summary 
In this thesis, I have presented 3 studies investigating the molecular mechanisms 
that regulate NMDAR trafficking. The first study in Chapter 3 aimed to identify 
sequence determinants localised in the C-terminal domains of NR2A and NR2B subunits 
that regulate the unique post-endocytic sorting of NMDARs. I generated two Tac- 
chimeras containing chimeras of parts of NR2A and NR2B C-termini. However, due to 
the intermediate phenotypes in trafficking patterns revealed by these constructs, no 
definite conclusion could be drawn from the results obtained in Chapter 3. Next, I 
investigated in Chapter 4 the differential trafficking of diheteromeric (NR1/NR2A or 
NR1/NR2B) versus triheteromeric (NR1/NR2A/NR2B) NMDARs. Previous findings 
show that the C-termini NR2 subunits regulate distinct trafficking and subcellular 
sorting of NR2A and NR2B subunits. Therefore, I developed a new approach using 
truncated MHCII aß-chain dimers as reporter molecules. I appended the distal C-termini 
of NR2A or NR2B subunits appended to both a and ß-chains. I first confirmed that aß- 
NR2A homodimers are sorted to late endosomes, whereas ap-NR2B homodimers are 
preferentially sorted to recycling endosomes. Strikingly, ap-NR2A/NR2B heterodimers 
traffic in a similar pattern as NR2B homodimers and sorted to recycling endosomes. 
Both NR2B homodimers and NR2A/NR2B heterodimers robustly recycle to the plasma 
membrane. This result suggests a dominant role for the NR2B C-terminus in regulating 
the trafficking and subcellular sorting of NRl/NR2B diheteromeric and 
NRIJNR2A/NR2B triheteromeric NMDARs. In Chapter 4, I also investigated the 
differential surface expression and ER-retention of NR1 splice variants. Intriguingly, 
NR1.1/NR1.2 heterodimers are readily expressed on the cell surface, whereas NRI. 1 
homodimers are retained in the ER. NR1.2 homodimers are robustly expressed on the 
cell surface, suggesting the ER-retention effect in NR1.1 is masked or overridden upon 
dimerisation with NR1.2. Results obtained in Chapter 4 give us an idea of the 
significance of multimeric complexes of NMDARs and how tetrameric assemblies 
determine the trafficking of NMDARs. Finally, in Chapter 5, I studied the role of 
dysbindin in NMDAR trafficking. Dysbindin plays an important role in regulating 
protein trafficking, especially in the lysosomal pathway, and the implication of 
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dysregulated NMDAR trafficking in schizophrenia. I investigated the trafficking 
patterns and functions of NR2A and NR2B subunits in the hippocampus of dysbindin 
knockout mice (Dys-/-), compared to wild-type control. Using a combination of imaging, 
biochemical and electrophysiological approaches, I showed that the surface expression 
of NR2A, but not NR2B, is dramatically increased in dys-/- neurones. This dramatic 
increase in surface NR2A- containing receptors results in elevated LTP, but not LTD, in 
Dys-/- hippocampal slices. These observations reveal that dysbindin is involved in 
regulating NMDAR trafficking in a subunit-specific manner, and suggest that disrupted 
NMDAR trafficking might contribute to the aetiology of cognitive impairments 
observed in schizophrenic patients. 
6.2. Identification of sequence determinants in the C-termini of NR1 
and NR2 subunits in regulating NMDAR trafficking 
NMDARs are crucial in regulating excitatory synaptic transmission and synaptic 
plasticity, which underlies learning and memory (reviewed in Lau & Zukin, 2007). The 
expression of functional NMDARs is dynamically regulated by mechanisms underlying 
NMDAR trafficking, including ER-retention, receptor insertion and endocytosis. Over 
the past decade, an extensive amount of work has been devoted to identifying motifs that 
reside in the cytoplasmic domains of NR1 and NR2 subunits, which regulate NMDAR 
ER-retention, surface expression, internalisation and post-endocytic sorting (Hawkins et 
al., 2004; Horak et al., 2008b; Horak and Wenthold, 2009; Lavezzari et al., 2004; 
Lavezzari et al., 2003; Roche et al., 2001; Scott et al., 2004; Standley et al., 2000). Some 
of these studies were able to identify precise motifs (Standley et al., 2000; Roche et al., 
2001; Lavezzari et al., 2004; Scott et al., 2004), whereas a number of studies were only 
able to narrow down to a region that includes a trafficking motif without specifically 
identifying the corresponding amino acid residues, due to the large number of amino 
acids in NMDAR C-termini (Horak et al., 2008b; Horak and Wenthold, 2009; Scott et 
al., 2004). Our lab has focused on the distal C-termini of NR2A and NR2B and has 
previously shown that the last 175 a. a. ' of NR2A and NR2B contain sequence . 
determinants that regulate endocytosis and post-endocytic sorting of NMDARs. 
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Therefore, my aim in the experiments described in Chapter 3 was to dissect out the 
sequence determinants that regulate the differential post-endocytic sorting of NR2 
subunits. I pursued this goal by making Tac chimeras containing a combination of the 
distal C-termini of NR2A and NR2B (chimeras of chimeras). However, due to the 
intermediate phenotypes observed using these Tac chimeras, I could not come to a 
definite conclusion. Unlike other receptors, such as the GPCRs, identification of 
degradation and recycling motifs in NR2 C-termini is particularly challenging for 
NMDARs. For example, the PDZ ligand binding domain is a novel recycling motif in 
GPCRs (Paasche et al., 2005); however deletion of the PDZ domain of the extreme C- 
terminus of TacNR2B did not affect TacNR2B recycling in HeLa cells (data not shown). 
Moreover, our lab has also attempted to identify tyrosine- or dileucine based motifs 
regulating endocytosis of chimeras containing the NR2A C-terminus; however, only one 
dileucine motif was actually a significant factor in regulating NR2A endocytosis 
(Lavezzari et al., 2004). In the future, perhaps these tyrosine- or dileucine based motifs 
can be revisited to study their potential role in regulating NR2A post-endocytic sorting. 
Furthermore, presumably the chimeric approach that I used in Chapter 3 may be 
applicable in determining the precise trafficking motifs localised in the C-termini of 
NMDARs if a smaller region and fewer amino acid residues are swapped between 
NR2A and NR2B C-termini in a Tac-chimera. However, this investigation can be very 
time consuming and conclusive results may not be revealed. 
6.3 MHCII up-chains -a novel approach to study trafficking of 
receptor complexes 
I have fully characterised a novel approach based on the unique features of the human 
MHC II proteins to study trafficking of transmembrane receptors which assemble in 
dimers. Human MHC II proteins are heterodimers consisting of a and ß chains (HLA- 
DR(i and HLA-DRß chains), and the MHCII a and ß chains must form dimers in order 
to exit the ER and reach the plasma membrane. The availability of specific antibodies 
against human MHCII aß-dimers (L243) ensures that all of the receptors labelled on the 
cell surface are in fact dimers. This approach is applicable for studying ER-retention, 
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receptor insertion and endocytosis from the plasma membrane. In addition, it is 
particularly useful in identifying trafficking motifs localised in the cytosolic domain of 
the receptors. In this thesis, the dimerisation of MHCII a and ß chains allows me to 
study the ER-retention and surface expression of NR1 splice variants, and it also enables 
me to characterise the patterns of post-endocytic sorting of homomeric and heteromeric 
NR2 chimeras. Our lab has already started to use this approach to study receptor 
trafficking of AMPARs, specifically upon dimerisation of GluRl or G1uR2 homomeric 
chimeras and GluR11G1uR2 heteromeric chimeras. 
6.4 Post-endocytic sorting of diheteromeric and triheteromeric 
NMDARs 
In the cortex and hippocampus, the existence of triheteromeric NMDARs containing 
NR1, NR2A and NR2B subunits in a complex have long been known (Didier et at., 
1995; Luo et al., 1997). However, they are still a big mystery in the field, largely due to 
the lack of tools such as specific antibodies and antagonists to distinguish triheteromers 
in a pool of mixed diheteromeric (NRl/NR2A and NR1/NR2B) and triheteromeric 
NMDARs (Neyton and Paoletti, 2006). Previous studies in our lab showed that NR2A 
and NR2B have distinct post-endocytic sorting pathways (Lavezzari et al., 2004), and 
these data raised a question regarding the trafficking pathway of triheteromeric 
NMDARs. In Chapter 4, the distal C-termini of NR2A or NR2B subunits were appended 
to MHCII aß-chains so they could assemble as dimers. My results first confirmed our 
previous findings that homomeric NR2A and NR2B chimeras are sorted to lysosomal 
and recycling pathways, respectively. Strikingly, I found that the NR2B C-terminus is 
dominant in heteromeric NR2A/NR2B trafficking through the recycling pathway, 
suggesting that NR2B would also be dominant in regulating triheteromeric NMDARs 
trafficking. This is a novel finding that may aid in understanding how NMDAR subunit 
assemblies are regulated. It may also help our understanding of how synaptic and 
extrasynaptic localisation of NR2A- and NR2B- containing NMDARs is determined, as 
NR2A and NR2B have been shown to be segregated to synaptic and extrasynaptic 
regions, respectively (Tovar & Westbrook, 1999). However, others have reported that 
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NR2B could be found in synaptic sites when co-expressed with NR2A in neurones, 
whereas NR2B is not solely confined to synapses but also detected at extrasynaptic sites 
(Fujisawa and Aoki, 2003; Kohr et al., 2003; Li et al., 1998; Thomas et al., 2006). 
6.5 Assembly of NR1 splice-variants release ER-retention of NR1 
subunits 
It is believed that NR1 dimer formation is obligatory in NMDAR assembly. Furthermore, 
co-assembly of both NR1 and NR2 subunits is required for trafficking of NMDARs to 
cell surface and to form functional channels (Mcllhinney et at., 1998; Okabe et al., 
1999). There are 8 splice variants of NR1; the NR1.1 variant is retained in the ER when 
expressed alone in heterologous cells, whereas other NR1 splice variants including 
NR1.2, NRI. 3 and NR1.4 are able to reach the plasma membrane (Standley et al., 2000). 
Over the past decade, research on NR1 splice variants has been focused on identifying 
sequence determinants that regulate ER-retention and surface expression (Standley et al., 
2000; Scott et at., 2004; Horak et al., 2008; Horak & Wenthold, 2009); however, the 
mechanisms of how NR1 and NR2 assembly can release ER-retention and how NR1 
splice variants regulate NMDAR trafficking are unclear. I therefore took advantage of 
the dimeric features MHCII aß-chains to investigate whether differential homomeric/ 
heteromeric combinations of NR1 splice variants would affect the ER-retention and 
surface expression of NMDARs. Using MHCII a or ß-chains appended to the entire C- 
termini of NR1.1 and NR1.2, I found that NR1.1 homodimeric chimeras are ER-retained 
whereas NR1.2 homodimeric chimeras are robustly expressed on the cell surface, 
consistent with data from monomeric chimeras (Standley et al., 2000). Intriguingly, 
NR1.1/NR1.2 heterodimeric chimeras were shown to be expressed on the cell surface, 
such that assembly of ER-retained NR1 splice variant and non- ER retained NR1 splice 
variant release ER-retention of NRl. These data suggest that there is a masking effect 
upon NR1.1 and NR1.2 dimerisation; which overrides ER-retention of NR1.1. It is also 
possible that NR1.1 and NR1.2 dimerisation changes the quaternary folding structure 
and disrupts the ER-retention motif(s) in NR1.1. Further studies may reveal the 
importance of tetrameric NMDAR assemblies. One particularly interesting line of 
179 
investigation would be to determine whether dimerisation of different combinations of 
NR1 splice variants and various NR2 subunits play a role in regulating NMDAR 
trafficking. 
6.6 Role of dysbindin in regulating NMDAR trafficking and the 
implication for schizophrenia 
Dysbindin is a schizophrenia susceptibility gene (Straub et al., 2002) and it is known to 
regulate protein trafficking in the lysosomal pathway (Di Pietro et al., 2006; Setty et at., 
2007). A recent study reported that dysbindin regulates cell surface expression of the 
dopamine receptor D2, but not DI (Iizuka et al., 2007). This result was confirmed by Dr. 
Bai Lu's lab, and they also observed increase in the insertion of D2 receptor in neurones 
derived from dysbindin null mice (Ji et al., 2009). It is interesting to note that, similar to 
the differential post-endocytic sorting of NR2 subunits (NR2A vs. NR2B), D1 is 
recycled to the plasma membrane after endocytosis, whereas D2 is trafficked to the 
lysosomal pathway and degraded (Ariano et al., 1997; Bartlett et at., 2005; Jeziorski and 
White, 1989; von Zastrow, 2003). Moreover, dopamine receptors have long been shown 
to interact with NMDARs and regulate NMDAR trafficking (Fiorentini et al., 2003; Gao 
and Wolf, 2008; Lee et al., 2002a; Wang et al., 2003). For example, D1 receptors were 
shown to regulate the surface expression of NRI and NR2B (Gao and Wolf, 2008). The 
interconnection between dysbindin, dopamine receptors and NMDARs raised my 
interest in investigating the potential role of dysbindin in regulating NMDAR trafficking 
in the hippocampus, which is the region of the brain that is critical for cognitive 
functioning, and NMDARs in hippocampus contain mostly NR2A- and NR2B subunits. 
Results in Chapter 5 first reveal an intriguing link between dysbindin and surface 
expression of NMDAR. It is shown that the surface expression of NR2A, but not NR2B, 
is dramatically increased in hippocampal neurones derived from Dys-/- mice, suggesting 
dysbindin regulates NMDAR trafficking in a subunit-specific manner. An increase in 
NMDA/AMPA ratio is shown to be mediated by primarily NR2A- containing NMDARs 
most likely at excitatory synapses in pyramidal neurones. It is shown that the increase in 
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surface-expressed NR2A also leads to a selective enhancement in LTP, but not LTD, in 
Dys-/- hippocampus. The increase in surface NR2A unavoidably causes an imbalance in 
the NR2A/NR2B ratio given that surface NR2B is unaltered, and dysregulated synaptic 
plasticity is likely to contribute to the cognitive impairments observed in schizophrenia. 
It is believed that imbalances between D1 and D2 receptor signalling play a role in 
leading to the psychotic symptoms of schizophrenia, due to the fact that D2 receptor 
antagonists are currently the most widely used antipsychotic drugs (Seeman et al., 2006). 
Moreover, a proper balance in NR2A and NR2B signalling is thought to be important for 
regulating the critical period in the visual cortex as well as the threshold for bidirectional 
synaptic plasticity (Cho et al., 2009). Therefore, an imbalance between NR2A and 
NR2B in the brain should be considered as a potential factor involved in schizophrenia. 
To understand the actual role of dysbindin in regulating NMDAR trafficking and 
to determine whether the link between dysbindin, NMDARs and possibly dopamine 
receptors is true candidate contribute to schizophrenia, an extensive line of investigation 
is required. The most important point is determining how the trafficking pathway of 
NR2A subunit is affected in Dys-/- neurones. Reagents that can interfere receptor 
insertion or endocytosis should be utilised to determine whether the increase of NR2A 
surface expression in Dys-/- is the consequence of a reduction in receptor internalisation 
or an increase in receptor insertion. 
Nevertheless, our findings in Chapter 5 that dysbindin controls NR2A surface 
expression and hippocampal LTP shed light on how dysregulation of NMDARs could 
possibly be involved in the cognitive impairments observed in schizophrenic patients 
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Fig. 8.1 Surface Wolin Oat ioit shoººs an increase in endogenous NR2A surface expression, but N12213 surface 
expression decreased in cultured I)ys-/- cirtical neurons. 
(A) 13iotinylated surface proteins from WF and I)ys-/- cortical neurones were isolated, resolved by SDS-PAGE, 
and probed with NR2A, NR213, or (t-tuhuIin antibodies. (13) Quantification of the biotinylation experiments. The 
innuno-reactive signals for surface NR2A and NR2R were normalized to total input and presented as a bar graph. 
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Fig. 8.2 Representative traces (A) and (C) and quantification (B) and (D) of amplitudes of evoked 
EPSCs, showing normal AMPAR-EPSCs and an increase in evoked NMDAR-mediated synaptic 
currents in Dys-/- neurones. 
Whole-cell, voltage-clamp recordings were performed to record AMPA-EPSCs (Vh = -80 mV) (A) and 
(C) or NMDA-EPSC5 (Vh= +50 mV, in the presence of CNQX) (B) and (D) in hippocampal slices 
derived from WT and Dys-/- mice (p26-p35; 5 WT mice, 4 Dys-/- mice). Traces from WT neurones (black) 
and those from Dys-/- neurones (red) are superimposed. Input-output curves were generated by plotting 
peak EPSC amplitudes against the intensities of presynaptic stimulation. 
Experiment done by Dr. Feng Yang. 
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Fig. 8.3 Increased NMDAR/AMPAR current ratio in evoked NMDAR-mediated synaptic 
currents in hippocampal CAI pyramidal neurones from Dys-/- mice. 
(A) Representative traces and (B) quantification of glutamatergic currents evoked by extracellular 
stimulation of presynaptic neurones at 50 µA and recorded at holding potentials of -80 mV and +50 
mV in WT and Dys -/- mice, respectively. The current traces represent responses to ten stimulations. 
The averaged peak currents were measured to determine AMPA (at -80 mV) and NMDA (at +50 mV) 
current amplitudes. Note that Dys -/- neurones showed higher NMDAR/AMPAR current ratio 
compared with WT neurones. 
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Fig. 8.4 Selective enhancement of NR2A- but not NR2B-mediated NMDA currents. 
(A) Superimposed traces of NMDA currents recorded from WT and Dys-/- neurones in the presence or 
absence of the NR2B antagonist ifenprodil (Ifen, 3µM, lower trace). Note that Dys-/- neurones exhibit much 
higher amplitude and faster decay time compared with WT neurones. (B) Changes in NMDA currents 
(Vh=+50 mV, in the presence of CNQX induced by ifenprodil in neurones from young adult WT and Dys-/- 
mice (p27-p3 1). (C) Total NMDA currents, normalised to the first 2.5-min of recording, were reduced 
similarly in WT and Dys-/- neurones by application of ifenprodil. (D) Changes in NMDA currents (Vh=+50 
mV, in the presence of CNQX) induced by Ro25-6981 in neurones from young adult WT and Dys-/- mice 
(p26-p31). After 2.5 min of recording, Ro25-6981 (I µM, indicated by the green bar) was applied to the 
hippocampal slices. (E) Total NMDA currents, normalised to the first 2.5-min of recording, were reduced 
similarly in WT and Dys-/- neurones in application of Ro25-6981. Experiment done by Dr. Feng Yang. 
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Fig. 8.5 (A) and (C) Marked increases in total and ifenprodil or Ro25-6981-insensitive NMDA 
currents in Dys-/- neurones. (B) Decreased decay time constants of total (before ifenprodil) and 
NR2A (after ifenprodil) NMDA currents in Dys-/- neurones. 
Data for total, and NR2B-antagonist sensitive NMDA currents were obtained by averaging the first and 
last 2.5 minutes of recordings, respectively. Data for NR2B currents were derived by subtracting the 
NR2B-antagonist sensitive current from the total currents for each recording. The decay phase of 
NMDA currents was fitted by single-exponential functions to calculate decay time constants. Student t- 
test, *: p<0.05; **: p<0.01. 
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Fig. 8.6 Significant increase In LTP, but not LTD, in Dys-/- hippocampus. 
(A-B) Dys-/- mice display normal LTD. LTD was induced by 900 pulses at 1 Hz (black bar in B in the 
CAI area of acutely-prepared hippocampal slices from 2-week old Dys-/- mice and WT littermates. 
Example fEPSP recordings before (green lines) and 60 min after LTD induction (red lines) are shown in 
A and the complete time courses are shown in B. LTD is comparable between Dys-/- and WT mice 
(69±2% vs. 68±3% at 70-75 min, respectively). (E, F) Slices from Dys-/- mice display elevated LTP. 
LTP was induced by 4 TBS at 10011z (arrows in F) in 8-week old animals. The magnitude of LTP was 
nearly double in Dys-/- that of WT mice (Dys-/-: 151±5%, WT: 125±5%, p<0.003, t-test). (C, G) 
Normal paired pulse facilitation (PPF). The ratios of the second and first EPSP slopes were calculated, 
and mean values are plotted against different inter-pulse intervals (lPI, 10 to 1000 msec). (D, H) 
Normal basal synaptic transmission. Input-output curves were generated by plotting the postsynaptic 
response (initial slope of fEPSP) as a function of the presynaptic fibre volley amplitudes. 
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Abnormalities In NMDA receptor (NMDAR) function have been 
implicated in schizophrenia. Here, we show that dysbindin, a 
schizophrenia-susceptibility gene widely expressed In the fore- 
brain, controls the surface expression of NMDARs In a subunit- 
specific manner. Imaging analyses revealed a marked increase in 
surface NR2A, but not NR26, in hippocampal neurons derived from 
dysbindin-null mutant mice (Dys-/-). Exogenous expression of 
dysbindin reduced NR2A surface expression in both wild-type and 
Dys-/- neurons. Biotinylation experiments also revealed an in- 
crease In surface expression of endogenous NR2A In Dys-/- 
neurons. Disruption of the dysbindin gene dramatically Increased 
NR2A-mediated synaptic currents, without affecting AMPA recep- 
tor currents, In hippocampal CAI neurons. The Dys-/- hippocam- 
pal slices exhibited an enhanced LTP, whereas basal synaptic 
transmission, presynaptic properties, and LTD were normal. Thus, 
dysbindin controls hippocampal LIP by selective regulation of the 
surface expression of NR2A. These results reveal subunit-specific 
regulation of NMDARs by dysbindin, providing an unexpected link 
between these two proteins implicated In schizophrenia. 
glutamate receptor I schizophrenia I synaptic plasticity 
T he DTNBPI gene, which encodes dybindin at chromosome 6p. 22.3, is a susceptibility gene for schizophrenia (1). In schizo- 
phrenic patients, dysbindin mRNA and protein are reduced in the 
hippocampus (2) and the prefrontal cortex (3), areas known to 
contribute to cognitive deficits in schizophrenia. A recent study also 
reported a reduction in dysbindin mRNA in the hippocampal 
formation of schizophrenic patients (4). Dysbindin is a key com- 
ponent of biogenesis of lysosome-related organelles complex-1 
(BLOC-1), which regulates the trafficking of proteins in the lyso- 
somal pathway (5,6). Dysbindin has been shown to regulate cell 
surface expression of the dopamine receptor D2, but not D1(7). It 
is interesting to note that D1 is recycled to the plasma membrane 
after endocytosis, whereas D2 is trafficked to the lysosomal pathway 
and degraded (8-11). However, how aberrant dysbindin expression 
contributes to the pathophysiology of schizophrenia has remained 
elusive. 
Abnormal NMDAR function in hippocampus has also been 
implicated in schizophrenia (12). NMDARs are tetrameric recep- 
tors consisting of two obligatory NR1 subunits and two NR2 
subunits (13). NR2A and NR2B are the major NR2 subunits 
expressed in the hippocampus (14), with expression patterns that 
change during development. In cortex and hippocampus, NR2B is 
predominantly expressed early in development and gradually de- 
creases. In contrast, NR2A expression is low at birth but gradually 
, 
increases during development (14-17). In adult cortical and hip- 
pocampal neurons, the NR2A subunit is preferentially localized in 
synaptic sites, whereas the NR2B subunit is expressed in both 
synaptic and extrasynaptic membranes (18-20). Furthermore, traf- 
ficking of NMDARs is subunit-specific (21-25). For example, 
NR2A and NR2B sort to different intracellular pathways following 
endocytosis. Specifically, NR2A is sorted to the lysosomal pathway, 
whereas NR2B preferentially traffics to recycling endosomes (23). 
Given that dysbindin is thought to be involved in protein traf- 
ficking in the lysosomal pathway, we asked whether it may differ- 
entially regulate the trafficking of NMDAR subunits in hippocam- 
pal neurons. We took advantage of a natural dysbindin mutant line 
(Dys-/-), the Sandy mouse, and backcrossed on the C57BL/6J 
background for >10 generations. Imaging and biochemical analyses 
showed that the surface expression of NR2A, but not NR2B, was 
significantly increased in Dys-/- neurons. The wild-type (WT) 
levels of NR2A surface expression was rescued by expression of 
exogenous dysbindin in Dys-/- cells. Electrophysiological record- 
ings revealed a dramatic increase in evoked NMDAR-mediated 
EPSCs, as well as NMDAR-dependent LTP, in Dys-/- hippocam- 
pal slices. Together, these data identify dysbindin as an important 
regulator of NMDAR in a subunit-specific manner. Our findings 
also support the view that a dysbindin deficit may contribute to 
glutamatergic imbalances characteristic of schizophrenia. 
Results 
Increased Surface NR2A in Nippocampal Neurons Derived from Dys-l- 
Mice. To determine whether disruption of the dysbindin gene affects 
the trafficking of NMDAR subunits, we compared the surface 
expression of NR2A and NR2B expressed in cultured hippocampal 
neurons derived from Dys-/- or WT mice. Primary hippocampal 
cultures derived from embryonic (E16-18) WT and Dys-/- mice 
were transfected with exogenous NR2A or NR2B containing a GFP 
tag in the extracellular N-terminal domain. We measured the 
steady-state levels of surface NR2A and NR2B using an antibody 
against GFP. As shown in Fig. IA, the levels of NR2A on the surface 
(Left), but not intracellular (Middle), were markedly increased in 
hippocampal neurons derived from Dys-/- mice, compared with 
that from WT mice. In comparison, surface levels of NR2B were 
not increased (Fig. 1B). Quantitative analyses, which normalized 
the fluorescence signal on the surface to total fluorescence (surface 
+ intracellular), revealed an approximate 50% increase in surface 
NR2A in Dys-/- neurons (Fig. 1C). 
To evaluate if surface levels of endogenous NMDARS are also 
increased by loss of dysbindin, we performed surface biotinylation 
assays to measure the amount of endogenous NR2A and NR2B on 
the neuronal surface. Due to the difficulty in obtaining a large 
number of hippocampal neurons from mouse embryonic brains, we 
used cultured cortical neurons for biotinylation experiments. Bio- 
tinylated proteins from the crude membrane lysates were extracted, 
pulled-down with streptavidin-Sepharose beads, resolved by SDS/ 
PAGE, and blotted with various antibodies (Fig. 1D). In cortical 
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Fig. I. Increased surface expression of NR2A, but not NR2B, in Dys-/- 
neurons. Cultured 
hippocampal neurons prepared from WT and Dys-/- 
E18 embryos were transfected with GFP-NR2A or GFP-NR2B at DIV9-10. 
After 5 days, live neurons were incubated with an anti-GFP antibody (red) 
to label surface-expressed receptors. The neurons were fixed, permeabil- 
ized and labeled again with anti-GFP antibodyto detect intracellular NR2A 
or NR2B (green). (A and 8) Representative 
images showing increased 
surface expression of (A) GFP-NR2A 
but not (B) GFP-NR2B in Dys-/- 
neurons. Images were collected using 40k objective at 0.34µm. 
(Scale bars, 
25 µm. ) (C) Quantification of the imaging experiments 
in A and B. Fluo- 
rescence intensities were measured using Metamorph software. (n = 27-36 
cells; n=4 independent experiments) and the ratios of surface (red)tototal 
(red + green) fluorescence for WT and Dys-/- neurons are presented. 
Error bars, mean i SEM. ": Pý0.02, Student's t test. (D and E) Increased 
surface expression of endogenous NRZA, but decreased NR2B in cultured 
Dys-/- cortical neurons. (D) Biotinylated surface proteins from WT and 
Dys-/- cortical neurons were isolated, resolved by SDS/PAGE, and probed 
with NR2A, NR2B, or a -tubulin antibodies. (E) Quantification of the bioti- 
nylation experiments. The immuno-reactive signals for surface NR2A and 
NR2B were normalized to total input and presented as a bar graph. n=3 
independent experiments. Error bars, mean ± SEM.; *, P 0.02, Student's 
t test. 
neurons prepared from Dys-/- mice, we observed a substantial 
increase in NR2A surface expression compared to the WT control, 
which is consistent with our imaging studies. However, we also 
found that surface NR2B was reduced in Dys-/- neurons (Fig. I 
D and E). 
It is important to note that the dysbindin mutation does not affect 
the expression level of endogenous NR2A and NR2B in the 
Fig. 2. NR2A and NR2B expression is not changed in Dys-/- neurons. 
Hippocampi were dissected from 4-week-old WT or Dys-/- mice. P2 crude 
synaptosomes were extracted, and 25 µg of protein were loaded in each lane. 
Expression of NR2A, NR2B, NR1, GIuR1, and a-tubulin was detected by West- 
ern blot analysis using antibodies as indicated. (A) Representative Western 
blots of hippocampal lysates from WT or Dys-/- mice. (B) Quantification of 
Western blots. Relative intensities of ECL bands were quantified by National 
Institutes of Health Image) software. Immunoreactivities of NR2A, NR2B, NR1, 
and GIuR1 were normalized to that of a-tubulin in the same sample, and the 
signals from Dys--/ hippocampal neurons were compared to that from WT 
control. n-4 independent experiments. Error bars, mean - SEM; in all cases, 
P 0.4, Student's t test. 
hippocampus. Western blot analysis demonstrated that the total 
levels of NR2A or NR2B were not changed in the adult hippocam- 
pus (4-week-old) of Dys-/- mice compared to age-matched WT 
control animals (Fig. 24 and B). There was also no difference in 
total expression levels of NR1. or G1uR1 between WT and Dys-/- 
mice (Fig. 2A and B). 
To verify whether the increase in surface NR2A in Dys-/- 
neurons is due to the disruption of dysbindin, we performed rescue 
experiments by introducing dysbindin into WT or Dys-/- neurons. 
We measured the steady-state level of surface-expressed NR2A in 
hippocampal neurons expressing GFP-NR2A and HA-dysbindin or 
HA, and we found that expression of exogenous HA-dysbindin 
significantly reduced the surface NR2A expression in Dys-/- 
neurons, compared with HA alone (Fig. 3A). Quantitative analyses 
of fluorescence images revealed a 25% reduction in surface NR2A 
in Dys-/- neurons (Fig. 3B) upon exogenous dysbindin expression, 
confirming that the reduction in dysbindin directly leads to in- 
creased surface expression of NR2A. Furthermore, expression of 
exogenous dyshindin also reduced surface NR2A in WT neurons, 
compared to the HA control (Fig. 3A and B). To confirm the 
specificity of our assay, we quantified surface expression of GFP- 
NR2B in Dys-/- hippocampal neurons expressing exogenous 
HA-dysbindin. As shown in Fig. Si, Dys-/- neurons expressing 
HA-dysbindin or HA control exhibited similar levels of surface 
NR2B. These results demonstrate that NMDAR surface expression 
is regulated by dysbindin in a subunit-specific manner, and specif- 
ically the level of NR2A surface expression is modulated by changes 
in the amount of dysbindin expressed in neurons. 
Increase in NRZA-Mediated EPSCs in Dys-I- Neurons. Our imaging 
and biochemical analyses demonstrated a consistent increase in 
surface expression of NR2A in Dys-l- neurons. However, the 
surface biotinylation assays also revealed a decrease in surface 
NR2B in Dys-/- cortical neurons (Fig. 1D and E). The differing 
results using these two assays prompted us to directly examine the 
function of synaptic NMDARs in hippocampal slices. Whole-cell, 
voltage-clamp recordings were performed on CAI pyramidal neu- 
rons of hippocampal slices derived from adult (26- to 31-day-old) 
mice. Excitatory postsynaptic currents (EPSCs) were evoked by 
stimulating Schaffer collaterals in the presence of the GABAA 
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Fig. 3. Expression of exogenous 
dysbindin reduces NR2A surface expression in both WT and Dys-/ hippocampal neurons. Cultured hippocampal neurons from 
pys- /- and WT mice were transfected with GFP-NR2A and HA-dysbindin or HA. Neurons were processed for staining of surface and intracellular GFP-NR2A with 
GFP antibody. Transfected cells were detected by HA antibody. (A) Representative images showing surface and intracellular NR2A in transfected Dys-/- and 
WT neurons, respectively. Note thattransfection of HA-dysbindin, but not HA alone, rescued WT levels of NR2A surface expression in Dys-/- neurons expressing 
exogenous 
NR2A, and reduced surface expression of NR2A in WT neurons. Images were collected using 40 - objective at 0.34 µm. (Scale bars, 25 µm. ) (B) 
Quantification of surface NR2A in HA-Dysbindin transfected Dys-/ - and WT hippocampal neurons. Image analysis was performed as described in Fig. 1C(n = 
27_37 cells; n=3 independent experiments). 
receptor antagonist bicuculline (10 µM) (Fig. 4A). When mem- 
brane potentials were held at -80 mV (Vh = -80 mV), the EPSCs 
were predominantly mediated by AMPA receptors. Input-output 
curves, derived by plotting peak AMPA current amplitudes against 
the intensities of presynaptic stimulation, were indistinguishable 
between WT and Dys-/- mice (Fig. 4C). Evoked NMDAR- 
mediated currents were then recorded at a holding potential of --50 
mV (Vh = 50 mV) in the presence of the AMPA receptor 
antagonist CNQX (50 µM) (Fig. 4B). The NMDAR-mediated 
synaptic currents recorded from the Dys-/- neurons were greater 
with faster decay time, compared with those from the WT control 
(Fig. 4B). Input-output curves revealed consistent differences in 
NMDAR currents between genotypes in the entire range of stim- 
ulation intensities (Fig. 4D). Moreover, the NMDA to AMPA ratio 
in Dys-/- neurons was also significantly higher than the WT 
control (Fig. S2 A and B). 
We next investigated the relative contributions of NR2A or 
NR2B to the changes in NMDAR synaptic currents. Application of 
the selective NR2B antagonist ifenprodil (3 µM) significantly 
reduced NMDAR-mediated synaptic currents in both WT and 
Dys-/- neurons (Fig. 4E and F). Likewise, a more specific NR2B 
antagonist Ro25-6981 (I µM) elicited a similar decrease in 
NMDAR-EPSCs in CAI pyramidal neurons from both genotypes 
(Fig. S2C). Given that both antagonists provide a maximal and 
selective inhibition of NRI/NR2B diheteromeric receptors and that 
the majority of NMDARs in CAI neurons contain NR2A and/or 
NR2B, the remaining (non-NR2B) currents reflected those medi- 
ated by NR2A-containing receptors. We found that hippocampal 
CAI synapses in Dys-/- mice exhibited a much greater proportion 
of NR2A-mediated currents, compared with WT mice (Fig. 4F and 
Fig. S2C). The normalized NMDAR currents decreased within a 
few minutes following perfusion of ifenprodil or Ro25-6981 onto 
the slices (Fig. 4G and Fig. S2D). Quantitative analyses revealed a 
significant increase in the total NMDAR currents (averaged from 
the first 2.5 min of recording before ifenprodil or Ro25-6981 
application) in Dys-/- neurons (Fig. 4H and Fig. S2E, Left 
columns). Further, NR2A-mediated EPSCs, obtained by averaging 
the last 2.5 min of the currents recorded in the presence of NR2B 
antagonists, also exhibited a big difference between WT and 
Dys-/- neurons (Fig. 4H and Fig. S2E, Middle columns). In 
contrast, when the NR2A-mediated currents were subtracted from 
the total NMDAR-EPSCs for each neuron, no significant differ- 
ence was found in the ifenprodil- or Ro25-6981- sensitive, NR2B- 
mediated currents between WT and Dys-/- neurons (Fig. 4H and 
Fig. S2E, Right columns). Given that NR2A-mediated currents 
usually decay faster than NR2B-mediated currents (26), we further 
analyzed the decay time constants of NMDAR currents. Indeed, 
there was a significant decrease in the decay time of NMDAR- 
EPSCs in Dys-/- neurons, both before and after ifenprodil 
application (Fig. 41). Taken together, these results suggest that the 
increase in NMDAR-EPSCs in Dys-/- neurons is due largely to 
elevated NR2A at the hippocampal CAI synapses. 
Elevated LTP at Dys-/- CA7 Synapses. To investigate whether the 
changes in synaptic NR2A could alter synaptic plasticity in the 
hippocampus, we performed field recordings of excitatory postsyn- 
aptic potentials (fEPSPs) in hippocampal slices. Because long-term 
depression (LTD) is prominent earlier in development, 2-week-old 
animals were used. Conventional LTD, induced by low frequency 
stimulation (LFS, 1 Hz, 900 pulses), was not affected in the Dys-/- 
slices (Fig. 5A and B). Control experiments showed no change in 
input-output of fEPSPs or paired-pulse facilitation (PPF) in 
Dys-/- mice at this age (Fig. 5C and D). Long-term potentiation 
(LTP), induced by a single tetanus (4 TBS, 100 Hz) was investigated 
in slices derived from 8-week-old mice. We found that LTP was 
significantly increased in Dys-/- mice compared to WT control 
(Fig. 5E and F). The fEPSP was 125 ± 5% in wild-type, but 151 
5% in Dys-/-, respectively (P < 0.003). However, input-output 
curves were normal in Dys-/- mice (Fig. 5H). PPFs were virtually 
identical over a wide range of interpulse intervals for Dys-/- and 
WT slices (Fig. 5G). These data suggest that the observed change 
in LTP in Dys-/- mice is due to a postsynaptic rather than 
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Discussion 
Although dysbindin has been implicated in schizophrenia (1), little 
is known about its cellular function in neurons. By using a dysbindin 
null mutant mouse line (Dys-/-), we have uncovered an unex- 
pected role of dysbindin in NMDAR regulation. A combination of 
imaging and biochemical approaches revealed that disruption of the 
dysbindin gene increases NR2A surface expression in neurons. This 
dramatic increase in NR2A surface expression was mitigated by 
introducing exogenous dysbindin in Dys-/- neurons, suggesting 
that dysbindin directly regulates NR2A surface expression, rather 
than indirectly by regulating neuronal development. In hippocam- 
pal slices from Dys-/- mice, NMDA-, but not AMPA-mediated 
synaptic currents were dramatically increased, and this effect is due 
largely to an elevated expression of N R2A at the excitatory synapses 
of CAI pyramidal neurons. We have also observed a marked 
increase in LTP, but not LTD, at CAI synapses in Dys-/ slices. 
Together, our data provide a link between dysbindin and 
NMDARs. These results have implications in synaptic plasticity and 
perhaps schizophrenia. 
By using a variety of techniques, we demonstrated a specific 
enhancement of NR2A expression on the surface of neurons and 
at synapses. We did not examine surface expression of endogenous 
NR2A in our imaging experiments because specific antibodies 
against the N-terminal domain of NR2A or NR2B are not available. 
However, our surface biotinylation assays demonstrated that dis- 
ruption of dysbindin resulted in more endogenous NR2A on the 
surface of cortical neurons. Electrophysiological recordings re- 
vealed an increase in NR2A-mediated synaptic currents in Dys-/- 
mice pyramidal neurons, suggesting that more endogenous NR2A 
has been incorporated into excitatory synapses. Unexpectedly, 
while no change in NR2B-mediated synaptic currents was observed 
in Dys-/- neurons, our biotinylation experiments also showed a 
reduction in NR2B on the surface of Dys-/- neurons. Given that 
NR2B is largely expressed in extrasynaptic sites (20,22,29,30), it 
is possible that surface biotinylation assays revealed a decrease in 
extrasynaptic but not synaptic NR2B in Dys-/- neurons. Alter- 
natively, NR2B surface expression in cortex may be different from 
that in hippocampus. Moreover, ifenprodil and Ro25-6981 are 
known to be most effective in blocking NR2B in NR1/NR2B 
diheteromeric NMDARs but less effective in blocking trihetero- 
meric (NRI/NR2A/NR2B) NMDARs (31), thus the possibility of 
an increase in triheteromeric NMDA receptor in Dys-/- neurons 
cannot be excluded. 
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NMDARs undergo a subunit-specific postendocytic sorting, with 
NR2A being sorted to the lysosomal pathway, whereas NR2B 
preferentially traffics to recycling endosomes 
(23). It should also be 
noted that we do not know whether the 
increased surface expres- 
sion of NR2A in Dys-/- hippocampal neurons 
is due to an 
increase in insertion or a decrease in endocytosis of NR2A. 
However, it is intriguing that dysbindin is thought to regulate 
protein sorting from early endosomes to lysosome-related or- 
ganelles (LROs), which have recently been implicated 
in the 
delivery of membrane proteins to the cell surface (5,6,32,33). 
Moreover, knockdown of dysbindin in rat cortical neurons has been 
shown to increase the surface expression of D2R, a subtype of 
dopamine receptor known to traffic to the lysosomal pathway 
(8-11). Thus, knockout of dysbindin may divert endocytosed mem- 
brane proteins normally destined to lysosomes back to the cell 
surface. Consistent with this idea, we found an enhancement in 
NR2A surface expression in neurons lacking dysbindin, whereas 
NR2B was not affected (Fig. 1). Furthermore, expression of 
exogenous dysbindin also reduced NR2A surface expression in both 
WT and Dys-/- neurons (Fig. 3). We also observed an increase 
in NR2A-mediated NMDAR currents in Dys-/- neurons (Fig. 4H 
and Fig. S2E), suggesting that dysbindin regulates the number of 
NR2A-containing NMDARs at synaptic sites. Together these 
results support a model in which dysbindin controls the amount of 
NR2A at excitatory synapses, potentially by regulating postendo- 
cytic sorting of NR2A from early endosomes into lysosomes or 
LROs. 
Fig. 5. Significant increase in LTP, but not LTD, in 
Dys-/- hippocampus. (A and B) Dys-/- mice display 
normal LTD. LTD was induced by 900 pulses at 1 Hz 
(black bar in B in the CA1 area of acutely prepared 
hippocampal slices from 2-week-old Dys-/-- mice and 
WT littermates. Example fEPSP recordings before 
(lower curves) and 60 min after LTD induction (upper 
curves) are shown in A and the complete time courses 
are shown in B. LTD is comparable between Dys-/- 
and WT mice (69 1 2% vs. 68 , 3% at 70-75 min, 
respectively). (E and F) Slices from Dys-/- mice dis- 
play elevated LTP. LTP was induced by 4 TBS (four 
bursts, each of four pulses at 100 Hz) (arrows in F) in 
8-week-old animals. The magnitude of LTPwas nearly 
double in Dys-/- that of WT mice (Dys-/-: 151 
5%, WT: 125 - 5%, P 0.003, ttest). (Cand G) Normal 
paired pulse facilitation (PPF). The ratios of the sec- 
ond and first EPSP slopes were calculated, and mean 
values are plotted against different interpulse inter- W 
vals (IPI, 10 to 1,000 ms). (D and H) Normal basal 
N 
0 
synaptic transmission. Input-output curves were gen- 
erated by plotting the postsynaptic response (initial z 
slope of fEPSP) as a function of the presynaptic fiber 
volley amplitudes. 
Activation of NMDARs is required for both LTP and LTD in 
hippocampal CA1 synapses. Several studies suggest that NR2A- 
containing NMDARs are preferentially involved in LTP whereas 
NR2B-containing NMDARs are critical for LTD (34-36). Al- 
though this model remains controversial (37,38), our findings 
revealed an increase in LTP in adult Dys-/- CAI pyramidal 
neurons, whereas there is no change in LTD (Fig. 5). It is conceiv- 
able that an increase in the number of NR2A-containing NMDARs 
present in Dys-/- synapses leads to an enhancement in LTP 
without interfering with LTD. 
Our finding that knockout of dysbindin leads to increased NR2A 
expression at synapses brings a twist to our understanding of the 
pathogenesis of schizophrenia. Several lines of evidence have 
pointed to a hypofunction of NMDAR in schizophrenia brains (12). 
In situ hybridization of postmortem brains revealed a reduced level 
of NMDARs, particularly NR1 in the hippocampus of schizo- 
phrenic patients (39,40). Moreover, administration of NMDAR 
antagonists such as PCP or ketamine to healthy volunteers pro- 
duces hallucination and psychosis (41,42). These results at first 
glance appear at odds with our findings. However, methods used to 
detect NMDARs in the postmortem brains cannot distinguish 
whether changes in NMDARs occur at synaptic or extrasynaptic 
sites. It is also unclear whether systemic administration of NMDAR 
antagonists act on hippocampus or other brain regions to achieve 
their effects. Furthermore, whether and how impairments in hip- 
pocampal synaptic plasticity contribute to the pathogenesis of 
schizophrenia have not been established. We here show a specific 
increase in NR2A surface expression in Dys-/- hippocampus, 
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most likely at excitatory synapses in pyramidal neurons, leading to 
a selective increase in LTP but not LTD. The specific increase in 
surface NR2A, but not NR2B, unavoidably changes the NR2A/ 
NR2B ratio, which is thought to be important for regulating the 
critical period in the visual cortex as well as the threshold for 
bidirectional synaptic plasticity (43). An imbalance between NR2A 
and NR2B in the brain should therefore be considered as a 
potential factor involved in schizophrenia. Thus, our findings that 
dysbindin controls NR2A surface expression and hippocampal LTP 
open up an avenue for schizophrenia research. 
Methods 
Animals, Primary Cultures. and Transfection. The use and care of animals in this 
study followed the guidelines of the National Institutes of Health Animal Re- 
search Advisory Committee. The Sandy mouse occurred spontaneously in the 
inbred DBA/21 strain atTheJackson laboratory and carries an autosomal recessive 
mutation, which results in lighter coat color. The Sandy mouse expresses no 
dysbindin protein owing to a deletion In the gene dystrobrevin-binding protein 
1 (Dtnbpl; encoding dysbindin). The mutation In Sandy mice (Dys-/-), was 
transferred to the C57B1/6J genetic background by >10 generations of back- 
crossing. Dys-/- mice and WT (+/+) littermates were bred by heterozygous 
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Stefano Vicini (Georgetown University, Washington, DC), with a GFPtag inserted 
In the N-termini of NR2A and NR2B following the signal sequences. HA-dysbindin 
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N-Methyl-D-aspartate (NMDA) receptors are expressed at 
excitatory synapses throughout the brain and are essential for 
neuronal development and synaptic plasticity. Functional 
NMDA receptors are tetramers, typically composed of NR1 and 
NR2 subunits (NR2A-D). NR2A and NR2B are expressed in the 
forebrain and are thought to assemble as diheteromers (NR1/ 
NR2A, NRl/NR2B) and triheteromers (NRl/NR2A/NR2B). 
NR2A and NR2B contain cytosolic domains that regulate dis- 
tinct postendocytic sorting events, with NR2A sorting predom- 
inantly into the degradation pathway, and NR2B preferentially 
trafficking through the recycling pathway. However, the inter- 
play between these two subunits remains an open question. We 
have now developed a novel approach based on the dimeric fea- 
ture of the a- and 13-chains of the human major histocompati- 
bility complex class II molecule. We created chimeras of a- and 
f3-chains with the NR2A and NR2B C termini and evaluated 
endocytosis of 
dimers. Like chimeric proteins containing only a 
single NR2A or 
NR2B C-terminal domain, major histocompat- 
ibility complex class II-NR2A homodimers sort predominantly 
to late endosomes, whereas NR2B homodimers traffic to recy- 
cling endosomes. Interestingly, 
NR2A/NR2B heterodimers traf- 
fic preferentially through the recycling pathway, and NR2B is 
dominant in regulating dimer trafficking in both heterologous 
cells and neurons. In addition, the recycling of 
NR2B-contain- 
ing NMDARs in wild-type neurons is not significantly different 
from NR2A-'- neurons. These data support a dominant role for 
NR2B in regulating the trafficking of triheteromeric NMDARs 
in vivo. Furthermore, our molecular approach allows for the 
direct and selective evaluation of dimeric assemblies and can be 
used to define dominant trafficking domains in other multisub- 
unit protein complexes. 
In the nervous system, trafficking of glutamate receptors to 
excitatory synapses is critical in regulating synaptic communi- 
cation between neurons. In addition, changes in synaptic 
strength underlie many forms of synaptic plasticity, which are 
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regulated, at least in part, by the dynamic expression of gluta- 
mate receptors on the postsynaptic membrane (1-3). There- 
fore, there has been intense interest in defining the molecular 
determinants within glutamate receptors that regulate their 
trafficking and synaptic expression. However, the immense 
heterogeneity of glutamate receptors complicates the study of 
endogenous glutamate receptor trafficking. For example, there 
are three subtypes of ionotropic glutamate receptors (NMDA, 2 
AMPA, and kainate), and each receptor subtype is composed of 
multiple subunits. 
NMDA receptors (NMDARs) are tetramers composed of 
NR1, NR2 (NR2A-D), and NR3 (NR3A-B) subunits. NR1 is a 
single gene product expressed throughout the brain. In con- 
trast, the four NR2 subunits are differentially distributed in the 
central nervous system and confer unique functional properties 
on endogenous NMDARs (4). In hippocampus and cortex, 
NMDARs are typically NR1/NR2B heteromers early in develop- 
ment, but the subunit composition is developmentally regulated 
with NR2A expression increasing over time (5,6). In mature hip- 
pocampal and cortical neurons, both NR2A and NR2B are 
expressed, and NMDARs consist of a combination of NRl/NR2B, 
NR1/NR2A, and NR1/NR2A/NR2B heteromers (7). 
The NR2 subunits contain divergent sequences that regulate 
unique protein-protein interactions and distinct receptor traf- 
ficking properties (8,9). For example, the NR2A and NR2B 
intracellular C-terminal domains contain trafficking motifs 
that regulate NMDAR endocytosis and intracellular trafficking 
(10-13). However, the postendocytic itineraries of these 
NMDA receptor subunits are distinct. Studies in heterologous 
cells and neurons have shown that NR2A-containing receptors 
undergo endocytosis and lysosomal sorting for receptor degra- 
dation, whereas NR2B-containing receptors undergo endocy- 
tosis and preferentially recycle to the plasma membrane (14, 
15). The subunit-specific postendocytic sorting is conserved 
when the NR2 C termini are appended to the simple, single 
transmembrane-spanning reporter protein Tac (interleukin 2 
receptor), demonstrating that the NR2 intracellular domains 
contain the relevant sorting information and can function inde- 
pendently. However, it has not been possible to identify the 
postendocytic sorting itinerary of NMDARs containing a com- 
bination of both NR2A and NR2B subunits. 
' The abbreviations used are: NMDA, N-methyl-D-aspartate; NMDAR, NMDA 
receptor; MHC II, major histocompatibility complex class 11; GFP, green 
fluorescent protein; PBS, phosphate-buffered saline; WT, wild type. 
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Regulation of NR2 Trafficking 
In the present study, we developed a novel strategy using 
the a-subunit and /3-subunit of the major histocompatibility 
complex class II molecule (MHC 11) as a reporter protein to 
study the contributions of individ- 
ual NR2 subunit cytosolic do- A Total 
mains in the intracellular traffick- p-char 
ing of assembled dimers. By 
engineering chimeras between the 
a- and /3-chains of MHC II with ilk 
the NR2A and NR2B C-terminal 
domains, we find that the NR2B C 
torrninus clays a dominant role in 
rabbit anti-GFP antibody was obtained from Invitrogen 
(Eugene, OR). Unconjugated rabbit lgG and unconjugated 
mouse IgG antibody were obtained from Sigma. 
Surface 
trafficking of NR2A/NR2B het- 
erodimers in both heterologous 
cells and neurons. In support of 
q7ý: 
this finding, we find that NR2B 
recycling 
does not differ signifi- 
cantly in 
NR2A knock-out mice D 
(NR2A- `), consistent with NR2B 
Flaying a central role in the traf- C 
, ___,. e KTP A /M D)P ...... ,..... n' tICK111r, - 11 -1-1 - -1-1 "1 1111111- Single Shcrv 
II» NMDARS in vivo. 
EXPERIMENTAL PROCEDURES 
DIVA Constructs-The following 
cDNA constructs were obtained as 
gifts: green fluorescent protein 
(GFP)-Rab9 from Dr. Juan Boni- 
facino (NICHD, National Institutes 
of Health, Bethesda, MD), GFP- 
Rab] I from Dr. James Goldenring 
(Vanderbilt University, Nashville, 
TN), GFP-NR2B from Dr. Stefano 
Vicini (Georgetown University, 
Washington, D. C. ). Tailless HLA- 
DRa (amino acids 1-239) and HLA- 
DRJ3 (amino acids 1-250) lacking 
the entire cytosolic domain were 
modified using PCR from the HLA- 
DRa and HLA-DRß cDNAs that 
were previously described (16). 
Both NR2A (amino acids 1304- 
1464) and NR2B (amino acids 
1315-1482) C termini were ampli- 
fied by PCR and were subcloned 
into the truncated MHC II a- and 
/3-chains in pcDNA3.1 using EcoRl 
restriction enzyme sites. The se- 
quences of all chimeric constructs 
were confirmed by automated 
sequence analysis. 
Antibodies-Mouse monoclonal 
antibodies that recognize the HLA- 
DR(3-chain alone (XD5. A11) (17) or 
only when dimerized with a-chain 
(1.243) were used as tissue culture 
supernatants and have been de- 
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Regulation of NR2 Trafficking 
Immunostainingfor Surface Protein Expression in HeLa Cells- 
HeLa cells grown on glass coverslips were transfected with the 
cDNAs indicated (4 µg of DNA/well in a 6-well dish) using the 
Calcium Phosphate Transfection kit (Clontech) and analyzed 
36 h later. Transfected cells were washed once with ice-cold 
PBS and labeled with anti-a/3-dimer antibody (L243) or anti-ß- 
chain antibody (XD5. A11) on ice for 1 h. After three washes in 
ice-cold PBS, the cells were fixed in 4% paraformaldehyde in 
PBS for 15 min at room temperature. The cells were permeabi- 
lized in 0.25% Triton X-100 in PBS, blocked in 10% normal goat 
serum in PBS, and labeled with Alexa Fluor 568-conjugated 
anti-mouse IgG2,, secondary antibody for 30 min at room tem- 
perature. After multiple washes in PBS, the coverslips were 
mounted (Prolong Antifade kit; Invitrogen), and cells were 
visualized using a 63 X objective on a Zeiss LSM510 confocal 
microscope (Carl Zeiss, Thornwood, NY). A series of optical 
sections was collected at intervals of 0.34 µm. 
Immunofluorescent Internalization Assay in HeLa Cells- 
Transfected HeLa cells were incubated with anti-aß-dimer 
antibody (L243) on ice for 1h before cells were returned to 
37 °C for the indicated amounts of time to allow internalization. 
The cells were washed and fixed in 4% paraformaldehyde in 
PBS for 15 min at room temperature before being permeabi- 
lized in 0.25% Triton X-100 in PBS for 5 min. After blocking in 
10% normal goat serum, the cells were labeled with secondary 
antibodies, washed multiple times, and mounted on glass slides. 
Recycling Assay in HeLa Cells-Transfected HeLa cells were 
incubated with anti-aß-dimer (L243) antibody on ice for 1h 
before incubation at 37 °C for 30 min to allow internalization. 
The cells were washed multiple times and labeled with excess 
unconjugated secondary antibody on ice 
for Ih to "block" all 
surface receptors. Cells were 
incubated at 37 °C for 30 min to 
allow recycling or maintained on 
ice to prevent protein traffick- 
ing as a control. The cells were washed three times in PBS, fixed, 
and blocked before being incubated with Alexa Fluor 568-con- 
jugated anti-mouse IgG2A secondary antibody for 30 min to 
label the surface receptors (red). Cells were permeabilized and 
blocked before being incubated with Alexa Fluor 488-conju- 
gated anti-mouse IgG2A secondary antibody for 30 min to label 
internalized receptors that had not recycled back to the plasma 
membrane (green). The level of recycling was plotted as the 
ratio of the average fluorescence intensities of recycled recep- 
tors (red) versus the total of surface and internalized receptors 
(red+green) fluorescence intensities. 
Recycling Assay in Cultured Primary Neurons-Transfected 
neurons were incubated with anti-GFP antibody at room tem- 
perature for 10 min before cells were returned to 37 °C for 30 
min to allow internalization. The cells were gently washed three 
times and labeled with excess unconjugated secondary anti- 
body for 20 min at room temperature to block all remaining 
surface receptors. Supplemental Fig. S1 shows that after the 
20-min incubation with unconjugated secondary antibody, 
labeling of any surface-remaining receptors was blocked. Cells 
were incubated at 37 °C for 30 min to allow recycling or incu- 
bated at room temperature as a control. The cells were washed 
3 times in PBS, fixed in 4% PFA with sucrose, blocked in 10% 
normal goat serum, and incubated with Alexa 568 secondary 
antibody for 30 min to label the surface receptors (red). Cells 
were then permeabilized, blocked, and incubated with Alexa 
Fluor 647-conjugated secondary antibody for 30 min to label 
internalized receptors that had not recycled back to the plasma 
membrane (green). The amount of recycled protein was plotted 
as the ratio of the average fluorescence intensities of recycled 
receptors (red) versus the total of surface and internalized 
receptors (red+green) fluorescence intensities. 
RESULTS AND DISCUSSION 
Use of MHC 11 a- and ß-Chains as Reporter Molecules to 
Study Protein Dimerization and Trafficking-Tac has been 
used as a plasma membrane reporter molecule and has been 
instrumental in defining trafficking and sorting motifs encoded 
in various proteins (11,13,14,19,20). However, these studies 
have been limited by the fact that Tac is a monomer, thereby 
restricting analysis to monomeric receptors or unassembled 
proteins. Therefore, we have now developed a novel approach 
using MHC II proteins to study protein trafficking. MHC II is 
composed of a- and 13-chains that must oligomerize to reach 
the plasma membrane. Furthermore, there are antibodies that 
specifically recognize an extracellular epitope on the fully 
assembled aß-heterodimer (18). We generated several trun- 
cated, cytoplasmic tailless, MHC II a- and 0-chains, and we 
found that when the MHC II ß-chain was expressed alone, it 
was not expressed on the cell surface, whereas coexpression 
with the MHC 11 a-chain led to dimerization and the aß-com- 
plexes were robustly expressed on the cell surface (Fig. 1A, sur- 
face/aß-dimer). To evaluate endocytosis, HeLa cells expressing 
aß-dimers were labeled on ice for 1h with the MHC II aß-het- 
erodimer-specific antibody (L243) and returned to conditioned 
media for 30 min to allow internalization. We observed robust 
steady-state surface expression of tailless aß-dimers (stack 
images) with negligible endocytosis (single-slice images) at both 0 
and 30 min of internalization (Fig. 1 C). Statistical analysis in Fig. IF 
FIGURE I. Tailless MHC 11-aß-dimers are stably expressed on the plasma membrane, whereas MHC II-aß-NR2 chimeras undergo endocytosis. A. MHC 
11 ß-monomers are not expressed on the cell surface unless coexpressed and dimerized with MHC II a-chains. HeLa cells were transiently transfected with MHC 
II ß-chain alone or with MHC II a-chain. For surface staining, live cells were labeled with anti-human MHC II ß-chain antibody (XD5A11) oranti-MHC II aß-dimer 
(L243) antibody as described under 'Experimental Procedures. " In contrast total protein expression was visualized by labeling fixed cells with the J-1-chain 
antibody. 8, schematic diagrams of the MHC II aß-NMDA receptor (NR2 subunit) chimeras are shown. The distal C terminus of NR2A (amino acids 1304-1464) 
or NR2B (amino acids 1315-1482) was appended to the cytosolic domain of the MHC 11 a- and 0-chains. C-E, aß-dimers are robustly expressed on the cell 
surface at steady state at 30 min (C), whereas NR2A (D) and NR2B (E) homodimers undergo internalization. Cells expressing aß, aNR2A-INR2A, or aNR2B- 
$3NR2B dimers were labeled on ice for 30 min before returning to conditioned media at 37 °Cto allow internalization for 30 min. Cells were fixed, permeabilized, 
and labeled with anti-mouse Alexa Fluor 568-conjugated secondary antibody. Images were collected using a 63 x objective at intervals of 0.34 µm. F, aß, 
aNR2A-1NR2A, and aNR2B-(NR2B dimer expression was quantified before and after 30 min of internalization in HeLa cells using National Institutes of Health 
Image) software (n - 11-28, n= 3). Data represent means ± S. E. (error bars) of the fluorescence intensities of aß, aNR2A-1NR2A, and aNR2B-$NR2B dimers. 
Student's ttestwas performed; ", p < 0.001 relative to aNR2A-ßNR2A expression in cells before internalization; "", p <0.01 relative to aNR2B-INR2B expression In cells before Internalization. 
. 
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Regulation of NR2 Trafficking 
also indicates same level of (r/3-dimer expression before and after 
internalization, statistically confirming that aß-dieters do not 
degrade and are stably expressed on the cell surface. 
a/3-NR2A or NR2B Homodimers Undergo Internalization 
We generated chimeras of the truncated MHC 11 a- or 0-chains 
and the distal NR2A or NR2B C-terminal domains (Fig. I B). To 
analyze whether homomeric dimers of the NR2A or NR2B (' 
termini drive endocytosis of surface-expressed MHC II, %Nr 
expressed aNR2A-13NR2A or aNR2B-ONR2B in HeLa cells. 
Robust endocytosis was observed for both NR2A and NR2 
homodimers. After 30 min of internalization, aNR2A-1NR2A 
homodimers exhibited a pronounced reduction in surface 
expression and distinct endosomal 
distribution mainly in the 
perinuclear region 
(Fig. ID). In contrast, aNR2B-13N1: 2ß 
homodimers showed pronounced residual surface expression, 
and they were also present 
in endosomes (Fig. 1E). Quantific. i 
tion of aNR2A-1NR2A and aNR2B-ONR2B 
homodimer 
expression 
before and after internalization in Fig. IF reveal, 
r_. 75%o reduction of 
NR2A homodimer expression after 30 min 
of internalization, whereas 
NR2B homodimer expression is 
only reduced --25% after 
internalization, confirming the dis- 
tinct intracellular sorting pathways of NR2A and NR2B 
homodimers. These data are consistent with NR2A predomi- 
nantly trafficking through the degradation pathway whereas 
NR2B preferentially sorts through recycling endosomes and 
traffics back to the cell surface. These data demonstrate that the 
C-terminal domains of both NR2A and NR2B drive endocytosis 
of homodimers and suggest that NR2A- and NR2B-containing; 
homodimers undergo distinct postendocytic sorting events. 
NR2A Homodimers Traffic to Late Endosomes, whereas NR-'IR 
Homodimers Preferentially Recycle to the Plasma Membrane-We 
next examined the postendocytic 
fate of homomeric aNR2A 
(3NR2A and aNR2B-ONR2B dimers using immunofluorescence 
microscopy. After 30 min of endocytosis, aNR2A-l3NR2A was 
colocalized extensively with GFP-Rab9 in perinuclear 
late endo- 
somes (Fig. 2, A and C), whereas aNR2B-ONR2B homodimers 
were colocalized with GFP-Rab] I in recycling endosomes at or 
near the cell membrane (Fig. 2, B and C). These results show that 
homomeric NR2A dimers preferentially traffic to late endo- 
somes, whereas homomeric NR2B dieters preferentially traf- 
fic to recycling endosomes. This is consistent with previous 
studies showing that NR2B-containing NMDARs pre- 
ferentially recycle, whereas NR2A-containing NMDARs do not 
(14,15). 
aNR2A-(3NR2B Heterodimers Preferentially Sort to Recy- 
clinq Endosomes and Recycle to the Plasma Membrane-It has 
not been possible to evaluate the trafficking itinerary of dihet- 
eromeric and triheteromeric NMDARs due to the lack of spe- 
cific tools to monitor particular subpopulations of receptors. 
To determine the relative contribution of NR2B and NR2A in 
NM DAR trafficking, we next evaluated the postendocytic sort- 
ing itinerary of heteromeric aNR2A-/3NR2B dimers. After 30 
min of endocytosis, aNR2A-1NR2B heterodimers colocalized 
well with GFP-Rabl l and less well with GFP-Rab9 (Fig. 3, A, 
upper panel, and B). Interestingly, aNR2A-J3NR2B dimers 
colocalized particularly well with GFP-Rab] ] on the cell surface 
along the distal edges of the cell in a distribution that is typical 




FIGURE 2. nNR2A-13NR2A dimers traffic to late endosomes following 
endocytosis, whereas tvNR2B-ßNR2B dimers preferentially traffic 
through recycling endosomes. A, homomeric oNR2A-j3NR2A dimers 
colocalize with the late endosomal marker GFP-Rab9 at 30 min of internal- 
ization. 8, homomeric aNR2B-0NR2B dimers colocalize with the recycling 
endosomal marker GFP-Rabl 1. Cells expressing nNR2A-ßNR2A or aNR2B- 
j3NR2B together with GFP-Rab9 or GFP-Rab11 were labeled with MHC II 
rYJ3-dimer (L243) antibody on ice for 45 min and returned to conditioned 
media for 30 min at 37 °C. The cells were fixed and permeabilized, and the 
immunoreactivity was visualized with Alexa Fluor 568-conjugated (red) 
secondary antibody. Images were collected using a 63 X objective at 
intervals of 0.34 µm. Projection images are shown. Arrows indicate colo- 
calization. C, statistical analysis of the amount of colocalization between 
aNR2A-(3NR2A and 0NR2B-(NR2B dimers with GFP-Rab9 or GFP-Rabl 1 
after 30 min of internalization. Colocalization analysis was measured with 
the software NIH Image) Overlap coefficient plug-in. Values represent the 
mean I S. E. (error bars) of overlap coefficient In = 15-20, n= 4). Student's 
t test was performed; ", p-0.01. 
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FIGURE 3. Heterodimers of twNR2A-ßNR2B preferentially traffic through recycling endosomes. A, 
heteromeric aNR2A-1NR2B dimers preferentially sort to recycling endosomes. Cells expressing aNR2A- 
/NR2B and GFP-Rab9 or GFP-Rabl 1 were labeled with MHC II tyß-dimer (L243) antibody on ice for 45 min 
and returned to conditioned media for 30 min at 37 °C. The cells were fixed and permeabilized, and the 
immunoreactivity was visualized with Alexa Fluor 568-conjugated (red) secondary antibody. Images were 
collected using a 63 x objective at intervals of 0.34 µm. Projection images are shown. Arrows indicate 
colocalization. B, statistical analysis of the amount of colocalization between aNR2A-ßNR2B dimers with 
GFP-Rab9 or GFP-Rabl 1. Colocalization analysis was measured with the software NIH Imagel Overlap 
coefficient plug-in. Values represent the mean ± S. E. (error bars) of overlap coefficient (n = 17-25, n= 4). 
Student's t test was performed; ', p<0.01. 
Regulation of NR2 Trafficking 
patterns of nvNR2A-13NR2B het- 
erodimer colocalization with GFP- 
tagged Rab9 and RabI1 are essen- 
tially indistinguishable from that of 
the aNR2B-, BNR2B homodimers. It 
should be noted that the overlap coef- 
ficient of aNR2B-I3NR2B homodi- 
iners (Fig. 2C) and aNR2A-13NR2B 
heterodimers (Fig. 3B) with RabI1 
are not significantly different from 
each other (0.59 versus 0.56). Thus, 
the postendocytic recycling itiner- 
ary of NR2B is dominant over the 
lvsosomal sorting of NR2A in het- 
eromeric complexes. 
To examine heterodimer recycling 
directly, we performed an antibody- 
based recycling assay. We expressed 
the MHC Il-NMDAR chimeras in 
HeLa cells and monitored the amount 
of protein that was recycled over 30 
min. We observed almost no recy- 
cling of homomeric aNR2A-(3NR2A 
dimers (Fig. 4, A and F). By contrast, 
internalized homomeric aNR2B- 
pNR2B dimers, heteromeric aNR2A- 
ONR2B dimers, and heteromeric 
aNR2B-/3NR2A dimers showed sig- 
nificant recycling back to the cell 
surface (Fig. 4, B-E). These results 
are consistent with our colocaliza- 
tion analyses demonstrating that 
NR2B-containing hotnodimers and 
heterodimers preferentially sort 
to recycling endosomes and reveal 
NR2B-dependent recycling of NR2 
heteromers. 
Differential Postendocytic Sorting 
of aNR2A-ONR2A, aNR2B-(3NR2B, 
and aNR2A-/3NR2B Dimers in Hip- 
pocampal Neurons-To determine 
whether these same rules govern 
the sorting of NR2A/NR2B homo- 
and heterodimers in neurons, we 
examined the postendocytic traf- 
ficking of aß-NR2A/NR2B dimers 
in hippocampal neurons. We tran- 
sfected dissociated hippocampal 
neurons with MHC II aNR2A- 
(3NR2A, aNR2B-f NR2B, or aNR2A- 
I3NR2B together with the recycling 
endosomal marker GFP-Rab11 and 
quantified colocalization between 
these proteins. After 30 min of 
internalization, aNR2B-(3NR2B 
showed almost double the amount 
ofcolocalization with GFP-Rab lI as 
aNR2A-/3NR2A (Fig. 5B), consis- 
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FIGURE 4. Homomeric fNR2B-ßNR2B dimers and heteromeric aNR2A- 
ßNR2B or uNR2B-13NR2A dimers recycle to the plasma membrane. 
A, aNR2A-ßNR2A dimers do not recycle to the plasma membrane efficiently. 
B-D, homomeric aNR2B-[3NR2B dimers (B), as well as heteromeric aNR2A- 
)3NR2B (C) and nNR2B-/3NR2A (D) dimers undergo robust recycling. HeLa cells 
expressing nNR2A-MNR2A, cvNR2B-pNR2B, aNR2A-pNR28, or aNR2B-ßNR2A 
were labeled with MHC II-tr(t-dimer (L243) antibody on ice for 1h and 
returned to conditioned media for 30 min at 37 °C. Remaining surface recep- 
tors were blocked with unconjugated secondary antibody. Cells were again 
incubated at 37 °C for 20 min, fixed, and blocked, and recycled receptors were 
labeled with Alexa Fluor 568-conjugated (red) secondary antibody. Cells were 
permeabilized, and internalized receptors were labeled with Alexa Fluor488- 
conjugated secondary antibody. Images were collected at intervals of 0.34 
µm, and projection images are shown. E, dimer recycling in HeLa cells was 
quantified with Metamorph software (n - 20, n- 4). Data represent means 
S. E. (error bars) of the recycled/internalized fluorescence intensities ratios. 
Student's r test was performed; ", p 0.02 relative to 4 °C (CTL); "", p -, 0.02 
relative to recycled cells expressing (YNR2A-3NR2A. 
tent with our findings in HeLa cells that NR2B homodimers 
prefer the recycling pathway compared with NR2A. Most im- 
portantly, trafficking of aNR2B-(3NR2B homodimers and 
aNR2A-(3NR2B heterodimers was indistinguishable in neu- 
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FIGURE 5. Heteromeric aNR2A-13NR2B dimers preferentially traffic 
through recycling endosomes in hippocampal neurons. A, hippocampal 
neurons were transientlytransfected at 9/10 days in vitro with NR2A-fNR2A, 
,, NR2B-13NR2B, or iYNR2A-jiNR2B together with GFP-Rabl 1. Five days after 
transfection, cells were labeled with anti-nß-dimer antibody (L243) for 15 min 
at room temperature, antibody was removed, and neurons were returned to 
conditioned media and incubated at 37 °C for 30 min to allow internalization. 
Cells were fixed, permeabilized, and immunoreactivity was visualized with 
Alexa Fluor 568-conjugated (red) secondary antibody. Arrows indicate colo- 
calization. B, statistical analysis of the amount of colocalization between var- 
ious nß-dimers and the endosomal marker GFP-Rabl 1 is shown. A series of 
optical sections was collected at 0.34 pm using a Zeiss LSM 510 confocal 
microscope. Colocalization analysis was measured with the software Image) 
Overlap coefficient plug-in. Values represent mean - S. E. (error bars) of 
overlap coefficient (n = 14-20, n= 3-4). Student's t test was performed; 
`, p. -0.01. 
rons, with each construct showing a high degree of overlap with 
the recycling endosomal marker GFP-Rab11 (Fig. 5, A and B). 
These data demonstrate that both homomeric aNR2B-ßNR2B 
and heteromeric aNR2A-3NR2B dimers preferentially sorted 
to recycling endosomes in neurons and that the distal C termi- 
nus of NR2B is a dominant regulator of receptor trafficking in 
heterologous cells and neurons. 
Recycling of NR2B Is Unaffected in NR2A Hippocampal 
Neurons-The data presented thus far strongly suggest that in 
vivo heteromers containing NR2B will preferentially recycle at 
synapses. To demonstrate conclusively that the NR2B sorting 
motif is dominant for NMDAR trafficking, we analyzed 
NMDAR recycling in NR2A-deficient neurons. We expressed 
full-length NR2B containing an N-terminal GFP epitope tag in 
hippocampal neurons derived either from wild-type (WT) or 
NR2A knock-out mice (NR2A-'-) and examined NMDAR 
recycling. Quantitative analysis revealed that the amount of 
NR2B recycled back onto the cell surface in NR2A-'- neurons 
was not significantly different from that seen in WT neurons 
(Fig. 6). These data demonstrate that the trafficking of NR2B 
was not affected by NR2A expression and are consistent with 
our findings that NR2B contains dominant sorting signals that 
regulate postendocytic NMDAR trafficking. 
NMDAR endocytosis is developmentally regulated in neu- 
rons such that NMDARs undergo robust endocytosis and rap- 
idly recycle back to the postsynaptic membrane early in devel- 
opment (13,15). At this stage of development, endogenous 
NMDARs contain NR2B, and the dynamic recycling of endog- 
20980 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 " NUMBER 27 -JULY 2,2010 
p CTL 
0.9   Recyded 
I Supplemeidtd Mahn, I can be found at 









FIGURE 6. Recycling of internalized NR2B is not affected in NR2A-'- hip- 
pocampal neurons. A, levels of recycled 
NR2B-containing NMDA receptors 
were not significantly different 
in WT versus NR2A-'- neurons. Cultured hip- 
pocampal neurons (derived from 
WT or NR2A ' mice) were transfected with 
GFP-NR2B at 11 days in vitro. After 3 days, neurons were incubated with anti- 
GFP antibody and incubated in conditioned media at 37°C. Remaining GFP 
antibody-bound receptors on the surface were blocked by unconjugated sec- 
ondary antibody. Neurons were incubated in conditioned media at 37 °C to 
allow recycling. Cells were fixed, and recycled receptors were labeled with 
Alexa Fluor 568-conjugated secondary antibody (red). Internalized receptors 
were visualized by labeling with Alexa Fluor 647-conjugated secondary anti- 
body (green) after permeabilization. B, quantification of NR2B recycling in A is 
shown. Fluorescence intensities were measured using Metamorph software 
(n = 43-46 cells; n=3 independent experiments). The ratios of recycled 
receptors (red) to total (red + green) of GFP-NR2B in WT and NR2A-'- neu- 
rons are presented. The errorbars represent mean _- 
S. E.; n. s., nonspecific; p > 
0.4, Student's t test. 
enous NMDARs early in development fits very well with the 
presence of dominant endocytic and recycling motifs in NR2B 
present in NMDAR heteromers. By contrast, later in develop- 
ment endogenous NMDARs become more stable on the plasma 
membrane. This stabilization corresponds with the increased 
expression of NR2A. Our data show that the NR2A cytosolic 
domain contains endocytic motifs, but the fate of internalized 
JULY 2,2010"VOLUME 285"NUMBER 27 'NQ, L"& 
Regulation of NR2 Trafficking 
NR2A is degradation in lysosomes. lt should be pointed out that 
the different extent of NMDAR endocytosis and recycling 
observed during development is not solely due to differences in 
NR2A/NR2B expression, as other factors such as expression 
of NMDAR-binding proteins or NRI-dependent regulation of 
NMDARs affect NMDAR trafficking and surface expression. 
Nevertheless, our novel use of the heterodimeric MHC 11 pro- 
teins as a reporter has clearly shown that the NR2B cytosolic 
domain can act as a dominant recycling signal and likely con- 
tributes to the developmental differences observed in NMDAR 
trafficking. Furthermore, we anticipate this approach will be a 
valuable tool to dissect out domains and motifs that are impor- 
tant in the trafficking of multirneric protein complexes. 
Acknowledgments- We thank Drs. Juan Bonijacino, James Golden- 
ring, and Stefano Vicini for GFP-Rab9, GFP-Rabl1, and GFP-NR2B 
cDNAs, respectively. We thank the NINDS Light Imaging Facility, 
National Institutes of Health, in particular the faculty manager Dr. 
Carolyn Smith, for advice and expertise in the collection and analysis 
of corfocal images. We acknowledge 1. Nagle and D. Kauffman 
(NJ, V[). S. cequýnrin, ý Frrrilff1) f autn, urrlrýll); V ýrrinw1(t analisiý. 
REFFRFNCf ti 
\Ialinow, R., and Malenka, R. C. (2002) Annu. Rev. Neurosci. 25,103-126 
\Venthold, R. I., Prybylowski, K., Standley, S., Sans, N., and Petralia, R. S. 
12003) Annu. Rev. Pharmacol. Toxicol. 43,335-358 
3. Rredt, D. S., and Nicoll, R. A. (2003) Neuron 40,361-379 
1. Cull-Candy, S. G., and Leszkiewicz, D. N. (2004) Sci. STKE 2004, rel6 
5 , Monyer, H., Burnashev, N., Laurie, D. I., Sakmann, B., and Seeburg, P. H. 
(1994) Neuron 12,529-540 
c,. Sans, N., Petralia, R. S., Wang, Y. X., Blahos, I., 2nd, Hell, J. W., and 
Wenthold, R. I. (2000) J. Neurosci. 20,1260 -1271 
-. Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., and Jan, L. Y. (1994) 
Nature 368,144-147 
8. Lau, C. G., and Zukin, R. S. (2007) Nat. Rev. 8,413-426 
9. Chen, B. S., and Roche, K. W. (2007) Neuropharmacolosy 53,362-368 
10. Lavezzari, G., McCallum, J., Lee, R., and Roche, K. W. (2003) Neurophar- 
macoln y45,729-737 
11. Scott, D. B., Michailidis, I., Mu, Y., Logothetis, D., and Ehlers, M. D. (2004) 
1. Neurosci. 24,7096-7109 
12. Barria, A., and Malinow, R. (2005) Neuron 48,289-301 
13. Roche, K. W., Standley, S., McCallum, I., Dune Ly, C., Ehlers, M. D., and 
Wenthold, R. J. (2001) Nat. Neurosci. 4,794-802 
14. Lavezzari, G.. McCallum, J., Dewey, C. M., and Roche, K. W. (2004) 1. 
Neurosci. 24,6383- 6391 
15. Washbourne, P., Liu, X. B., Jones, E. G., and McAllister, A. K. (2004) /. 
Neurosci. 24,8253 8264 
16. Pinet, V., Vergelli, M., Martin, R., Bakke, 0., and Long, E. O. (1995) Nature 
375,603- 606 
17. Radka, S. F., Machamer, C. E., and Cresswell, P. (1984) Hum. Immun,!. 10, 
177-186 
18. Lampson, L. A., and Levy, R. (1980) J. Immun!. 125,293-299 
19. Hawkins, L. M., Prybylowski, K., Chang, K., Moussan, C., Stephenson, 
F. A., and Wenthold, R. I. (2004) /. BioL Chem. 279,28903-28910 
20. Standley, S., Roche, K. W., McCallum, 1., Sans, N., and Wenthold, R. J. 
(2000) Neuron 28,887-898 
JOURNAL OF BIOLOGICAL CHEMISTRY 20981 
[UNIVERSITY 
OF BRISTOL 
MEDICAL LIBRARY 
WT NR2A-/- 
